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ABSTRACT
All organisms must contend with the consequences of DNA damage, induced by a
variety of both endogenous and exogenous sources. Mechanisms of DNA repair and
DNA damage tolerance are crucial for cellular survival after DNA damage. Translesion
DNA synthesis (TLS) is one such mechanism of DNA damage tolerance which utilizes a
specialized translesion DNA polymerase capable of catalyzing DNA synthesis on
imperfect templates. There are two TLS polymerases present in Escherichia coli encoded
by the dinB (Pol IV) and umuDC (Pol V) gene products. While TLS polymerases provide
a variety of benefits to the cell, it is important that they are properly regulated as they
have reduced fidelity on undamaged DNA compared to replicative DNA polymerases.
Here I present evidence that the essential transcriptional modulator NusA
associates with TLS polymerases in E. coli both physically, as noted for DinB, and
genetically, with DinB and the umuDC gene products. Mutation of nusA renders cells
sensitive to DNA damaging agents and produces phenotypes reminiscent of mutants with
altered DNA processing. Moreover, I report that the nusAll mutation completely
eliminates the formation of adaptive mutants, revealing that nusA+ function is required
for cells to adapt and mutate in response to stress. Though the phenomenon of adaptive
mutagenesis also requires dinB+, my data suggest that the role for nusA in adaptive
mutagenesis extends beyond an interaction with DinB.
Furthermore, I report that NusA in addition to having a role in transcription
elongation is also important for promoting survival after DNA damage. Phenotypes of
nusA mutants are more exaggerated than those of TLS polymerase mutants. Genetic
interactions of nusA+ with the nucleotide excision repair pathway suggest that nusA+ may
play a role in a new class of NusA-dependent transcription coupled repair. Moreover, I
have isolated RNA polymerase mutants with altered ability to survive after DNA
damage, and this altered ability is absolutely dependent on nusA+ and uvrA+.
The completion of translesion DNA synthesis requires both the insertion of a
nucleotide opposite the adducted template base and extension from that position by
several subsequent nucleotide additions. We present evidence that DinB is specialized to
perform strikingly proficient extension after insertion opposite an N2-dG lesion. Our data
indicate that cellular survival is coupled to completion of TLS and regulation of these
precise steps in vivo is genetically complex and involves the toxin-antitoxin module
MazEF and the iron import protein TonB.
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Chapter 1
Introduction
Portions of this introduction were published in Y-family DNA polymerases in
Escherichia coli. Daniel F. Jarosz, Penny J. Beuning, Susan E. Cohen, and Graham C.
Walker. Trends in Microbiology 2007; 15(2):70 and Lyle A. Simmons, James J. Foti,
Susan E. Cohen, and Graham C. Walker. Chapter 5.4.3, The SOS Regulatory Network.
Escherichia coli and Salmonella: cellular and molecular biology.
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Overview
Cellular DNA can be damaged by a wide variety of both endogenous and
exogenous sources (23). It is estimated that that nearly 10,000 abasic sites are
spontaneously generated in a single eukaryotic cell each day (69), and this statistic is for
only one type of DNA damage. If ensuing lesions are left unrepaired, they may lead not
only to mutagenesis but also to replication fork collapse, chromosomal breakage and
potentially result in cell death. Given the huge spectrum of genomic insults cells must
deal with, it is no surprise that all organisms have evolved a variety of mechanisms to
deal with DNA damage. Mechanisms of DNA repair, which restore the DNA to its
original undamaged state, and DNA damage tolerance, involving the replication of
damaged DNA, are of great importance to human health as mutations in these pathways
result in a variety of cancers and diseases. Here I will provide an introduction on the
many ways cells deal with the problem of DNA damage. My graduate work has primarily
focused on the DNA damage tolerance pathway of translesion DNA synthesis (TLS) in
Escherichia coli.
The SOS Response
SOS, an acronym used as the international distress signal, also describes the
induced cellular response after genotoxic stress in E. coli. Control of the SOS response is
dependent upon the lexA+ and recA+ gene products. LexA, the transcriptional repressor
of the SOS response, binds as a dimer to imperfect palindromic operator sequences
present in the promoters of SOS-regulated genes, also referred to as SOS boxes,
inhibiting transcription of downstream genes (23). The recA+ gene product is important
for not only the induction of the SOS response but also for many other aspects of the
cell's ability to deal with DNA damage, including homologous recombination and
translesion DNA synthesis. After DNA damage has occurred, continued activity of the
helicase ahead of the blocked replication fork leads to accumulation of ssDNA. RecA
binds to this single-stranded DNA (ssDNA), forming a nucleoprotein filament in the
presence of nucleoside triphosphates. This filament stimulates a latent autoproteolytic
activity of LexA, causing LexA to cleave itself into two halves of roughly equal size (38).
This cleavage inactivates LexA as a transcriptional repressor and enabling the expression
greater than 50 genes, many of which are involved in DNA repair or DNA damage
tolerance (117) (Figure 1, sections i and ii). Induction of genes in the SOS regulon
ranges from 4-5 fold to 100 fold, due in part to the strength in which LexA binds to
particular SOS boxes and the position of the SOS box relative to the promoter (23). lexA+
itself is induced as part of the SOS regulon, ensuring that after the DNA damage has been
dealt with, LexA levels are restored and SOS returned to an uninduced state.
Identification of genes regulated as part of the SOS network
Genes regulated as part of the SOS response have been identified by the use of
gene-fusions, computational searches for consensus SOS boxes and through microarray
analysis examining gene expression after exposure to DNA damaging agents (15, 46, 67,
134). In the first approach, the bacteriophage Mu dl was used to generate random
promoterless fusions carrying the structural genes for the lac operon. Using this
technique, a collection of E. coli strains bearing these fusions was used to identify genes
that displayed a damage inducible (din) phenotype even before the details of the SOS
response had been determined. The inducible expression of P-galactosidase displayed by
some of these fusions after treatment with ultraviolet radiation (UV) or mitomycin C
(MMC) was dependent on recA+ and lexA+ (46). Many of the din genes and their gene
products have still not been characterized in detail. Since then a set of SOS inducible
genes have been identified by the identification of LexA binding sites (SOS boxes)
within the E. coli genome (19, 67, 134), bringing the number of SOS regulated genes to
31 (23). Recent microarray analysis of E. coli strains irradiated with UV has identified
several more genes that are regulated as part of the SOS network in a lexA+ dependent
fashion (15). Curiously, lexA independent induction of gene expression as well as gene
expression that decreased after UV irradiation were also observed (15). Intriguingly,
agents that do not damage DNA, such as p-lactam antibiotics can also induce the SOS
response through the two-component signal transduction system dpiBA (83). This
observation raises the possibility that crosstalk between the SOS response and other
cellular signaling pathways could be more extensive than previously realized. Finally, the
SOS response is one component of a broader cellular response to DNA damage.
Exposure of E. coli to the DNA-damaging agent MMC results in expression changes of
>1000 genes (47). These results indicate that a simplistic view of the SOS response is far
from complete, and suggests that other transcriptional networks may be involved in
regulating gene expression in response to DNA damage as well as to various other stress
responses.
Chronic partial SOS induction
Even without exposure to exogenous DNA damage, the SOS response can
become induced by mutations in genes that affect DNA metabolism. Several mutations
have been identified that display chronic partial SOS induction, which presumably results
in difficulty repairing endogenous DNA damage. Some of these genes include uvrD
(3'-+5' DNA helicase II) (96), dam (GATC-specific DNA methylase) (73, 99), polA
(DNA pol I) (3), dnaQ (3'-5' exonuclease epsilon subunit of DNA pol III) (68, 118), and
priA (primosome component/3'-*5' DNA helicase) (90, 107). A missense mutation in the
3 clamp, an essential component of the replicative DNA pol III, also elicits chronic
partial SOS induction (119). Additionally, genetic screens have isolated 42 transposon
insertion mutants that display chronic partial SOS induction (91). As expected the
majority of mutants isolated in this screen have known functions in the synthesis and
repair of DNA. However also isolated were several genes involved in membrane
structure and function, comprising a new class of constitutive SOS mutants. Is this
chronic partial SOS induction manifested through low levels of SOS induction
throughout the entire population of cells or by high levels of SOS induction in only a sub-
population of cells? Using a GFP reporter placed under the control of an SOS regulated
promoter (PsulA) it was found that for many of these mutations chronic partial SOS
induction is due to a high degree of SOS induction in a sub-population of cells (79).
These data suggest that even under normal growth conditions; these mutants with altered
ability to maintain chromosome integrity induce the SOS response in only a sub-
population of cells. This is in contrast to specific mutations in lexA or recA in which all
cells are induced for the SOS response.
DNA damage repair
Repair of damaged DNA is defined as the restoration of DNA to an undamaged
state and can occur through mechanisms of direct reversal or excision repair (Figure 2).
Direct reversal of DNA damage, used for only a few types of lesions, usually involves a
single protein which catalyzes a single step required to restore the DNA to its native state.
For example, the Ada protein of E. coli irreversibly catalyzes the transfer of alkyl groups
from the damaged DNA onto itself (78) and the universal enzyme photolyase found from
bacteria to humans, reverses the covalent linkage of two adjacent pyrmidines resulting in
the original pyrimidine monomers (23). Excision of the damaged base and synthesis of
new DNA can occur through repair mechanisms of mismatch repair (MMR), base
excision repair (BER) or nucleotide excision repair (NER). MMR recognizes DNA
mismatches produced during DNA replication or by deamination events (23, 56, 110).
BER, which primarily acts on endogenously generated oxidative and hydrolytic damage,
utilizes a glycosylase to remove the damaged base, leaving behind an abasic site. In E.
coli this abasic site is then removed by an endonuclease and deoxyribophosphodiesterase,
with the ensuing gap filled in by DNA pol I and remaining nick sealed by DNA ligase.
NER, on the other hand, acts on all unnatural base modifications and is the only
mechanism for repair of bulky adducts. The process of NER in E. coli is mediated
through the concerted action of the uvrA, uvrB and uvrC gene products resulting in
excision of a patch of DNA that includes the damaged nucleotide. This step-wise process
is initiated by the (UvrA)2UvrB complex, required for the recognition and binding of
damaged DNA, after which UvrA dissociates from the complex (94, 106). The UvrB-
DNA complex is recognized by UvrC, binding of UvrC induces a conformational change
in UvrB, resulting in the incision of the damaged strand on either side of the damaged
base. Following nicking UvrD, also called DNA helicase II, mediates release of the
oligonucleotide fragment (12-13 nucleotides in length) (95). Completion of NER
requires that the gap be filled in by DNA pol I and sealed by DNA ligase.
Transcription coupled repair
Nucleotide excision repair can occur through two distinctive pathways, global
NER (described above) and transcription-coupled NER, also known as transcription
coupled repair (TCR). It has been appreciated for many years that lesions that block
replication by replicative DNA polymerase can also stall RNA polymerase (RNAP),
leading to inhibition of transcription. Transcription coupled repair targets nucleotide
excision repair processes to actively transcribed genes, resulting in preferential repair of
the transcribed strand relative to the untranscribed strand (5, 82). In bacterial cells the
mfdc gene product couples the process of NER to transcription and is also known as the
transcription coupling repair factor (TCRF) (111, 112). The phenomenon of mutation
frequency decline, noted by Evelyn Witkin in the 1950's, describes the loss of UV
induced mutations when the E. coli culture is held under conditions that inhibit protein
synthesis (139, 140). Mfd recognizes RNA polymerases stalled at sites of DNA damage
and is capable of translocating or backtracking the RNAP, exposing the DNA lesion.
Then through a domain homologous to UvrB, Mfd recruits UvrA to this site of damage,
initiating the process of NER. Further investigation has shown that Mfd, highly
conserved among bacteria, stimulates the nucleotide excision activity of UvrABC in vitro
(112). Eukaryotes also perform transcription-coupled repair, in humans, defects in genes
involved in TCR result in hereditary disorders such as xeroderma pigmentosum (XP),
Cockayne's syndrome (CS) and trichothio-dystrophy (TTD) (35). The human
transcription repair coupling factor (TRCF) gene has been identified as ERCC6 also
known as CSB (129). Despite the fact that ERCC6/CSB and mfd share no significant
sequence homology, they are structurally and functionally homologous.
DNA damage tolerance
Mechanisms of DNA damage tolerance, in which the lesion remains in the DNA
through the replication of the damaged template, also play an important role in the cell.
This is in contrast to repair mechanisms in which DNA lesions are removed, restoring
DNA to an undamaged state. Although not generally considered the first line of defense
after DNA damage, tolerance mechanisms are crucial for cellular survival after DNA
damage (23). There are two main branches of DNA damage tolerance: recombinational
or template switching strategies that avoid using the lesion as a template and translesion
synthesis in which specialized DNA polymerases can replicate over lesions, often in a
mutagenic manner. Replication fork regression, also referred to as template switching, is
one mechanism used to rescue stalled replication forks and allow for bypass of lesion in
an error free manner. Upon encountering a replication blocking lesion, the replication
fork may migrate backwards, resulting in re-annealing of the two original templates and
annealing of the newly synthesized strands. DNA synthesis past the site of the lesion by
using one of the newly synthesized strands as a template, results in bypass of the lesion.
Fork regression reversal then allows for continuation of DNA replication in an error-free
manner, meaning that the newly synthesized DNA doesn't carry any mutations, as an
undamaged strand was used as the template rather than the damaged template strand
(Figure 2). This is in contrast to the process of translesion DNA synthesis, which
involves direct replication of the damaged template and is potentially error-prone. The
process of translesion DNA synthesis (TLS) will be discussed in greater detail (see
below).
Daughter strand gaps
While there exist a variety of mechanisms to either repair or tolerate DNA
damage, DNA synthesis can re-initiate downstream of a blocked replication fork, leaving
behind a lesion containing ssDNA gap. In 1968, Rupp and Howard-Flanders noticed that
when E. coli lacking uvrA (NER) activity were irradiated with UV, they accumulated
fragments of newly synthesized DNA that were initially smaller than in un-irradiated
controls (104). These smaller DNA fragments eventually, with time, became converted
to higher molecular weight DNA, approaching that of undamaged DNA. DNA synthesis
required to fill in gaps, corresponding to the low molecular weight fragments, is also
referred to as post-replicative repair and implies that DNA synthesis can occur in a
discontinuous manner. It was thought for many years that daughter strand gaps could
only generated on the lagging strand, with replication resuming at the site of the next
Okazaki fragment. However, there is now evidence that gaps can be formed on the
leading strand as well. In vitro studies in E. coli have found that origin independent
replication restart can occur downstream of blocked replication fork on the leading
strand, resulting in the formation of a gap on the leading strand (37). Furthermore in S.
cerevisiae, daughter strand gaps have been visualized in vivo on both the leading and
lagging strands (74). These daughter strand gaps have been estimated to be
approximately 1000 nucleotides in length (37, 39, 53, 104), and can be repaired by
recombinational exchange. Using the homologous sequence from a homologous
chromosome, which has presumably completed replication, these gaps can be filled in
without the loss of any genetic material or introduction of new mutations (105).
However, newly emerging models have suggested that some of these lesion containing
gaps are filled in by TLS polymerases (14, 37, 65, 74, 138).
Translesion DNA Synthesis
One important mechanism of DNA damage tolerance is translesion DNA
synthesis (TLS), a process in which a specialized DNA polymerase copies past DNA
lesions that block the highly accurate, stringent replicative DNA polymerases. TLS
polymerases are conserved throughout all domains of life, with the majority being
members of the Y-family of DNA polymerases (92). Whereas TLS polymerases share no
clear sequence homology with replicative polymerases, their tertiary structures reveal a
similar right-hand fold consisting of a thumb, palm and fingers domain (Figure 3). Y-
family polymerases have an additional little-finger domain that seems to play an
important part in both substrate specificity and processivity (6). Unlike the tight grip seen
in active sites of canonical DNA polymerases (42), some Y-family polymerases may
have open active sites that are relatively solvent accessible. Moreover, an a-helix
responsible for several orders of magnitude of fidelity by sterically checking the correct
geometry of the newly-forming base pair in canonical DNA polymerases (the O helix) is
entirely absent in Y-family polymerases (Figure 3). These structural features provide an
explanation for the comparatively low fidelity of Y-family polymerases relative to
replicative polymerases when replicating undamaged DNA. For example, E. coli DinB
has an error rate of 10-4- 10 -5 compared to 10 7 for the replicative polymerases. In addition,
it appears that, each of the Y-family polymerases is specialized to insert the appropriate
nucleotide opposite a cognate lesion (discussed below).
Y-family of DNA polymerases
While Y-family DNA polymerases are present in all domains of life, they are not
evenly distributed between them (92). The UmuC family of DNA polymerases is only
present in bacteria, while family members Revl, Pol l (Rad30A), and Pol t (Rad30B) are
specific to eukaryotes. DinB is the most ubiquitous Y-family DNA polymerase, having
homologs in bacteria, eukaryotes and archaea. Of the eukaryotic members, Pol 1 has
received the most attention, as loss of Pol r activity in humans results in the cancer-prone
syndrome xeroderma pigmentosum variant (XPV), characterized by an increased
incidence of skin cancers and sensitivity to sunlight. XPV is similar to the other forms of
xeroderma pigmentosum, which result from mutations in nucleotide excision repair and
transcription coupled repair. However the other eukaryotic TLS polymerases are also
important for damaged induced mutagenesis and thought to be important for somatic
hymermutation and immunoglobulin diversification (11).
Escherichia coli has two TLS polymerases, DinB (pol IV) and UmuD'2C (pol V),
both of which are transcriptionally induced as part of the SOS network. Mutants of umuD
and umuC display modest sensitivity to UV (23) and abolish mutagenesis induced by UV
irradiation and thus have been termed un-mutable (umu) (45). In contrast phenotypes of
dinB mutants, originally isolated as a damaged inducible gene using Mu dl fusions
described above (46), have been more enigmatic (25), and will be discussed in greater
detail below.
Substrate specificity of TLS polymerases
DinB is capable of bypassing several N2-dG adducts including N2-furfuryl-dG
(40), DNA-peptide crosslinks (84), N2 N2 interstrand cross-link intermediates (55), and
N2-1 -carboxyethyl-dG (143). In contrast, UmuD'2C has a much broader substrate
specificity. In vitro Pol V has been found to bypass abasic sites (97, 124), the two major
UV lesions cyclobutane pyrimidine dimmers and 6-4 (T-T) photoproducts (123), as well
as several covalent adducts on the C8 position of a template G (88, 114). These lesions
were bypassed with varying efficiencies and fidelities. The eukaryotic TLS polymerases
pol K and pol rl, have similar substrate specificities to that of DinB and UmuD'2C
respectively. pol K has been implicated in the bypass of mismatched primer template ends
(52, 136), thymine glycols (20), and can proficiently and accurately bypass bulky
covalent modifications at the N2 position of guanine (2, 40, 122, 142). In contrast, pol q
acts primarily in preferential and accurate bypass of cyclobutane pyrimidine dimers (41,
80, 135), and also participates in modest bypass of thymine glycols (57) and intrastrand
crosslinks induced by the chemotheraputic agent cisplatin (130).
The TLS polymerase Revl, isolated by virtue of its reversionless phenotype after
UV irradiation (66), is perhaps the most uniquely adapted TLS polymerase. Revl has a
limited catalytic activity restricted to inserting dCMP across from template G's and is
important for the bypass of abasic sites and certain covalently adducted guanine residues
(60, 89, 137). Rev1 is not capable of bypassing UV induced lesions in vitro, however
revl is required for -95% of all UV induced base pair substitutions (61). Moreover the
catalytic activities of Rev 1 are dispensable for cellular survival after most DNA
damaging agents, leading to the idea that the major role for Revl is as a protein-protein
interaction scaffold, required to recruit and coordinate other DNA damage tolerance
factors at the sites of DNA lesions (33, 36, 125).
Complete TLS involves insertion of a nucleotide opposite an adducted base (i.e.
lesion bypass) and extension from that position by several subsequent nucleotide
additions. Replication by the TLS polymerase must continue for several nucleotides
beyond the site of DNA damage, greater than 5 nucleotides in the case of pol V in E.
coli, in order to avoid reversal by the proofreading activity of the replicative DNA
polymerase (26). In eukaryotes, these steps are often catalyzed by at least two distinct
DNA polymerases (102). The increased number of TLS polymerases in a eukaryotic cell
may allow for the separation of the insertion and extension phases. Specifically DNA
polymerase , a TLS polymerase belonging to the B-family of DNA polymerases in
eukaryotes, seems to be particularly specialized for the extension phases of TLS (60,
102). In prokaryotes, the insertion and extension steps of TLS seem to be performed by a
single TLS polymerase. In particular, DinB catalyzes strikingly proficient extension after
insertion opposite a N2-furfuryl-dG lesion, and will be discussed in greater detail in
Chapter 5.
umuDC
The umuD and umuC genes, present in an operon, encode for the components of
translesion DNA polymerase, DNA pol V. Despite the fact that there are three DNA
polymerases induced as part of the SOS response, DNA pol V is thought to be the major
polymerase responsible for damaged-induced mutagenesis in E. coli. UmuD shares
significant homology to the SOS transcriptional repressor LexA, both in sequence and
structure (23). Similar to LexA, UmuD forms a homodimer in solution and undergoes a
RecA-nucleoprotein activated auto-digestion, removing its N-terminal 24 amino acids to
form the truncated product UmuD'2. It is upon binding this form (UmuD'2) that UmuC,
the catalytic component of DNA pol V, becomes active as TLS polymerase. This
additional layer of regulation, where UmuD is cleaved to UmuD' over the time frame of
20-30 minutes (120) is important for the timing of TLS relative to other forms of DNA
repair induced by the SOS response, allowing for TLS activity only when needed.
Overexpression of the umuDC gene products leads to inhibition of growth at 300C, a
phenomenon referred to as umuDC-mediated cold sensitivity. Cold sensitivity seems to
result from an exaggeration of a primitive DNA-damage induced checkpoint in which
UmuD2C delays the resumption of DNA synthesis after DNA damage to enable error-free
repair processes to occur (93, 121). Phenotypes of UmuD'2C are reminiscent to those of
pol ri, in that they are both required for UV induced mutagenesis, capable of bypassing
UV lesions in vitro, and both are thought to be the major polymerases required for the
bypass of these lesions in vivo (41, 80, 123, 135). Computational modeling studies have
bolstered the notion that the eukaryotic TLS polymerase DNA pol r is a functional
homolog of UmuD' 2C (64).
DinB
Isolated in 1980 as a damage inducible (din) gene (46), the dinB gene product was
not found to be a DNA polymerase (pol IV) for two more decades (133), and even for
several years after that the physiological role of dinB in vivo remained unclear. While
deletion of the dinB+ gene has almost no discernable effect on spontaneous mutagenesis
(54), dinB+ has been found to be required for untargeted mutagenesis of k phage. In this
phenomenon E. coli are UV-irradiated and transfected with unirradiated k phage, but
surprisingly UV-induced mutagenesis is seen in the k DNA (7). The mutation spectrum
observed is distributed between base substitution mutations and -1 frameshift events with
a strong preference for mutation at G:C base pairs. DinB is the most conserved TLS
polymerase, present in all domains of life, and in fact is the most abundant DNA
polymerase after DNA damage in E. coli. However, it was difficult to believe that these
subtle in vivo phenotypes associated with dinB accounted for its striking conservation,
and implied that there was still much to be discovered.
Several lines of investigation have pointed that one of DinB's specialized
functions is in -1 frameshift mutagenesis. Overproduction of dinB+ leads to an increase
in spontaneous and 4-nitroquinoline- -oxide (4-NQO) induced -1 frameshifts and, to a
lesser extent, spontaneous base substitutions (49, 50). Specifically, overexpression of
DinB resulted in an approximately 800 fold increase in spontaneous - 1 frameshifts
occurring in a run of six G:C base pairs (49, 103).
The dinB+ gene is also important for the phenomenon of adaptive mutagenesis in
E. coli. Adaptive mutagenesis describes the accumulation of mutations that occur in non-
growing cells, and is also referred to as stress-induced or stationary phase mutagenesis.
Adaptive mutagenesis is monitored by the reversion of a lac allele, allowing for cells that
accumulate compensatory mutations to now grow on lactose minimal medium. When E.
coli are starved for a carbon source and plated onto minimal lactose medium, Lac+
mutants occur at a rate of approximately 10-7 per cell per day for about 7 days within a
lacI-lacZ fusion with a +1 frameshift (fs) in a run of G:C base pairs on a conjugal
plasmid (9). Adaptive mutations nearly always almost result from a -1 fs in a run of
consecutive bases (22, 103), and mutations of dinB result in loss of 50 to 80 percent of
adaptive mutants (21, 81).
Another mutant that is deficient for adaptive mutagenesis is the stationary phase
sigma factor, encoded by the rpoS gene (62). It was found that this is due in part to the
fact that rpoS regulates dinB transcript levels, in addition to the regulation of dinB as part
of the SOS response. Additionally it has been reported that dinB expression can become
induced in the presence of 3-lactam antibiotics, in an SOS independent manner (98).
These observations underscore the notion that the regulation of DinB is genetically
complex.
Recent studies have shed light onto native DinB function in vivo and suggest that
DinB maybe conserved to replicate a class of ubiquitously occurring N2-dG DNA
adducts. AdinB strains of E. coli have been found to display increased sensitivity to the
DNA damaging agents nitrofurazone (NFZ) and 4-NQO, which cause a significant
fraction of N2-dG lesions (40). Despite this marked sensitivity to both NFZ and 4-NQO,
deletion of the dinB+ gene does not reduce mutagenesis induced by either agent (40).
These data suggest that the dinB+ gene product is able to contend with DNA damage
produced by at least some DNA damaging agents with comparable fidelity to other repair
processes available to the E. coli cell. Strikingly, it has been discovered that purified
DinB is 15-fold more proficient at adding dC opposite N2-furfuryl-dG, a structural analog
of a lesion generated by nitrofurazone, than it is opposite undamaged DNA (40). This
preference is conserved evolutionarily as DinB orthologue pol K from M musculus
displays similar specificity for replicating N2-furfuryl-dG containing templates (40).
DinB bypass of an N2-furfuryl-dG lesion is not only proficient but is also relatively
accurate, with misinsertion frequencies between 10-3 and 10-5 (40). Furthermore, this
preferential activity on certain damaged templates is governed by DinB's 'steric gate'
residue (F 13). Mutation of this residue to valine (F13V) completely eliminates DinB's
ability to bypass an N2-furfuryl-dG lesion (40). These data suggest that at least one
reason for the DinB conservation throughout evolution is to catalyze TLS across from
ubiquitously occurring N2-dG adducts.
Regulation of TLS polymerases by protein-protein interactions
While TLS polymerases provide a variety of benefits to the cell, it is extremely
important that their activity is properly regulated as they display reduced fidelity on
undamaged DNA relative to replicative polymerases. In addition to transcriptional
regulation through the SOS response, TLS polymerases are regulated by their interactions
with other proteins. Genetic characterization over the past 30 years has underscored the
importance of the recA and umuD gene products in regulation of umuC-dependent
mutagenesis (23). Initial reports of UmuD'2C polymerase activity invoked a requirement
for UmuD'2 , RecA, ssDNA binding protein (SSB) and, in one case, various components
of the polymerase III holoenzyme for UmuC activity (27). The demonstration of
polymerase activity of UmuD'2C established UmuD'2 as a subunit of DNA pol V (124).
The RecA nucleoprotein filament has also been found to be important for efficient
UmuD'2C mediated lesion bypass. It was originally assumed that the RecA bound to the
ssDNA template in this activating role, but it has now been proposed that stimulation of
UmuD'2C activity by the RecA-nucleoprotein filament occurs in trans (108). This has
important implications for models of UmuD'2C action given that the most proficient
transactivating RecA nucleoprotein filament is one formed on gapped DNA. Recent
studies have discovered that regulation by RecA and the umuD gene products extends to
DinB as well as UmuC (see below) (29).
The mutagenic functions of both UmuD'2C and DinB are also affected by
interactions with the molecular chaperone GroEL and the P processivity clamp (16, 29,
76, 132). Mutations in groE are defective for umuDC-dependent UV induced
mutagenesis (17) and also display reduced adaptive mutagenesis, only expressing approx.
I/10th the normal levels of DinB (63). Furthermore, it has been reported that
overexpression of GroEL helps to increase the fitness of cells which have been
accumulating mutations due to increased expression of DinB in Salmonella (75).
Interactions with replicative processivity clamps are crucial for regulating Y-
family polymerase activity and dictating their access to DNA. Although they are
characterized by low processivity on undamaged DNA, Y-family polymerases exhibit an
increased processivity in the presence of the P clamp. Indeed, DinB processivity is
enhanced 300 fold by the P clamp (132), whereas that of UmuC is stimulated between 5-
and 100- fold (27, 76). In either case, the processivity enhancement as a result of P is far
less than that of polymerase III (-105-fold) (53). Mutation or deletion of the 3 interaction
motif in either UmuC or DinB causes a loss of translesion synthesis in vivo (4). In
eukaryotes, polymerase management is even more complex. The processivity clamp
PCNA is subject to several different post-translational modifications that dictate its roles
in replication, DNA repair and DNA damage tolerance mediated by Y-family DNA
polymerases (44, 100). Specifically, the mono-ubiquinated form of PCNA is important
for the recruitment of TLS polymerases to sites of damaged DNA (85). Moreover, the
alternative processivity clamp in eukaryotes (Rad9-Radl-Husl) is important for
modulating the activity of Y-family polymerases (100).
A recent study employing a DinB affinity column was used to search for potential
DinB-interacting proteins within lysates of cells that constitutively express the SOS
response. This study found that surprisingly, RecA, UmuD, and UmuD' physically
interact with and regulate DinB function, in addition to their previously known roles in
regulating UmuC. Moreover, these proteins are important for regulating DinB's -1
frameshift activity (29). Characterization of this complex has led to a model where RecA
and UmuD may bind and enclose DinB's otherwise open active site. Extension of this
study has identified the essential transcriptional modulator NusA as an additional
interaction partner and will be discussed in greater detail in Chapter 2. The major focus
of my work has been to characterize the interaction between DinB and NusA.
NusA is a general transcription elongation factor
nusA+ function is indispensable for the viability of bacteria and was originally
discovered for its requirement in k phage development. Mutants of nusA (nusAl) inhibit
k phage development (24). This inhibition arises from the inability of mutant NusA
proteins to bind the phage X protein N and effect antitermination of the k genome, thereby
allowing RNA polymerase (RNAP) to read through transcription terminators and express
the late genes of X phage. nusA was thus named for N utilization substance A. It has also
recently been discovered that NusA forms a shield with kQ protein to protect the
emerging transcript from termination mechanisms (113).
In E. coli, the nusA gene encodes an essential transcription factor associated with
both termination and antitermination of transcription (12, 18, 30, 58, 70, 72, 109),
furthermore nusA has been characterized as one of 206 genes making up the minimal
bacterial gene set (28), and has orthologs present in archaea as well. Transcription by
RNA polymerase proceeds in a series of steps, notably initiation, elongation and
termination. In contrast to eukaryotes which possess three forms of RNAP, in bacterial
systems, there is only one RNAP comprised of the P and P' catalytic subunits, two a and a
(o subunit. Transcription is initiated with the help of a sigma (o) subunit that recognizes
and binds promoter elements in a sequence specific manner, of which there several in E.
coli. NusA is a key modulator of RNAP that induces pausing of RNAP during the
elongation and termination steps of transcription. Effects of NusA on transcription
elongation have seemed contradictory and the molecular mechanism of RNAP pausing
induced by NusA remains unclear and complicated. In vitro, NusA has been shown to
slow down the rate of transcription elongation (59, 109, 115), and preferentially enhances
pausing associated with nascent RNA hairpins (1, 18, 32, 141). NusA is required for the
termination of the tR2 transcript (32), attenuated leader regions of the rrnB and his
operons (13, 51), and at the trp operon (18). In contrast or counterintuitively, roles for
NusA also extend to the antitermination of transcription. Specifically, NusA is an
essential component of antitermination complexes that form on ribosomal RNA (rrn) and
phage k operons (77, 113, 126). NusA, then known as the L factor, was shown to be
required for -galactosidase expression in vitro and necessary for antitermination at a
Rho sensitive terminator within the lacZ coding region (31). Furthermore, in vivo
synthesis of P-galatosidase is reduced in the nusAll background (31), where the nusAll
mutation is a conditional lethal allele that permits growth at 300 C but not at 420 C (87).
Transcription termination occurs through either Rho-dependent or Rho-independent
mechanisms. NusA has been shown to both inhibit (8, 59, 115) and stimulate (43) Rho-
dependent termination.
NusA is an essential gene in E. coli and is conserved in even the smallest of
bacterial genomes, however nusA function has been found to be dispensable in specific
situations. Specifically, it has been reported that under altered Rho function, deletion of
nusA results in viable cells (144). Though deletion of nusA in this background resulted in
slow growth (120 minute doubling time) compared to the rho isogenic parent (40 minute
doubling time), it was the first report of a viable nusA deletion strain. These results led to
the hypothesis that the essential function of NusA was to enhance RNAP pausing,
allowing for the coupling of transcription and translation (144). However, this theory
does not explain why NusA is also essential in organisms that lack Rho. More recently it
has been reported that nusA can be deleted in reduced genome background (10), in which
14 percent of the E. coli genome has been removed, by the targeted deletion of
horizontally acquired DNA (101). Analysis of this mutant revealed that nusA function
was required for the suppression of cryptic prophage, specifically the rac prophage,
expression. This mutant also displays a slow growth phenotype. Together, these results
have specified conditions under which nusA function is no longer essential and identified
additional alleles for the study of nusA and transcription elongation.
Association of NusA with RNA polymerase
The NusA protein has three separate domains: an N-terminal domain required for
binding to RNA polymerase, an internal region with RNA binding motifs, and a C-
terminal autoinhibitory domain. Details of the NusA-RNAP interaction such as where
specifically NusA associates with RNAP and how many molecules of NusA are
associated with elongating RNAP's have remained elusive. NusA has been found to
compete with sigma factor (o) for binding to RNAP (131), and NusA has been found to
associate with the core RNAP, but not holoenzyme containing 070 in vitro (32).
Consistent with this finding, NusA has been found by ChIP-chip experiments to be
uniformly associated with elongation complexes and was only found bound to RNAP
after a70 (the housekeeping sigma factor) dissociation, which occurs after the RNAP
escapes from the promoter (86). Additionally crosslinking experiments have found NusA
bound to the a (71), 0 (34, 71, 113, 127) and 03' (128)subunits of RNAP, and it has been
hypothesized that NusA binds near the RNA exit channel. While the role for nusA in
transcription has been appreciated for many years, my work has focused on uncovering a
role for nusA+ in the DNA repair/damage tolerance.
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Figure 1. The SOS response to DNA damage. (i) The inducing signal for the SOS
response forms when RecA polymerizes on a region of ssDNA, which is formed as a
result of the failure to replicate damaged DNA. (ii) Binding to RecA-ssDNA
nucleoprotein filament induces LexA to undergo autoproteolytic cleavage, which
inactivates it as a transcriptional repressor and leads to induction of at least 50 genes,
among which are those that encode the Y-family DNA polymerases UmuD'2C and DinB.
(iii) The cleavage of UmuD to UmuD' is also facilitated by the binding of UmuD2 to the
RecA-ssDNA nucleoprotein filament, which provides temporal regulation of the
potentially mutagenic translesion synthesis activity of UmuC. (iv) Activation of the SOS
response is also regulated by dpiBA and p-lactam antibiotics.
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Figure 3. X-ray structures reveal key mechanistic details of TLS. (A) The structure of
Bacillus stearothermophilus replicative DNA polymerase I in a closed conformation (48)
shows numerous close protein (yellow) contacts with DNA (red). An a-helix (orange)
performs a geometric check to ensure the fidelity of the incipient base pair (blue). (B) By
contrast, the Y-family polymerase Dpo4 from Sulfolobus solfataricus (116) shows a loose
grip on the DNA, a relatively open active site, and has no a-helix to check the geometry
of the incipient base pair.
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Figure 2. DNA repair vs. DNA damage tolerance. DNA damage can be generated by
endogenous or exogenous sources. (i)The resulting DNA lesion, designated by the red
triangle, can be removed through DNA repair mechanism of direct reversal or excision
repair, resulting in undamaged DNA. (ii) Damage tolerance through fork regression.
Replication stalled by a DNA lesion can migrate backward, re-annealing of the original
templates allowing for the newly synthesized strands to anneal. DNA synthesis past the
site of the lesion using the newly synthesized daughter strand as a template (shown in
blue) and reverse regression allow for continuous DNA synthesis. (iii) DNA damage
tolerance mechanism of translesion DNA synthesis, utilized a translesion DNA
polymerase to replicate the damaged template.
Chapter 2
Transcriptional Modulator NusA Interacts with Translesion DNA
Polymerases in Escherichia coli
This chapter was previously published as Susan E. Cohen, Veronica G. Godoy, and
Graham C. Walker (2009) "Transcriptional Modulator NusA Interacts with Translesion
DNA Polymerases in Escherichia coli." Journal of Bacteriology. 191: 665-672. I am co-
first author on this manuscript, my contributions include Figure 2C and Figure 3.
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ABSTRACT
NusA a modulator of RNA polymerase, interacts with DNA polymerase, DinB.
Increased expression of dinB or umuDC suppresses the temperature sensitivity of the
nusAll strain, requiring the catalytic activities of these proteins. We propose NusA
recruits TLS polymerases to RNA polymerases stalled at gaps, coupling translesion DNA
synthesis to transcription.
INTRODUCTION
DNA is damaged from a variety of endogenous and exogenous sources, which
can result in a variety of cellular problems, including cell death (12). All organisms have
mechanisms of DNA repair and DNA damage tolerance to help them to survive DNA
damage (12). One important mechanism of DNA damage tolerance is translesion DNA
synthesis (TLS), a process in which a specialized DNA polymerase copies past DNA
lesions that block the highly accurate, stringent replicative DNA polymerases. Although
certain TLS polymerases can catalyze proficient DNA synthesis across from cognate
lesions, they have reduced fidelity on undamaged templates (11, 16). TLS polymerases
are conserved throughout all domains of life, with the majority being members of the Y-
family of DNA polymerases (37). Escherichia coli has two Y-family DNA polymerases,
DinB (Pol IV) and UmuD'2C (Pol V).
DinB (termed DNA pol kappa in eukaryotes) is the only Y-family polymerase
found in all domains of life, yet despite its striking conservation, the role of DinB in vivo
is still incompletely understood. E. coli DinB is known to be involved in the
phenomenon of X untargeted mutagenesis (4), adaptive mutagenesis (19), and when
expressed at increased levels it causes an increase in -1 frameshift mutations (22). It was
recently discovered that AdinB strains are sensitive to DNA damaging agents
nitrofurazone and 4-nitroquinolone- -oxide, and that DinB preferentially and accurately
bypasses certain N2-dG adducts (21, 24, 32, 51). This ability to preferentially bypass
these N2-dG adducts is conserved evolutionarily (21), suggesting a possible reason for the
conservation across all domains of life. Additionally, DinB has been shown to
incorporate oxidized nucleotides (50), possess lyase activity (42) and is suggested to be
involved in replication-arrest-stimulated recombination (29). Intriguingly mammalian
pol kappa has been implicated in nucleotide excision repair (NER) and is proposed to
function in the patching or gap filling step (36) . Given that improper access to DNA or
misregulation by increased expression of TLS polymerases can be mutagenic under
normal conditions, it is extremely important that TLS polymerases are properly regulated.
In E. coli, dinB and umuDC are both transcriptionally induced as part of the SOS
response to DNA damage (12). In addition, the activity of UmuC is controlled by an
elaborate post-transcriptional regulatory process that includes the RecA mediated
cleavage of its partner UmuD to UmuD' and interactions with the 0 processivity clamp
and RecA (12, 31, 46). DinB also interacts with the P clamp and its activity has recently
been shown to be controlled by the umuD gene products and RecA (14). Both DinB and
UmuC also interact with the molecular chaperone GroEL (8, 14, 48).
RESULTS AND DISCUSSION
A DinB affinity column used to search for potential DinB-interacting proteins
within lysates of cells that constitutively express the SOS response found that UmuD,
UmuD' and RecA physically associate with DinB (14). Extension of this study (14) by
binding purified recombinant (His) 6-HMK-DinB to a Ni2 + charged affinity resin to
generate a DinB affinity column identified NusA as a potential interactor as determined
by N-terminal sequencing (Figure lA). However, identification of protein interaction
partners by affinity methods can lead to a high frequency of false positive interactions (9,
38). Furthermore, confirmation of an interaction by other methods does not necessarily
imply any relevance in vivo. Here we report that NusA, long known to be a RNA
polymerase associated factor, physically interacts with DinB and that nusA genetically
interacts with both dinB and umuDC. These unexpected findings suggest additional
biological roles for NusA besides modulating RNA polymerase function.
NusA is an essential protein that functions in both termination and antitermination
of transcription, and is thought to be associated with the RNA polymerase throughout the
elongation and termination steps of transcription (6, 10, 17, 25, 26, 28, 40). Originally
reported in 1974, NusA forms an antitermination complex with ?N protein that is
required for successful k phage infection (13), and has been recently found to form a
shield with kQ protein to protect the emerging transcript from termination mechanisms
(41). NusA is highly conserved throughout bacterial and archaeal domains of life,
however to date no eukaryotic sequence or functional homolog has been identified.
To test whether the interaction between DinB and NusA detected by affinity
chromatography is direct or indirect, we performed a far-western experiment using cell
lysates expressing NusA and NusA derivatives (30) (Figure IB). As shown in Figure 1C,
our observations indicate that DinB and NusA do indeed interact and that they do so
directly. Interestingly, the C-terminal 263 amino acids of NusA, which seem to be
especially important for the interaction with DinB, are also implicated in binding to RNA
polymerase (30), implying that this region is involved in the binding of both RNA
polymerase and DinB. We also used cellulose filter peptide arrays to search for peptides
of NusA which might potentially interact with DinB. Filter peptide arrays containing 12
mer peptides of NusA each overlapped by two residues were probed with purified
recombinant DinB (Figure 2A), or were performed without a DinB incubation step
(Figure 2B). Interacting peptides were then mapped to a homology model of NusA based
on the Thermotoga maritima crystal structure (43) (Figure 2C). Interestingly, we found
that one potential DinB binding region of NusA encompasses several surface residues
around the site of the temperature sensitive mutation of the nusAll(ts) allele (33). While
some peptides found to potentially bind to DinB are located within the C-terminal 263
amino acids of NusA, consistent with the far-western results, others are found outside of
this region. Further study will be required to define the exact details of how DinB and
NusA interact, but it is possible that there are multiple contact sites since neither the far
western approach nor the peptide array approach take into account the full tertiary
structures of the proteins.
Nevertheless, the peptide array data led us to consider the possibility that elevated
levels of DinB might stabilize the NusA I I protein, resulting in dinB+ serving as a
multicopy suppressor of the temperature sensitivity of a nusAl strain. We found that
increased expression of DinB, from a low copy number plasmid under the lac promoter,
indeed suppresses the temperature sensitivity of the nusAl] strain and does so by
approximately three orders of magnitude (Figure 3A).
Although this multicopy suppression could have resulted from DinB stabilization
of the NusAl 1 protein, it could also have resulted from DinB functioning as a TLS DNA
polymerase. To distinguish between these possibilities, we tested the ability of various
dinB derivatives to serve as a multicopy suppressor of nusAl]. Strikingly, we found that
DinB requires its catalytic activity to act as a multicopy suppressor of the nusA I
temperature sensitivity as shown by the failure a nusAll strain to grow at 420 C when
harboring pdinBOO03, which encodes a catalytically inactive DinB (D103N). Furthermore
pdinBAf, which encodes for a truncation mutation of DinB eliminating its P processivity
motif (7) and pdinB(F13V), which encodes for a variant of DinB that can catalyze DNA
synthesis but not across N2-adducted-dG residues-in vitro (21), also fail to support growth
of the nusAll strain at 420 C (Figure 3A). These observations indicate that the
suppression of the temperature sensitivity of the nusA I strain by DinB, not only requires
DinB's ability to catalyze DNA synthesis and to interact with the processivity clamp, but
also its ability to perform translesion DNA synthesis. Western blotting experiments show
that the various dinB mutants are expressed as well as dinB+ (Figure 3E) and none of the
above mentioned plasmids affect growth of a nusA+ strain (Figure 3B). It is possible that
the interaction with DinB is also stabilizing the NusA 11 protein but, if so, this
stabilization is not sufficient to account for the multicopy suppression we have observed.
Our discovery that the TLS function of DinB is necessary for multicopy
suppression of the nusAll temperature sensitivity prompted us to test whether umuD+C+
could also function as a multicopy suppressor. Using a plasmid with umuD+C+ under its
native promoter with an operator constitutive mutation (olC) on a medium copy number
plasmid, pDC, we found that indeed elevated levels of the umuDC gene products
increases the survival of the nusAll strain at 420 C by approximately 4 orders of
magnitude (Figure 3C). The difference in suppression between dinB and umuDC, may
reflect a qualitative difference, but it may also be explained at least in part by the
differences in the vector and promoter used for expression. Neither of the umuD gene
products alone, pD or pD', under the operator constitutive promoter (olC), can support
growth of the nusA I strain at 420 C indicating that UmuC function is required for
multicopy suppression of the nusAll strain. Similar to the suppression by DinB,
suppression of nusAll strains at 420 C requires UmuC's catalytic activity. This is shown
by the facts that the temperature sensitivity of a nusAll strain cannot be suppressed by
pDC(101), which encodes a catalytically inactive UmuC (D101N), nor by pDC(AP),
which encodes for a variant of UmuC that is deficient for binding to the 3 clamp. It also
requires the autoproteolytic activities of UmuD, shown by pD(S60A)C, which encodes
for a non-cleavable UmuD variant. However to our surprise, pD'C, which directly
expresses UmuD'C from the plasmid, does not support growth of the nusA I I strain at
42 0C, suggesting that both UmuD and UmuD' must be present along with UmuC for the
multicopy suppression to occur. Interestingly UmuD and UmuD' form a heterodimer that
is considerably more stable than the UmuD2 or UmuD'2 homodimers (1), raising the
possibility that the UmuD-UmuD' heterodimer may be required for the multicopy
suppression by umuDC. Alternatively, the additional methionine used to initiate the
translation of UmuD' in our pD'C construct may alter the ability for multicopy
suppression. pDC(122), which encodes for a truncation of the UmuC protein that results
in hydroxyurea resistance (15), also does not support growth at 420 C, implying that the
requirements for hydroxyurea resistance are not the same for multicopy suppression
(Figure 3C). Additionally, western blotting experiments show that the various mutant
umuDC gene products are expressed at least as well a umuD+C (Figure 3E), and that
expression of these variants does not alter growth of nusA+ strains (Figure 3D).
In summary, we find that NusA, an essential E. coli protein, physically interacts
with DNA polymerase DinB, in addition to its well known RNA polymerase contacts.
We have shown that peptides implicated in DinB binding form distinct patches on the
NusA surface including residues around the site of mutation of the nusA1l(ts) allele.
Furthermore elevated expression of dinB+ or umuD+C+, results in multicopy suppression
of the temperature sensitivity of the nusA ll(ts) strain. For both of these translesion DNA
polymerases, this multicopy suppression requires their catalytic activities, as well as their
ability to bind to the 0 clamp.
Taken together, our results suggest the existence of a previously unsuspected
cellular process involving physical and genetic interactions between an important RNA
polymerase modulator and translesion DNA polymerases. Furthermore, the fact that the
lethality of a nusA 1] mutant at 420 C can be suppressed by elevating the expression of
either of two translesion DNA polymerase implies a hitherto unrecognized role for NusA
in DNA repair and/or DNA damage tolerance. Such a role for NusA might be an
additional reason that the nusA gene is present in all bacteria and archaea.
What type of molecular mechanism could account for these unanticipated results?
We propose that, by binding to DinB or some complex involving UmuC and the umuD
gene products, NusA can couple the process of transcription to the process of translesion
synthesis to enable transcription-coupled translesion synthesis (TC-TLS), in a manner
analogous to the coupling of transcription to nucleotide excision repair during
transcription-coupled repair (TCR). In principle, a process of TC-TLS could be helpful
when transcription becomes stalled by gaps in the transcribed strand that are opposite
lesions in the non transcribed strand. Such gaps can be caused by lesions that cannot be
bypassed by the replicative DNA polymerase. On the lagging strand, gaps are generated
by replication resuming at the site of the next Okazaki fragment, while replication re-start
can generate similar gaps on the leading strand; gaps formed in this manner are estimated
to average about 1,000 nucleotides in length (18, 20, 23, 39). Alternatively, gaps
opposite lesions could also be formed by UvrABC-dependent nucleotide excision repair
if two lesions are very close together but on opposing strands or by UvrABC-dependent
incisions during repair of an intrastrand crosslink (12). In these latter two cases, the gaps
would be smaller, 12-13 nucleotides (12). DinB has recently been shown to be capable of
accurately filling the gaps that could be generated during repair of N2,N2 guanine
intrastrand crosslinks (24), an observation that might help rationalize the involvement of
DNA pol Kappa in mammalian nucleotide excision repair (36).
We hypothesize that, if an RNA polymerase encounters one of these gaps in the
transcribed strand opposite a lesion, it would stall. In this case NusA, which is associated
with the RNA polymerase throughout the elongation phase of transcription, might then
recruit a TLS polymerase to fill in the gap in the template strand (Figure 4). Repairing the
gap would permit transcription of the gene by subsequent RNA polymerases, possibly
even by the original RNA polymerase if it is retained during process as in TCR. TC-TLS
would provide a way of prioritizing the use of the cells translesion DNA synthesis
resources to benefit maximally transcription, the same way TCR prioritizes nucleotide
excision repair resources to maximally benefit transcription.
The mechanism of TC-TLS we are proposing is unrelated to the phenomenon of
template strand gap bypass that has been characterized previously (27, 52). It has been
shown that two phage RNA polymerases and E. coli RNA polymerase are capable of
bypassing a small gap in the transcribed strand, thereby generating faithfully transcribed,
but internally deleted, mRNAs that would be non functional in most cases. Although T7
RNA polymerase can bypass a template strand gap of up to 24 nucleotides, E. coli RNA
polymerase only inefficiently bypasses a one nucleotide gap and generates the equivalent
of a -1 frameshift mutation in the process (27, 52). Many of the gaps we are considering
would be too big to bypass in this fashion and, the mechanism we are proposing would
usually result in the production of biologically functional mRNAs.
If a process of transcription-coupled translesion synthesis does exists, and if it is
universal as most DNA repair and DNA damage tolerance processes tend to be, it might
be of particular importance in mammals where some mRNAs can take many hours to
transcribe (47) so that the consequences of encountering a template gap late in the
transcriptional process would be severe. Alternatively NusA may be important in
recruitment of DinB to serve as the polymerase in the patching step of NER that takes
place during transcription coupled repair, as DNA pol Kappa has been implicated in
eukaryotes (36).
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MATERIALS AND METHODS
Affinity Chromatography
IMAC (Immobilized Metal Ion Chromatography) where purified recombinant (His)6-
HMK-DinB was bound to a Ni2+ charged affinity resin using conditions and reagents as
recommended by QIAGEN. Recombinant (His) 6-HMK-DinB was purified as previously
described (3).
Farwestern assays and peptide array experiments
Farwestern blots were performed as previously described (14, 45). Briefly, BL21 (DE3)
cell lysates expressing NusA and NusA derivatives (30) (Table 1) were separated by
SDS-PAGE, transferred to a PVDF membrane and probed with 32 P labeled (His)6-HMK-
DinB. Cellulose filter peptide array was synthesized with overlapping 12-mer peptides
scanning the primary sequence of NusA, each peptide offset by 2 residues from the
previous (MIT CCR Core Facility) probed with 150nM purified recombinant DinB or
without a DinB incubation step and developed with an anti-DinB antibody as described in
(34). Recombinant DinB was purified as previously described (3).
Multicopy suppression assays
nusAl] cells (SEC29) or nusA+ cells (P90C) harboring plasmids containing dinB+ and
dinB derivates (Table 1) were grown to saturation in LB plus ampicillin (100 jig/mL) at
300 C and diluted (1:100) into LB supplemented with ampicillin and IPTG (1mM) and
again allowed to reach saturation. The cultures were then diluted in M9 salts and plated
onto LB agar plates, supplemented with ampicillin and IPTG, pre-heated to either 300 C
or 42 0 C and incubated at the respective temperature, CFU/mL were then scored on plates
growing at 300 C and 42 0 C. Survival of nusAll strains at 300 C vs. 42 0 C harboring
plasmids. umuDC suppression assays were performed as for the dinB suppression assays
except IPTG was omitted.
Western Blots
nusA I cells harboring dinB plasmids were grown as they would for multicopy
suppression assays except cells were harvested, lysed with lysozyme, and treated with
deoxyribonuclease I (Sigma). 15gg total protein of each lysate was loaded onto 4-20%
SDS-polyacrylamide gel. After electrophoresis proteins were transferred to a PVDF
membrane and probed with an anti-DinB antibody, with western conditions as described
in (2) except with the addition of a high salt (0.5M NaC1) wash after incubation with the
secondary antibody. Antibodies against UmuD and UmuC can only detect plasmid borne
protein levels after SOS induction. Thus expression of umuDC under the conditions used
for nusAll multicopy suppression cannot be detected by western blotting. In order to
check that the different mutants used were stably expressed as compared to the wild type,
AB 1157 cells harboring umuDC plasmids were irradiated with UV to induce the SOS
response, western blots were then performed as described in (2).
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Figure 1. DinB physically interacts with NusA.
(A) Coomassie stained SDS-PAGE gel showing several steps of traditional IMAC
(Immobilized Metal Ion Chromatography) where purified recombinant (His)6-
HMK-DinB was bound to a Ni2+ charged affinity resin using conditions and
reagents as recommended by QIAGEN. Recombinant (His) 6-HMK-DinB was
purified as previously described (3). Lane 1- Molecular weight markers. Lane 2-
Non specific binding to resin. Lane 3- Washes with 20mM imidazole. Lane 4-
DinB affinity column eluate, eluted with 300mM imidazole. Interacting proteins
NusA and GroEL were identified by Edman degradation (MIT CCR Core
Facility).
(B) Schematic of NusA constructs used for far western experiment, adapted from
(30).
(C) Far Western Blot demonstrates that the interaction between DinB and NusA is
direct. BL21 (DE3) cell lysates expressing NusA and NusA derivatives (30)
(Table 1) were separated by SDS-PAGE, transferred to a PVDF membrane and
probed with 32P labeled (His) 6-HMK-DinB as previously described (14, 45).
Lane 1- vector (pET16b), Lane 2- pNusA(1-495), Lane 3- pNusA(232-495), Lane
- pNusA(132-240), and Lane 5- pNusA(1-137).
Figure 2
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Figure 2. Peptides of NusA which bind to DinB encompass the site of nusAll
temperature sensitive mutation.
(A) Depicts a 1 hour exposure of a cellulose filter peptide array consisting of 12-mer
peptides scanning the primary sequence of NusA, each peptide offset by 2
residues from the previous (MIT CCR Core Facility) probed with 150nM purified
recombinant DinB and developed with an anti-DinB antibody as described in
(34). Recombinant DinB was purified as previously described (3). Red boxes
highlight peptides that interact with DinB and were mapped onto homology
model in (C).
(B) Depicts a 1 hour and 15 minute exposure of a control peptide array which was
performed as in (A) except without a DinB incubation step.
(C) Mapping of interacting peptides onto a homology model of NusA. NusA residues
shown in green, interacting peptides are shown in blue and temperature sensitive
mutation of the nusAll allele, shown in red. NusA homology model, constructed
with SWISS-MODEL, based on crystal structure of full length NusA from
Thermotoga maritime, with the N terminus of NusA at the top.
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Figure 3. DinB or umuDC act as multicopy suppressors of the nusAll temperature
sensitivity.
(A) Survival of nusAll strains at 30'C vs. 420 C harboring plasmids. pWSK29 the
empty vector, pdinB+, pdinBOO03, which encodes a catalytically inactive DinB,
pdinBAP, encodes for a truncation mutation of DinB eliminating its 0
processivity motif, and pdinB(F13V), which encodes for a variant of DinB which
can catalyze DNA synthesis but not across N2-adducted-dG residues (in vitro).
(B) Survival of nusA+ strains (P90C) at 300 C vs. 42 0 C harboring the same set of
plasmids as in (A), show that these plasmids do not confer any growth
phenotypes in a wild type background.
(C) Survival of nusAll strains at 300 C vs. 42 0 C harboring plasmids. pBR322 (empty
vector), pDCoc (pumuD C+ , operator constitutive promoter), pD, expresses only
umuD, and pD', expresses only UmuD', pDC(101), which encodes a catalytically
inactive UmuC, pDC(AP), encodes for a variant of UmuC with the P binding
motif mutated to alanines, pD(S60A)C, which encodes for a non-cleavable
UmuD variant, pD'Coc, which contains UmuD'C under the operator constitutive
promoter, and pDC(122), which encodes for a truncated variant of UmuC.
(D) Survival of nusA+ strains at 300 C vs. 42oC harboring the same set of plasmids as
in (C), show that these plasmids do not confer any growth phenotypes in a wild
type background.
(E) Western blots demonstrate that dinB and umuDC derivatives are stably expressed
as well as dinB+or umuD+C+.
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Figure 4. Proposed model of transcription coupled translesion synthesis (TC-TLS).
Model of transcription coupled translesion synthesis (TC-TLS) is as described in text.
Briefly we propose that an RNA polymerase stalled by a gap in the template strand
opposite a DNA lesion on the non transcribed strand, could recruit TLS polymerases
through NusA to fill in the gap opposite the lesion to allow for the continuation of
transcription.
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Table 1. Strains and Plasmids.
Strains
P90C
IQ419
YN2351
SEC26
Genotype
A(lac-pro)xii ara gal
zha-132::Tn10 arg rpsL25 7
metB trpE9829(am) tyr(am) sup-126
nusAll
Same as YN2351 except zha-132::Tnl0,
constructed by P1 vir transduction (IQ419
x YN2351)
Same as P90C except nusAll
zha0132::Tnl 0
SEC29
BL21 (DE3)
AB1157
Plasmids
pWSK29
pYG782
(pdinB+)
pdinBO03
pdinBA
thr-1 leuB6proA2 hisG4 thil argE3 lacY1
galK2 ara-14 xyl-5 mtl-1 tsx-33 rpsL31
supE44
Vector, pSC101-like replicon, AmpK
dinB ene cloned in the pWSK30 plasmid
(Amp ) which is the same as pWSK29 but
with the MCS cloned in the opposite
orientation under the lac promoter
Same as pYG782, except dinB gene
encoding D 103N mutation
Same as pYG782, except dinB gene
encoding truncation mutant to delete C
terminal residues, deleting the 0 binding
motif, premature stop codon inserted
using site directed mutagenesis kit by
Stratagene.
pdinB(F13V)
pBR322
pDCoc
pDC(IO01)
pDC(AP3)
pD'Coc
Same as pYG782, except dinB gene
encoding F 13V mutation
Vector, AmpR
umuDC cloned into pBR322 under its
operator constitutive promoter olc
Same as pDCoc except that it encodes a
catalytically inactive UmuC (D 101N),
constructed using site directed
mutagenesis kit by Stratagene.
Same as pDCoc except UmuCP3 motif,
residues 357-361, are mutated to alanine
UmuD'C cloned into pBR322 under the
(21)
New England Biolabs
(2)
This work
(2)
This work
Reference
(5)
CGSC
(33)
This work
This work
Novagen
Lab Stock
(21)
(22)
(49)
This work
pDC(122)
pD(S60A)C
pGW2020
(pUmuD)
pGW2122
(pUmuD')
pET16b
pNusA(1-495)
pNusA(232-495)
pNusA(132-240)
pNusA(1-137)
C
operator constitutive promoter o l
Constructed by subcloning from
pGY9738 (44).
Same as pDCoc expect stop codons, in all
three reading frames using site directed
mutagenesis kit from Stratagene, were
inserted to correspond to the UmuC 122
truncation, lacking the last 102 residues.
Same as pDCoc except umuD gene
encoding S60A mutation, constructed
using the site directed mutagenesis kit
from Stratagene.
umuD cloned into pBR322 under the
operator constitutive promoter ol1
UmuD' cloned into pBR322 under the
operator constitutive promoter ol1
Vector, pBR322 origin of replication
AmpR, similar to pET1 ld except contains
His 6
N-terminal His 6-tagged full length NusA
cloned into pET11 d
N-terminal His 6-tagged amino acids 232-
495 of NusA cloned into pET11 d
N-terminal His 6-tagged amino acids 132-
240 of NusA cloned into pET 11 d
N-terminal His 6-tagged amino acids 1-137
of NusA cloned into pET 11 d
This work
This work
(35)
(35)
Novagen
(30)
(30)
(30)
(30)
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Chapter 3
The transcriptional modulator NusA is essential for adaptive
mutagenesis in Escherichia coli
This chapter has been submitted for publication as: Susan E. Cohen and Graham C.
Walker. The transcriptional modulator NusA is essential for adaptive mutagenesis in
Escherichia coli.
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ABSTRACT
Adaptive mutagenesis describes the accumulation of mutations that occur in non-
growing cells over time. In Escherichia coli, a lacI33-lacZ fusion reporter is used to
monitor the appearance of adaptive mutants from a Lac- to a Lac+ phenotype. While many
cellular processes are implicated in the adaptive response, loss of DinB (DNA pol IV)
function results in loss of 50 to 85 percent of adaptive mutants. I have previously reported
that the essential RNA polymerase modulator NusA, physically and genetically interacts
with DinB. Here I report my unexpected observation that a function altered in the
nusAll(ts) allele, at the permissive temperature, eliminates the formation of adaptive
mutants. I present evidence that this reduction in adaptive mutation is not due to a defect
in transcribing lacI33-lacZ, but rather an inability to adapt and mutate in response to
environmental stress. Furthermore, I have extended a previously existing reporter used to
monitor the appearance of unselected mutations to be able to monitor the formation of
adaptive mutants in response to antibiotic treatment. My results are the first to implicate a
specific function of NusA, a key component of elongating RNA polymerases, in adaptive
mutagenesis.
INTRODUCTION
Adaptive mutagenesis describes the accumulation of mutations that occur in non-
growing cells, and is also referred to as stress-induced or stationary phase mutagenesis.
The widely used system devised by Cairns and Foster, utilizes a strain (FC40) which has
lac deleted on the chromosome and carries an F'128 episome with a lac133-lacZ fusion
with a +1 frameshift in a run of G:C base pairs (2). When E. coli are starved for a carbon
source and plated onto minimal lactose medium, Lac+ mutants occur at a rate of
approximately 10-7 per cell per day for about 7 days (2). The reversion of this mutant
from a Lac to Lac+ phenotype has been found to occur by both adaptive mutation and
adaptive amplification (1, 21, 23, 24). Furthermore, it has been found that adaptive Lac+
mutations nearly almost result from a -1 frameshift mutation in a run of consecutive bases
(8, 38). While the mechanisms underlying adaptive mutation and amplification remain
unclear, a variety of cellular factors have been implicated, such as DNA recombination
functions (9, 19, 20, 22) and induction of the SOS response (2, 31, 32). The dinB+ gene
product, DNA Pol IV, is also important for -1 frameshift mutations. The analysis of
dinB's role is complicated by the fact that dinB+ is present on the F' episome as well as on
the chromosome. However, depending on the dinB alleles used, loss of DinB function
results in loss of 50 to 85 percent of the -1 frameshift mutations in the lacI33-lacZ fusion
that lead to a Lac+ phenotype (6, 32).
DinB, also known as Pol IV in E. coli (pol Kappa is its ortholog in eukaryotes), is
a translesion DNA polymerase which is induced as part of the SOS regulon in response to
DNA damage (11, 26, 36). Translesion DNA polymerases are a specialized class of DNA
polymerases that are capable of replicating imperfect or damaged templates in a process
termed translesion DNA synthesis (TLS) (11). While TLS polymerases provide a variety
of benefits to the cell, it is extremely important that they are properly regulated as their
fidelity on undamaged DNA is lower than that of their replicative counterparts (10, 14,
16). DinB in both prokaryotes and eukaryotes is proficient for the formation of -1
frameshift mutations, and has been found to be responsible for both adaptive -1
frameshift mutations as well as for -1 frameshift mutations that occur during exponential
growth (27, 32, 35). Furthermore, it has recently been found that dinB+ is the only SOS
regulated gene required at induced levels for adaptive mutagenesis (12).
I have previously reported that DinB physically and genetically interacts with the
essential transcriptional modulator NusA (4). NusA associates with RNA polymerase
(RNAP) throughout the elongation and termination steps of transcription, where it
functions as both a terminator and antiterminator (3, 5, 17, 28-30, 39). Here I report that a
specific function of NusA modified by the nusAll temperature sensitive mutation at the
permissive temperature is essential for the formation of adaptive mutations. The
deficiency of a nusAllmutant for adaptive mutagenesis was observed both in the
starvation conditions using the lacI33-lacZ reporter as well, as in a second system based
on the reversion of a +1 frameshift tetA allele. I propose that NusA, in addition to its well
established roles in transcription, plays a previously unrecognized role in the
phenomenon of stress induced mutagenesis. My results are the first to implicate a specific
function of NusA, a key component of the elongating RNA polymerase, in the
phenomenology underlying adaptive mutagenesis.
RESULTS AND DISCUSSION
nusA+ function is indispensible for the viability of bacteria and its roles in
transcription elongation and termination have been appreciated for many years, however
my recent data suggest that NusA may also be involved in the process of DNA damage
repair/tolerance. I previously reported that the temperature sensitivity of the nusAl 1 (ts)
allele (34) can be suppressed by overexpression of the TLS polymerase DinB, in a
manner that requires the catalytic capabilities of DinB (4). Intrigued by these
observations, I looked to see if the DinB-dependent phenomenon of adaptive mutagenesis
was altered in a nusAll background.
Using the lacI33-lacZ fusion system described above, I found that FC40 cells
carrying the nusAll mutation are incapable of adaptive mutation to Lac+ at the
permissive temperature (300 C) (Figure 1A and B). This reduction in adaptive mutations
observed in a nusAll background is even more extreme than the reduction that is seen in
cells which are deleted for both the chromosomal and episomal copies of dinB (Figure 1A
and B). These results suggest that the role of nusA+ in adaptive mutagenesis may extend
beyond an interaction with DinB and the formation of-1 frameshift mutations. Agar
plugs taken from plates on day 7 contained roughly equal amounts of Lac- bacteria for the
nusA+ and nusAl] strains. This observation indicates that the nusAl] cells were not dying
upon incubation on minimal lactose plates, but rather were incapable of mutating (Figure
SC).
One caveat to our results above is that NusA is known to be the L factor required
for P3-galactosidase transcription in vitro (18). At the permissive temperature, the nusAll
mutation is reported to cause a 40 percent reduction in 3-galactosidase activity in vivo
(34), due to a Rho-dependent termination signal within the lacZ coding region. Could this
defect in lacZ expression explain the elimination in adaptive mutagenesis we are seeing?
To test this I isolated adaptive mutants that arose from the wild type FC40 strain (FC40
Lac), introduced the nusAll mutation, and then monitored P-galactosidase activity as
well as the ability to form colonies on lactose medium at 300 C. Although nusAll strains
showed an approximately 40 percent reduction in P-galactosidase activity from the
episomal lacI33-lacZ reporter compared its wild type parent (Figure 2A), colony
formation on minimal lactose medium was unaltered, matching colony formation on
glucose medium (Figure 2B). These results suggest that, even under the conditions of
modestly reduced P-galactosidase activity in a nusAll strain, there remains sufficient P-
galactosidase function to grow when lactose is the only carbon source. Thus, the
elimination of adaptive mutagenesis seen in the nusAll strain is not likely due to a defect
in lacZ expression, but rather in an inability to adapt and mutate in response to
environmental stress.
Although the above observations suggest that loss of adaptive mutagenesis in a
nusAll I background is not due to improper expression of the lacI33-lacZ fusion, I wanted
to see if this observation would repeat in another context. In an effort to accomplish this,
I thought I might take advantage of a pre-existing reporter that has been previously used
to monitor unselected mutations in adaptive mutagenesis experiments employing the
lac133-lacZ system. The strain FC722, carries an inactivated tetA gene due to a +1
frameshift mutation in a run of G:C base pairs within a TnlO transposon, on the episome
(F'128) (7). Tetracycline is a bacteriostatic antibiotic which functions through inhibition
of the 30S ribosome (15). Tetracycline resistance (TetR) as measured from a
chromosomal TnlO was not altered in a nusAll background indirectly showing that tetA
expression is not altered. In fact, the presence of the nusAll allele even modestly
improves tetracycline resistance at higher doses (Figure 3A). At the concentration of
tetracycline used in the experiments described below (12 [g/mL), both the nusA+ and
nusA1] Tet R strains showed 100 percent survival. Adaptive mutagenesis is defined as
mutations that arise in non-growing bacteria held under non-lethal selection, allowing for
growth (40). Thus I hypothesized that by plating FC722 cells on tetracycline medium,
non-growing cells should accumulate mutations in the defective TnlO that would then
allow for growth on tetracycline medium, analogously to the Lac+ mutations that
accumulate in starved FC40 cells plated on minimal lactose medium.
When independent cultures were plated onto minimal glucose plates
supplemented with tetracycline, I observed TetR colonies appearing over a period of
several days, an observation reminiscent of the appearance of Lac+ colonies over several
days in standard lacI33-lacZ adaptive mutagenesis (Figure 3B). Although the total
number of mutants that are produced is lower when compared FC40 strains plated on
lactose minimal medium, mutations occur with similar kinetics. The genetic requirements
for adaptive mutations that occur after tetracycline treatment are similar to those in
response starvation in that they require dinB+ and the recombination functions of ruvC+
(9) (Figure 3B). Furthermore, adaptive hypermutability after tetracycline treatment can be
achieved through mutation of recG (Figure 3C), as occurs in the Lac system (9, 19).
nusA+ function is also essential for tetracycline adaptive mutagenesis, as the nusAll
mutation eliminates the formation of adaptive mutants (Figure 3B). These data further
support the notion that defect in adaptive mutagenesis seen in the nusAll strain is not due
to improper transcription but rather to a disruption of a process that allows the cells to
adapt and mutate in response to stress. The role of adaptive amplification in adaptive
mutagenesis experiments is not manifested until later time points, usually day 7, and thus
not likely a key factor within the time frame of our experiments. Interestingly E. coli cells
plated on medium containing a bacteriostatic concentration of the gyrase inhibiting
antibiotic, ciprofloxacin, acquired resistant mutants in non-growing cells over the course
of a week (37), implying that adaptive mutagenesis in response to bacteriostatic antibiotic
treatment may be a general phenomenon.
In summary, I have discovered a previously unrecognized role for the essential
gene nusA+ in the process of adaptive mutagenesis. Specifically a function of nusA
altered by the nusA Il(ts) mutation at the permissive temperature is critical for the
formation of adaptive mutations. Since the nusAll cells are viable at 300 C, the function
of NusA altered by the mutation is genetically separable from the essential roles of NusA
in normal RNAP elongation and termination/antitermination. Our finding that the
reduction in adaptive mutants seen in the nusAl] background is greater than that seen
when dinB is deleted, leads us to hypothesize that NusA may play a role in adaptive
mutagenesis that extends beyond an interaction with DinB. Though future experiments
will be required to elucidate what this role may be, I propose that NusA is required to link
transcription to adaptive mutation. Specifically, I suggest that the process of adaptive
mutagenesis is initiated by the stalling of elongating RNA polymerases by an irregularity
in the DNA. For example, under the conditions of glucose starvation used in adaptive
mutagenesis experiments, the very limited growth allowed by the leaky lacI33-lacZ allele
might result in DNA replication intermediates that have more single stranded gaps than in
exponentially growing cells. Alternatively, a deficiency in DNA repair under stressed
conditions would result in lesions being present in the transcribed strand or in the
generation of gaps opposite lesions when DNA replication is attempted. If this were the
case, the function lost by the nusAll mutation might be the ability to recruit the other
cellular factors, including DinB, required for adaptive mutagenesis to the stalled RNA
polymerase. The process of transcription-coupled translesion synthesis we have
hypothesized (4) might therefore contribute to the generation of adaptive mutations.
MATERIALS AND METHODS
Mutagenesis Assays
All strains used are listed in supplemental Table I and constructed using standard
techniques. Lactose adaptive mutagenesis assays were performed as previously
described, except all incubation steps were performed at 300 C (13). Tetracycline adaptive
mutagenesis assays were performed by growing each strain to saturation in M9 minimal
media (0.2% Glucose) and diluted 105 fold into fresh medium (0.2% Glucose), divided
into several cultures, and allowed to reach saturation, to produce at least five independent
cultures. Approximately 109 cells from each independent culture is mixed with minimal
top agar and overlaid onto M9 minimal glucose (0.2%) plates containing tetracycline
(12mg/mL). Viable cells were determined by dilution in M9 salts and plating cells on to
M9 minimal glucose (0.2%) plates without tetracycline. Plates were incubated at 300 C
and tetracycline resistant colonies are counted and marked every day.
p-galactosidase activity assays
Strains were grown at 300 C in minimal M9 lactose (0.2%) medium and P-galactosidase
activity assays were performed as previously described (33).
Determination of nusAll effects on reporter genes
TetA expression from Tnl 0. Strains harboring chromosomal Tnl0 (SEC527, SEC29)
were grown in LB medium, diluted in M9 salts and plated onto LB plates supplemented
with tetracycline, CFU/mL were determined after incubation at 300 C. CFU/mL formation
on minimal glucose and minimal lactose was determined by growing cultures in M9
minimal glucose (0.2%) media to saturation, cultures were then diluted in M9 salts and
plated onto minimal glucose (0.2%) or minimal lactose (0.2%) plates, incubated at 300 C.
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Figure 1. Adaptive mutation in response to starvation A) nusAll strains are defective for
adaptive mutagenesis. Wild-type FC40 (squares), AdinB (SEC1414) (triangles) deleted on
both chromosome and episome, and nusA I (SEC182) (diamonds). B) Magnification of
A). C) Recovery of viable Lac- cells from agar plugs on day 7 reveals that roughly equal
number of bacteria were recovered from all strains. Error bars represent the standard
deviation from three independent experiments.
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Figure 2. P-galactosidase activity and growth on lactose medium of nusAl] strains at
300C. A) FC40 Lac+ nusAll (SEC1429) strains show an approximately 40 percent
reduction in P-galactosidase activity as compared to FC40 Lac+ nusA+ (SEC 1419). B)
FC40 Lac+ nusAl] cells do not show altered ability to form colonies on minimal lactose
medium compared to FC40 Lac+ nusA+ determined by CFU/mL on lactose divided by
CFU/mL on glucose. Error bars represent the standard deviation determined from three
independent experiments.
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Figure 3. Adaptive mutagenesis in response to tetracycline. A) Tetracycline resistance
from chromosomal Tnl O. Percent survival of nusA+ (SEC527) (squares) and nusAll
(SEC29) (diamonds) strains to tetracycline (0-50tg/mL) shows that nusAll strains are
not altered in their ability to express tetracycline resistance. Error bars represent the
standard deviation determined from three independent experiments. B) Adaptive
mutation of FC722 upon tetracycline treatment. Wild-type FC722 (SEC361) (closed
squares), nusA]] (SEC369) (closed diamonds), AdinB on the chromosome and episome
(SEC611) (closed triangles), and AruvC (SEC1466) (open triangles). C) Tetracycline
adaptive hypermutability. Hypermutation observed in FC722 ArecG mutants in response
to tetracycline as is seen during lactose adaptive mutagenesis of FC40. Wild-type FC722
(SEC361) (closed squares) and ArecG (SEC1464) (open squares).
Figure 3
B 160
140
100
,80
> 60
40
20
0
C
C
C
Time (Days)
700
600
500
3 400
c
300
, 200
100100O
Table I. Strains used in this study
----
Strain
FC40
SEC182
SEC1414
SEC1419
SEC 1429
FC722
SEC361
SEC364
SEC369
SEC 611
SEC1466
SEC1464
SEC527
SEC29
IQ419
CAG12127
P90C
JW1852
JW3627
AB1157
AdinB::CAT
Genotype
ara A(lac-proB)xilithi RifR/ F'
D(lacl33-lacZ)
as FC40 except nusAl
zha0132:: Tnl O
as FC40 execpt AdinB::frt on
chromosome, AdinB::CAT on episome
as FC40 except Lac+ revertant
as SEC 182 except Lac+ revertant
as FC40 except with a defective Tnl 0
(tetracycline sensitive)
as FC722 except sfsB3198::TnlOkan
as SEC361 except AdinB::frt on
chromosome
as SEC361 except nusAll
as SEC364 except AdinB::CAT on
episome
As FC722 except AruvC::Kan
As FC722 except ArecG::Kan
as P90C except zha0132:: Tnl0
as P90C except nusAll
zha0132:: Tnl 0
zha0132::Tn 0 arg rpsL257
F LAM sfsB3198::Tnl Okan rph-1
ara A(lac-proB)xjilthi RifR
F A (araD-araB)567
AlacZ4787(::rrnB-3) LAM
JruvC789:.:kan rph-1 A(rhaD-
rhaB)568 hsdR514
F J (araD-araB)567
dlacZ4787(::rrnB-3) LAM
ArecG756::kan rph-1 A(rhaD-
rhaB)568 hsdR514
thr-1 leuB6proA2 hisG4 thil argE3
lacY1 galK2 ara-14 xyl-5 mtl-i tsx-33
rpsl31 supE44 AdinB::CAT
Reference or Source
(2)
This work
This work
This work
This work
(7)
This work
This work
This work
This work
This work
This work
This work
(4)
CGSC
CGSC
(2)
Keio Collection
(Baba et al., 2006)
Keio Collection
(Baba et al., 2006)
(25)
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ABSTRACT
All organisms must contend with the challenges of DNA damage, which can
result in a variety of cellular catastrophes including cell death. Here I report my
unexpected observations that the essential transcriptional modulator NusA is also
involved in promoting survival after the challenge of DNA damage in Escherichia coli.
My results are the first to implicate NusA, a protein associated with RNA polymerase
throughout elongation and termination phases of transcription, in the processes of DNA
repair/damage tolerance. Mutation of nusA results in reduced viability after exposure to
DNA damaging agents and, even without the addition of exogenous DNA damaging
agents, nusA mutants display phenotypes reminiscent of mutants with altered DNA
processing. Furthermore, I can genetically link transcription/RNA polymerase to the
nusA-dependent events that help promote survival after DNA damage through the
isolation of RNA polymerase mutants with altered ability to deal with the lethal effects of
DNA damage. Together, my results suggest that NusA, in addition to its roles in
transcription elongation and termination, is important for coordinating the cellular
responses to DNA damage by coupling the processes of translesion DNA synthesis and
nucleotide excision repair to transcription.
INTRODUCTION
DNA can become damaged from a variety of endogenous and exogenous sources,
which can result in a variety of cellular problems including cell death (14). All
organisms must contend with the challenges of DNA damage and thus possess a variety
of mechanisms for dealing with DNA damage, including mechanisms of DNA repair and
DNA damage tolerance to help them to survive DNA damage (14). One mechanism of
DNA repair, in which the ensuing lesion is removed from the DNA, occurs through the
nucleotide excision repair (NER) pathway. In Escherichia coli the NER factors UvrA,
UvrB and UvrC can recognize and repair damaged DNA on either a global scale or by
being specifically recruited to transcribed DNA in the process of transcription-coupled
repair (TCR) (14). The process of translesion DNA synthesis (TLS) is one important
mechanism of DNA damage tolerance, in which a specialized DNA polymerase copies
past DNA lesions that block the highly accurate, stringent replicative DNA polymerases.
While there exist mechanisms to recruit NER to transcription no conceptually similar
recruitment mechanism has yet been identified for TLS.
DNA polymerases belonging to the Y-family of DNA polymerases exhibit this
specialized ability to perform TLS and are present in all domains of life (46). Y-family
DNA polymerases have been implicated in diverse biological phenomena ranging from
adaptive mutagenesis in bacteria to several human cancers. Although certain TLS
polymerases can catalyze proficient DNA synthesis across from cognate lesions, such
broadened substrate specificity often comes at a mutagenic cost, as these enzymes display
lower fidelities on undamaged DNA compared to their replicative counterparts (13, 19,
25). Organisms in all domains of life have therefore developed elaborate regulatory
systems to restrict the access of Y-family DNA polymerases to the appropriate termini
where TLS function is required (1, 2, 5, 17, 19, 21, 25, 27, 28, 32, 50, 63). E. coli has
two Y-family DNA polymerases, DinB (polymerase IV) and UmuD'2C (polymerase V),
both of which are transcriptionally induced as part of the SOS response to DNA damage
(14). In addition to transcriptional regulation through the SOS response, TLS
polymerases are regulated by their interactions with various other cellular proteins.
Notably, regulation of both DinB and UmuD'2C are strongly influenced by interactions
with the f3 processivity clamp of DNA polymerase III (2, 3, 66), the umuD gene products
UmuD2 and UmuD'2 (16, 18, 52, 63, 64), and RecA (53, 55, 56). In eukaryotes, TLS is
similarly controlled by association with the PCNA processivity clamp (1, 32, 43, 50, 69)
and interactions with recombination proteins (53, 55, 56).
DinB (termed DNA polymerase kappa in eukaryotes) is the only Y-family
polymerase to be found in all domains of life (46) and in E. coli is the most abundant
DNA polymerase in the cell after DNA damage (29). E. coli DinB is known to be
involved in the phenomena of X untargeted mutagenesis (7) and adaptive mutagenesis
(22). More recently it has been discovered that AdinB strains are sensitive to the DNA-
damaging agents nitrofurazone (NFZ) and 4-nitroquinolone- 1-oxide (4-NQO), which
mainly form adducts on the N2 position of guanine. Strikingly, in vitro DinB
preferentially and accurately bypasses certain N2-dG adducts (26, 30, 39, 67). This
ability to preferentially bypass these N2-dG adducts is conserved evolutionarily (26),
suggesting a possible reason for the conservation of DinB across all domains of life.
I have recently reported that DinB physically interacts with the essential
transcriptional modulator NusA and that nusA interacts genetically with both the dinB
and the umuDC gene products (11). NusA is an essential protein that functions in both
termination and antitermination of transcription and is associated with the RNA
polymerase (RNAP) throughout the elongation and termination phases of transcription
(10, 12, 20, 31, 33, 34, 40, 57). Originally identified in 1974, NusA forms an
antitermination complex with the ,N protein that is required for successful k phage
infection (15). NusA is an essential gene in E. coli and is conserved in even the smallest
of bacterial genomes, however nusA function has been found to be dispensable in specific
situations. In particular, it has been reported that, in the presence of rho alleles that
reduce transcription termination, deletion of nusA results in viable cells (68). More
recently it has been reported that a viable AnusA mutant can be constructed in reduced
genome background (9), in which 14 percent of the E. coli genome has been removed by
the targeted deletion of horizontally acquired DNA (49). Analysis of this AnusA mutant
revealed that nusA function was required for the suppression of cryptic prophage
expression, specifically the rac prophage. NusA is highly conserved throughout bacterial
and archaeal domains of life; however, to date, no eukaryotic sequence or functional
homolog has been identified. I have previously shown that the temperature sensitivity of
the nusAll allele (41) can be suppressed by overexpression of either dinB or umuDC, in a
manner requiring the catalytic activities of these proteins (11). Furthermore, I have
shown that nusAI I mutants are defective in the dinB-dependent phenomenon of adaptive
mutagenesis (Chapter 3).
Here I report that nusA, in addition to roles in transcription elongation and
termination, plays a previously unrecognized role in the DNA repair/damage tolerance
pathways in E. coli. I show that mutants of nusA, both the nusAll and AnusA mutants,
are sensitive to DNA damaging agents. Additionally the nusAll mutant, at the
permissive temperature, displays phenotypes reminiscent of mutants that have defects in
DNA processing. I present evidence that the role for nusA in promoting survival after
challenge with DNA damage, in addition to participating in a pathway involving dinB,
likely extends to a role for nusA in nucleotide excision repair/transcription coupled repair.
I have obtained genetic evidence for a role of RNA polymerase in such a process through
the isolation of RNA polymerase mutants that display altered cellular survival after
exposure to nitrofurazone. Specifically I show that the altered ability of these RNA
polymerase mutants to deal with NFZ is dependent upon nusA+ and uvrA+. Taken
together, my results suggest that NusA is important for allowing cells to cope with the
lethal effects of DNA damage by two mechanisms. I propose that NusA is required to
couple the process of transcription to the process of TLS to enable transcription-coupled
translesion synthesis, and also that NusA may also be involved in a new class of NusA-
dependent transcription-coupled nucleotide excision repair in E. coli.
RESULTS
nusA mutants are sensitive to DNA damaging agents
Intrigued by my initial observations linking nusA to translesion DNA synthesis, I
looked to see if nusA mutants shared any phenotypes with TLS polymerase mutants, i.e.
sensitivity to DNA damaging agents. Strikingly, I found that at the permissive
temperature, nusA I strains were specifically sensitive to the DNA damaging agents NFZ
and 4-NQO (Figure 1 A), which are the same DNA damaging agents to which a AdinB
strain is sensitive (26). These experiments were carried out at the permissive temperature
(30'C), a condition under which the sensitivity of the AdinB strain to NFZ is less than the
degree of sensitivity observed at 37C. I noted that the nusA I strain was considerably
more sensitive than the AdinB strain, implying that NusA may play a role in NFZ/4-NQO
resistance that is independent of DinB. Furthermore, the sensitivity of the nusAl] strains
to NFZ and 4-NQO can be complemented in trans at the restrictive temperature (42°C)
(Figure 1C-D). Efforts to construct a nusAllAdinB double mutant yielded what are
likely to be strains carrying suppressors since some isolates of the double mutants
displayed a synergistic phenotype, being much more sensitive than either single mutant,
while other isolates displayed an epistatic phenotype, where the double mutant resembled
a nusA ll single mutant. Although this phenomenon prevented me from being able to
unambiguously define the phenotype of the nusA]]AdinB double mutant, it is clear from
all these data that NusA is important for cellular survival after exposure to the DNA
damaging agents NFZ and 4-NQO, thus making nusA a novel gene involved in this
response. I can also conclude that the nusAll mutation at 300C very specifically affects a
function related to withstanding DNA damage that is genetically separable from the nusA
functions required for viability.
Due to the complications I encountered in my efforts to determine the phenotype
of the nusA I]AdinB double mutant, I decided to look at the viable AnusA mutant
constructed by Cardinale et al. (9) in a reduced genome background (MDS42) where
approximately 14% of the genome has been removed (9, 49). Working in this genetic
background allowed me to analyze the effects of a complete deletion of nusA in addition
to the nusAl] point mutant. I find that the AnusAAdinB double mutant is much more
sensitive to nitrofurazone than either of the single mutants (Figure 1B), suggesting that
perhaps it is the second class of nusAllAdinB strain described above that carries the
suppressor mutation. Interestingly, the AdinB single mutant does not display the same
degree of NFZ sensitivity as is seen in wild-type strains of E. coli, which possess the
original 14% of the chromosome that is missing in the reduced genome strain. These
data imply that NusA likely acts in a pathway with DinB as well as in a separate pathway
to allow cells to survive NFZ treatment.
In the reduced genome background, I find that both the nusAll and AnusA
mutants are sensitive to NFZ (Figure 2A and D). However, the AnusA mutant is more
sensitive than the nusAll mutant in this background. These data lend support to the
notion that the nusAll mutant is a partial loss of function mutant with respect to NFZ and
4-NQO survival. Additionally, I noticed that the AnusA strain is sensitive to wider
variety of DNA damaging agents compared to the nusA I strain. The AnusA strains are
sensitive to both ultraviolet (UV) radiation and to methyl methanesulfonate (MMS),
whereas the nusAll mutant is not (Figure 2 B-C and E-F). These data suggest that nusA
is generally required for survival after exposure to genotoxic stress, and suggest that there
are specific parts of nusA that are required for cellular survival after DNA damage.
Specifically, these analyses reveal that functions of nusA required for survival after
exposure to NFZ are genetically separable from those required for survival after UV
irradiation.
Peptide array analysis reveals that NusA preferentially binds to one surface of DinB
Previous analysis of the NusA peptides that interact with DinB identified a
potential DinB binding region on the surface of NusA that encompassed the residue
mutated in the nusAll allele (11). It was this observation that had originally stimulated
me to discover that overexpression of DinB results in suppression of the temperature
sensitivity of the nusA ll temperature sensitive allele, in a manner that required the
catalytic activities of DinB (11). I performed the reciprocal experiment by using
cellulose filter peptide arrays to search for peptides of DinB that potentially interact with
NusA. The membrane was probed with NusA and visualized with an anti-NusA
antibody. Interacting peptides were identified and mapped onto a structural model of
DinB (26). Interestingly, I found that the NusA-interacting peptides on DinB localize
mostly to a single face of the protein (Figure 3A). The binding of NusA to DinB maps to
the "back" surface of DinB, which is distinct from the interaction surfaces on the "front"
of DinB that interact with RecA and UmuD (18). These data suggest that the binding of
all of these potential modulators of DinB might be able to occur at the same time.
In an effort to design a DinB variant that is unable to interact with NusA, I
mutagenized several residues present in a group of strongly interacting peptides identified
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from the DinB peptide array. These mutants were scored for failure to serve as a
multicopy suppressor of the nusAI temperature sensitivity, implying a lack of genetic
interaction with nusA. I was able to identify one mutant of DinB, in which a surface
exposed lysine was mutated to a glutamic acid (K217E) (Figure 3A). When this variant
was overexpressed, it failed to suppress the temperature sensitivity of the nusAll strain
(Figure 3B).
I then looked to see whether the dinB(K2] 7E) mutant, which no longer exhibits a
functional genetic interaction with nusA, complemented the survival of a AdinB strain
after exposure to NFZ. I found that the expression of dinB(K217E), from a low copy
number plasmid under its native promoter, can restore the NFZ sensitivity of a AdinB
mutant at lower doses of NFZ, but is approximately 5-fold reduced for complementation
at higher doses of NFZ (2.251ag/mL-2.5 pg/mL) (Figure 3C). These data imply that, with
respect to survival after exposure to NFZ, DinB likely acts in a nusA-dependent as well as
nusA-independent manner. A possible explanation might be that DinB may act at stalled
transcription complexes in addition to at replisomes. Similarly, the greater sensitivity of
the nusA mutants to NFZ and 4NQO compared to a AdinB mutant implies that NusA
likely acts in a DinB-dependent as well as DinB-independent pathways with respect to
survival after DNA damage.
nusA mutants display phenotypes of altered DNA processing
Because of the phenotypes displayed in the nusAI 1 mutant at the permissive
temperature, I decided to look at the morphology of nusAll mutant strains. At the
permissive temperature, I found that the nusAll cells were elongated compared to wild-
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type (Figure 4A). Filamentation is a hallmark of SOS induction, due to in part to
induction of sulA as part of the SOS regulatory network, which blocks cell division. The
purpose of this filamentation is thought to be to keep the daughter chromosomes together
so that repair strategies based on homologous recombination can be employed.
Quantification of this filamentation phenotype revealed that nusAll cells were somewhat
elongated compared to wild-type, with a smaller population of cells displaying extreme
filamentation, more than 30 times the size of wild-type cells (Figure 4A). Since nusA
deletion mutants are viable in a background that has been deleted for cryptic prophages
(9), I considered the possibility that the filamentation seen in the nusAll background
might be due to partial induction of these cryptic prophages. In order to test this
hypothesis, I measured cell length of AnusA cells in this reduced genome background. In
this background, which is deleted for cryptic phages, the AnusA mutant similarly results
in filamentation (Figure 4B). These results suggest that the filamentation seen in the
nusAl] background is not likely due to induction of cryptic prophages, but rather to
another cellular process.
The similarities between the nusAll and lexA(Def) cells (which are deleted for
lexA as well as sulA so that cell division can occur) (Figure 4A) led me to question if the
filamentation seen in the nusAll background was sulA-dependent. Further analysis of
this mutant revealed that the filamentation seen in the nusAll background is sulA-
independent (Figure 4C). However, it is unclear as to what this may mean as there exist
examples of sulA-independent filamentation that is dependent on induction of the SOS
response (23). SOS induction is important for survival after exposure to NFZ or 4-NQO,
as is seen by the reduced survival of a lexA3(Ind) strain, a background in which the SOS
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genes are constitutively repressed (Figure 5). Furthermore, addition of either a AdinB or
nusAll mutation does not increase the sensitivity of a lexA3(Ind) strains, indicating that
NusA is only able to help cells cope with the lethal effects of DNA damage if the cells
are capable of inducing the SOS response. Nevertheless, the filamentation seen in the
nusAll background, led me to consider the possibility that the nusAll cells were
displaying a phenotype of chronic partial SOS induction.
SOS induction can occur in cultures of strains carrying certain mutations even
without the addition of exogenous DNA damaging agents, a phenomenon known as
chronic partial SOS induction. Such chronic partial induction can occur either because
all cells are partially induced for the SOS response or because only a sub-population of
cells becomes induced (36, 44). Utilization of a reporter in which GFP is placed under
the control of a LexA regulated promoter (PsulA), integrated into the attB locus on the
chromosome (36), allowed me to monitor SOS induction on a single cell level. Analysis
of cells grown at the permissive temperature revealed that approximately 2.5% of nusA ll
cells are induced for the SOS response in comparison to wild-type or lexA(Def) controls
in which SOS induction is -0. 1% or 100% of cells respectively (Figure 6A-D). Thus, at
the permissive temperature the nusA]] strains exhibit chronic partial SOS induction. The
chronic partial SOS induction exhibited in the nusAll mutant is reminiscent of mutants
that have altered DNA processing such as uvrD (3'--5' DNA helicase II) (47) and dam
(GATC-specific DNA methylase) (35, 48) that display this two-population chronic partial
SOS induction (36). Thus my observations suggests that NusA plays a role in
maintaining chromosomal integrity even in cells that have not been exposed to an
exogenous DNA damaging agent.
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Is this chronic partial SOS induction seen in a sub-population of nusAll cells
caused by an accumulation of ssDNA? To answer this question, I monitored the presence
of ssDNA through the formation of RecA-GFP foci, using a RecA-GFP translational
fusion integrated into the chromosome (51). Wild-type E. coli strains grown at the
permissive temperature accumulate RecA-GFP foci in approximately 2% of the
population with 72% of those foci located at the poles (Figure 6 E and H). Polar RecA-
GFP foci have been observed before and are thought to be RecA storage structures (51).
If wild-type strains are irradiated with UV, all cells then have RecA-GFP foci (Figure 6F
and H), an indication that this RecA-GFP fusion is responding to DNA damage.
Approximately 19% of nusAll cells, grown at the permissive temperature without the
addition of exogenous DNA damaging agents, have RecA-GFP foci with 64% of those
foci being present at the poles (Figure 6 G-H). These data are consistent with nusAll
cells having more ssDNA present, which results in induction of the SOS response. Also
there is precedent for RecA-GFP foci forming without SOS induction in response to
DNA damage (60), which may explain why there are more RecA-GFP foci than SOS
induced cells in the nusAll strain. Together, these data show that the nusAll mutation
displays phenotypes reminiscent of mutations in genes involved in DNA processing and
suggest a role for nusA+ in the maintenance of DNA. The inferred presence of ssDNA in
the nusA I background lends support to my proposed model of transcription-coupled
translesion synthesis (11), in which NusA recruits TLS polymerases to fill in gaps
opposite lesions on the transcribed strand potentially allowing for the continuation of
transcription (Figure 10).
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Interactions between nusA and nucleotide excision repair
My data show that nusA+ is required to promote survival after exposure to DNA
damaging agents and suggested a role for NusA beyond its involvement with DinB/TLS
polymerases. Intriguingly, a high-throughput screen looking at the E. coli protein
interactome identified NusA as an interaction partner of the nucleotide excision repair
(NER) factor UvrA (8). These results suggested to me that NusA might play a role in a
type of transcription-coupled repair (TCR). In E. coli, as well as in other organisms, UV
photoproducts are preferentially repaired on the transcribed compared to the non-
transcribed strand (37, 38), a phenomenon known as transcription coupled repair. In E.
coli TCR is initiated by the stalling of RNAP by a lesion in the transcribed strand, which
is then recognized by the transcription coupling repair factor, Mfd (59). Mfd is capable
of translocating the stalled RNAP, exposing the damaged DNA, and recruiting NER to
repair the lesion (58). Thus, the interaction between NusA and UvrA was of particular
interest as UvrA is the first NER protein recruited to stalled RNAP's during Mfd-
dependent transcription-coupled repair.
To determine if the physical interaction between NusA and UvrA was relevant in
vivo, I performed epistasis analysis for the nusAll, AdinB and AuvrA alleles. These
analysis revealed that the AuvrA strain is much more sensitive to NFZ than the nusA l or
AdinB single mutants (Figure 7A), suggesting that the major pathway for dealing with
NFZ-induced damage is through NER. Intriguingly, I discovered that addition of either
the nusAll or AdinB mutation to a AuvrA background did not further sensitize the cells to
NFZ, with uvrA displaying an epistatic relationship to both nusA and dinB. These data
support the notion that NusA acts in the NER pathway in addition to the TLS pathway.
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The epistatic relationship between dinB and uvrA may imply a role for DinB in gap
filling step of NER as has been implicated for pol kappa in eukaryotes (45).
One possible explanation for the genetic interaction between nusA and uvrA is
that NusA is involved in a pathway of transcription coupled repair. To test this
hypothesis, I similarly performed epistasis testing with nusAll, AdinB and Amfd. To my
surprise, I found that for both NFZ and 4NQO mfd displayed an additive phenotype with
AdinB and nusAll, implying that they function in separate pathways (Figure 7B-C).
While the additive phenotype between the nusAll and Amfd alleles could imply that
NusA is not involved in TCR, it could also implicate NusA in the process of transcription
coupled repair but in a manner that is Mfd-independent, comprising a novel class of the
transcription coupled repair pathway. A novel class of NusA-dependent TCR would be
of particular interest as transcription-coupled repair has been thought to be less important
in bacteria than in eukaryotes. However this inference could be incorrect if there exists a
second class of TCR, NusA-dependent TCR, which has not been previously recognized.
Screen for RNA polymerase mutants with altered ability to deal with nitrofurazone
The roles for nusA+ in transcription elongation and termination have been
appreciated for many years, but my data suggest a role for nusA in helping cells to cope
with the lethal effects of DNA damage. The sensitivity of AnusA and nusAll mutants to
DNA damaging agents indirectly suggest a role for transcription/RNAP in the NusA-
dependent events that help promote survival. However, I was interested in establishing a
direct link of RNAP to DNA damage repair/damage tolerance through NusA. Using
mutagenized plasmid libraries of rpoB (54), the P catalytic subunit of RNAP, I screened
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for mutants of rpoB that displayed altered ability to deal with NFZ-induced damage,
compared to an rpoB+ plasmid control. These mutant variants of rpoB, generated by
random PCR mutagenesis, are regulated by an IPTG inducible promoter and, under
induced conditions, it has been estimated that approximately 85-90% of cellular RNAP's
have incorporated the plasmid-encoded His 6-tagged subunit, with the wild-type genomic
copy of rpoB still expressed (54).
Mutagenized plasmid libraries were introduced into wild-type E. coli cells
(AB 1157) and screened at 370 C for either NFZ sensitivity (NFZ s) or NFZ resistance
(NFZR), compared to rpoB+ plasmid control. Out of-800 mutants screened, 36 mutants
were isolated that, when expressed in wild-type E. coli, displayed altered cellular survival
after NFZ exposure. 6 NFZR mutants and 30 NFZ s mutants were isolated in this screen.
This was not a full coverage screen. I decided to further characterize existing mutants
rather than continue to screen for more, since I isolated such a high percentage (-4.5%)
of mutants which, when expressed in wild-type E. coli, displayed an altered response to
NFZ. NFZ sensitive or resistant phenotypes were confirmed by a second round of
screening and mutations were identified by sequencing. All types of mutations from
missense, nonsense and silent base substitutions to frameshift mutations were isolated
(Table 1), and several carried more than one mutation. Interestingly, all the mutations
mapped to the N-terminal half of rpoB. While this may mean that not enough mutants
were screened in order to be able to isolate mutations in the C-terminal half, it suggests
that there is a specific function in the N-terminal portion of rpoB required for dealing
with NFZ related damage.
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By eliminating mutants with many amino acid changes, nonsense mutants and
frameshift mutants, in consultation with Bob Landick (U.W. Madison) I then selected
mutants that displayed robust NFZs/R phenotypes for further characterization. NFZs
mutant rpoB(D185Y) and NFZ R mutants rpoB(V287A), rpoB(D320N) displayed either
10-fold sensitivity or 10-fold resistance to NFZ compared to the rpoB+ plasmid control
(Figure 9A). None of these mutants showed altered cellular survival after UV irradiation
nor did they display rifampicin resistance (data not shown). Several of the NFZR
mutations including, rpoB(V287A) and rpoB(D320N), affect residues that are located on
the surface of the RNAP when mapped onto the crystal structure of the T. thermophilus
RNAP elongation complex (65). The rpoB(D185Y) (NFZs ) mutation affects a residue
that could potentially make contact with the DNA (Figure 8).
How is it that these mutant RNAP's are able to alter cellular survival after
exposure to NFZ? In order to address this question I expressed these variants in a
variety of mutant backgrounds, and scored cellular survival after exposure to NFZ.
Strikingly, I found that NFZs mutant, rpoB(D185Y), loses this sensitive phenotype in
either a nusAll background at 300C or a AuvrA background at 370C (Figure 9A-C).
Similarly, NFZR mutants rpoB(V287A) and rpoB(D320N), confer the same survival after
NFZ exposure as the rpoB+ plasmid control in a AuvrA background (Figure 9C).
Analysis of the class of NFZR mutants in the nusA I background were complicated by
the rpoB+ plasmid control, which is not as sensitive to NFZ at 300 C as is seen at 37C
(data not shown), thereby making it difficult to determine if these variants displayed a
resistant phenotype in the wild-type background. Nevertheless in the nusAll
background, the NFZR mutants, rpoB(V287A) and rpoB(D320N), displayed similar levels
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of sensitization as the rpoB+ plasmid control (Figure 9B), implying that these effects were
nusA-dependent. These data indicate that the ability of these RNAP mutant variants to
display altered NFZ effects is dependent upon nusA+ and uvrA+. The dependence of the
rpoB NFZR and NFZs phenotypes on nusA+ and uvrA+ lends support to the model of
alternative NusA-dependent transcription-coupled repair described above and in
discussion. In contrast, in a AdinB mutant background, rpoB(D185Y) (NFZS), retains
some sensitivity, while the NFZR mutants, rpoB(V287A) and rpoB(D320N), continue to
display NFZR compared to the rpoB+ plasmid control, even though the resistance of these
mutants in a AdinB background is slightly greater than the NFZR seen in the wild-type
background (Figure 9D).
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DISCUSSION
My previous observation that the essential RNA polymerase modulator NusA
physically and genetically interacts with the translesion DNA polymerase DinB led me to
investigate the potential role for NusA in the DNA damage response. In so doing, I
discovered that NusA plays an important role in helping cells deal with the lethal effects
of DNA damage in Escherichia coli.
I report that nusA mutant strains are sensitive to DNA damaging agents.
Specifically I show that nusAll(ts) strains, at the permissive temperature, are specifically
sensitive to NFZ and 4-NQO, while AnusA strains, in a reduced genome background, are
sensitive to a wider variety of DNA damaging agents, including UV radiation. I have
previously suggested a model of transcription-coupled translesion synthesis (TC-TLS) to
explain the genetic interactions between dinB and nusA (11) (Figure 10). While the
sensitivity to DNA damaging agents in strains with altered nusA function is consistent
with this model, my results also suggest that NusA acts in another pathway independent
of DinB that helps cells to survive after DNA damage.
Peptide array analysis of the surfaces of DinB that interact with NusA allowed me
to generate mutants that could potentially disrupt this interaction. Characterization of one
such mutant suggests that DinB likely functions in nusA-dependent as well as nusA-
independent pathways. These separate pathways might possibly involve i) DinB acting at
the replisome and ii) DinB being recruited by NusA to sites of RNA polymerases that
have been stalled by gaps in the transcribed strand, as is suggested by my model of TC-
TLS.
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Furthermore, I report that, at the permissive temperature, nusAll strains are
elongated and display chronic partial SOS induction. These phenotypes are often seen in
strains that have mutations in genes that are involved in DNA processing. These data
suggest that, in addition to its roles in transcription elongation, NusA may also be
involved in maintaining the integrity of the chromosome. Analysis of RecA-GFP foci in
a nusA I background showed an accumulation of RecA-GFP foci at the permissive
temperature, compared to nusA+ strains. These observations suggest that nusAll cells
have a higher frequency of single stranded gaps in their DNA. Such single stranded gaps
could arise from the inability of the mutant NusAl 1 protein to recruit TLS polymerases
to gaps that have resulted from DNA damage by endogenous DNA damaging agents.
Roles for NusA in promoting cellular survival after DNA damage also extend
beyond a pathway involving DinB. I propose an alternative model of transcription-
coupled repair, in which NusA participates in a previously unrecognized class of
transcription-coupled repair (Figure 10). Data supporting this model include the epistatic
relationship between nusA and uvrA, the gene encoding the first NER protein to be
recruited during Mfd-dependent TCR. Also, sensitivity to a wider variety of DNA
damaging agents observed in the AnusA mutant support that NusA is involved in the
repair of a variety of DNA lesions. These data imply that the functions of NusA required
for survival after NFZ exposure are genetically separable from those required for survival
after UV irradiation, suggesting the possibility of isolating a mutant of nusA that
displayed the phenotype of UVs but NFZR.
The additive phenotype between the nusAl] and Amfd alleles implies that NusA
is functioning separately to Mfd, the known transcription-coupling repair factor in E. coli.
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While these data could imply that NusA is not involved in TCR, it could also implicate
NusA in a previously unrecognized class of transcription-coupled repair. This is an
attractive model considering that TCR is thought to be a more prominent pathway for the
removal of DNA lesions in eukaryotes compared to bacteria, a rationale based on the
view that eukaryotic cells spend more time in a quiescent state compared to bacteria.
However, in the environment bacteria are not always growing under lab conditions of
plentiful nutrients. Thus the existence of a novel class of hitherto unrecognized TCR
could imply that TCR is as important in bacteria as in eukaryotes.
Additionally, I have genetic evidence for a role for RNA polymerase in the nusA-
dependent events that help promote survival after DNA damage. A screen for mutants of
rpoB, the P catalytic subunit of RNAP, revealed several rpoB mutants that either
displayed NFZ resistance or sensitivity compared to an rpoB+ plasmid control. This
ability to confer NFZ resistance or sensitivity when expressed in a wild-type background
is dependent upon nusA+ and uvrA+, as these mutants act as the rpoB+ plasmid control in
a nusAll or AuvrA background. When expressed in a AdinB background, NFZ resistant
mutants still confer NFZ resistance, although to a greater extent than displayed in a wild-
type background. These data suggest that dinB is either not involved in the NFZ
sensitivity/resistance displayed by these rpoB mutants or could also suggest that DinB
somehow interferes with the NFZ resistance of these mutants. These data support a
model of alternative NusA-dependent transcription-coupled repair, as the effects exerted
in strains expressing rpoB variants, is dependent upon nusA+ and uvrA+.
This is the first report of nusA+ involvement in DNA repair/damage tolerance
pathways in E. coli. Taken together my data suggests roles for nusA+ in DNA damage
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tolerance (through TLS DNA polymerases) as well as in DNA repair (through NER or
TCR). Furthermore, at the permissive temperature, nusAll strains display phenotypes of
altered DNA processing, suggesting that in addition to roles in transcription elongation/
termination, nusA+ is required to maintain chromosomal integrity.
In order to explain my observations I have suggested two models; a model of
transcription-coupled translesion synthesis (TC-TLS) and a model of NusA-dependent
transcription-coupled repair (NusA-TCR). In the model of TC-TLS, I hypothesize that if
an RNA polymerase encounters a gap in the transcribed strand opposite a lesion, it would
stall. In this case NusA, which is associated with the RNA polymerase throughout the
elongation phase of transcription, might then recruit a TLS polymerase to fill in the gap
in the template strand. Repairing the gap would permit transcription of the gene by
subsequent RNA polymerases, possibly even by the original RNA polymerase if it is
retained during process as in TCR. TC-TLS would provide a way of prioritizing the use
of the cells translesion DNA synthesis resources to benefit maximally transcription, the
same way TCR prioritizes nucleotide excision repair resources to maximally benefit
transcription. My model of NusA-TCR suggests that NusA, independently of Mfd, is
also able to recruit NER machinery to sites of RNAP stalled by a lesion in the transcribed
strand. However the molecular determinants of this model are unclear. Why the
existence of a second class of TCR? One intriguing possible explanation involves a
particular class of DNA lesion, such as an N2-dG lesion, which can be efficiently
bypassed by DinB and thus is not a hindrance during replication. However, such lesions
would cause a problem when transcription is attempted. In this case, a novel class of
TCR involving NusA could be important for the recognition and removal of these DNA
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lesions. Since some of these minor groove lesions are not efficiently recognized by
normal NER (6, 24), NusA-TCR could help a cell remove this class of lesions from its
DNA.
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MATERIALS AND METHODS
Bacterial strains and plasmids
The strains and plasmids used in this study are listed in Table 2 and constructed using
standard molecular biology techniques. Plasmids were maintained with ampicillin
(100tg/mL) when necessary.
DNA damage sensitivity assays
Sensitivity to DNA damaging agents was determined essentially as described previously
(4, 26). Briefly, independent overnight E. coli cultures grown in LB medium were
diluted in M9 minimal starts and plated on LB agar containing DNA damaging agent
nitrofurazone, 4-NQO, or MMS. For UV survival assays, cells were plated on LB agar
and then irradiated with UV light (0-40 J/m 2) by using a G 15T8 UV lamp (General
Electric) at 254 nm, then incubated in the dark. A concentrated stock solution of each
DNA damaging agent was first made in N,N-dimethylformamide (for NFZ and 4-NQO),
stored at -200C, and diluted appropriately for each experiment. Percent survival was
determined relative to growth in the absence of DNA damaging agent.
Live cell microscopy
Live-cell microscopy was performed as described previously (61, 62). Aliquots of cells
were then stained with the membrane dye FM4-64 (240 ng/ml to 1 tg/ml; Molecular
Probes). Cells were then placed on a pad of 4% low melt agarose in a solution of M9
minimal salts and covered with a coverslip. The following Chroma filter sets were used:
41002b (TRITC) for FM4-64 and 41012 for GFP. Images were acquired using a Nikon
E800 microscope with a charge-coupled device camera (Hamamatsu; model C4742-95)
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and OpenLab software (Improvision). Images were colorized in OpenLab and then
transferred to Photoshop (Adobe) for figure assembly.
Protein purification
Purification of NusA was achieved by expression of NusA from pNusA in BL21(DE3)
pLysS cells and induction with 100pM IPTG at an OD 600 of 0.5 for 4 hours at 300 C.
Cultures were harvested by centrifugation and subjected to lysozyme treatment. The
resulting lysate was treated with DNAse and purified using Ni-NTA resin from
QIAGEN.
Peptide array mapping
Cellulose filter peptide array consisting of 10-mer peptides scanning the primary
sequence of DinB, each peptide offset by 2 residues from the previous (MIT CCR Core
Facility) were probed with 5pM purified recombinant His-NusA and developed with an
anti-NusA antibody (Neoclone) as described in (42). Control peptide array was
performed as described above except without a NusA incubation step.
RNA polymerase mutant screen
Mutagenized libraries of pRL706 (54) transformed into ABI 157 were grown in LB
medium supplemented with ampicillin induced with 1mM IPTG. Cultures were diluted
in M9 minimal salts and 10-fold dilutions stamped onto LB agar containing either 0 or
2pg/mL NFZ with a 96 well pin replicator. Plates were incubated at 370C and scored for
NFZ sensitivity or resistance the next day.
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Figure 1. nusA mutant cells are sensitive to DNA damaging agents. A) Percent survival
of strains (AB 1157 derivatives) treated with either 2pg/mL NFZ (black bars) or 2pg/mL
4-NQO (gray bars) at 300C, shows that at the permissive temperature nusAll strains are
sensitive to the same DNA damaging agents as AdinB. In this and all graphs in this
figure, error bars represent the standard deviation determined from three independent
cultures. B) Percent survival of strains treated with 1 pg/mL NFZ, shows that in the
reduced genome background (MDS42) AnusA strains are also sensitive to NFZ and the
AnusAAdinB double mutant is more sensitive than either of the single mutants. C-D)
Complementation of nusAll sensitivity to C) NFZ and D) 4NQO in trans at the
restrictive temperature 42oC. Black lines/symbols represent wild-type (AB 1157) and red
lines/symbols represent nusAl] strains. The empty vector (pBR322) is shown as squares
and pNusA (pNAG2010) is shown as triangles.
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Figure 2. Comparison of the nusAI I and AnusA mutation in the reduced genome
background (MDS42). A-C) Percent survival of MDS42 (squares) and AnusA (triangles)
to the DNA damaging agents NFZ, UV and MMS respectively at 37C, show that AnusA
strains are sensitive to a wide variety of DNA damaging agents. D-F) Percent survival of
MDS42 (squares) and nusAl] (diamonds) to the DNA damaging agents NFZ, UV and
MMS respectively at 300C, show that nusAll strains are specifically sensitive to NFZ.
Error bars represent the standard deviation determined from three independent cultures.
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Figure 3. Mapping peptides of DinB that interact with NusA. A) Peptide array mapping
of the NusA binding surface on DinB reveals that NusA preferentially binds to only one
side of DinB. DinB homology model (in blue) and NusA interacting peptides (shown in
red). Inset displays a magnification of the thumb region of DinB with the K217 residue
shown in red. B) Overexpression of the dinB(K217E) (pYG782-K217E) mutant in fails to
suppress the temperature sensitivity of the P90C nusAll temperature sensitive strain
(SEC29) compared to dinB+ (pYG782). C) Complementation of nitrofurazone
sensitivity of the AB 1157 AdinB strain. Reveals that expression of dinB(K2] 7E)
(triangles) from a low copy number plasmid under its native protomer (pGY768-K217E)
does not completely complement the nitrofurazone sensitivity of a AdinB strain, as
compared to dinB+ (pYG768) (squares) and the empty vector/pWSK29 (diamonds). In
graphs B) and C), error bars represent the standard deviation determined from three
independent cultures.
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Figure 4. nusA mutant cells are elongated. A) Cell length distributions of wild-
type/AB l157 (black bars), lexA(Def) (open bars) and nusAl (SEC164) (grey bars),
show that nusAll strains are elongated compared to wild-type and similar to lexA(DEF).
B) Cell length distributions of wild-type/MDS42 (black bars) and AnusA (grey bars),
shows that AnusA strains are also elongated compared to a wild-type control. C) Cell
length distributions of wild-type/AB 1157 (black bars), AsulA (TP651) (open bars), and
nusAllAsulA (SEC524)(grey bars), show that filamentation seen in the nusAll strains is
sulA-independent.
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Figure 5. A role for the SOS response in survival after exposure to nitrofurazone. At a
concentration of 2pg/mL nitrofurazone, lexA3(Ind-) (DM49) mutants are very sensitive to
nitrofurazone and this sensitivity is not exaggerated by the addition of either AdinB
(SEC900) or nusAll (SEC813) mutation. These experiments were done at the
permissive temperature (30'C). Error bars represent the standard deviation of three
independent cultures.
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Figure 6
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Figure 6. nusAll cells display phenotypes of altered DNA processing. A-C)
Representative micrographs of A) wild-type (AB 1157) (SEC677), B) lexA(Def)
(SEC678) and C) nusAl] cells (SEC679). Cell outlines (shown in red) were visualized
with the vital membrane stain FM4-64, and SOS induction as monitored from PSuIA-GFP
fusion (shown in green). D) Quantification of SOS induced cells show that at the
permissive temperature nusAll cells display chronic partial SOS induction. E-G)
Representative micrographs of E) wild-type/AB 1157 cells, F) wild-type/AB 1157 cells
irradiated with 25 J/m UV, and G) nusAlI cells. Cell outlines (shown in red) were
visualized with the vital membrane stain FM4-64, and RecA-GFP foci are shown in
green. H) Quantification of RecA-GFP foci, show that at the permissive temperature
nusAll cells have more RecA-GFP foci compared to nusA+.
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Figure 7. Interactions between nusA and nucleotide excision repair. A) Nitrofurazone
killing curve, shows that AuvrA (closed circles) (SEC 316) strains are more sensitive to
NFZ than wild-type/AB 1157 (squares), AdinB (closed triangles) or nusA I (closed
diamonds) (SEC 164) strains. Furthermore AdinBAuvrA (open triangles) (SEC317) or
nusAllAuvrA (open diamonds) (SEC318) strains are not any more sensitive and a AuvrA
alone. Doses of nitrofurazone are in pg/mL. In this and all graphs in this figure, error bars
represent the standard deviation determined from three independent cultures. B) At 30'C
nusAll (SEC164) and Amfd strains show an additive phenotype with respect to
nitrofurazone (2 pg/mL) sensitivity. C) AdinB and Amfd strains show an additive
phenotype with respect to nitrofurazone (2 pg/mL) sensitivity at 370C.
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Figure 8. Position of residues affected by NFZs or NFZR RNA polymerase mutants on
the crystal structure of T. thermophilus RNAP elongation complex. DNA is shown in
green. RNA is shown in red. rpoB, P catalytic subunint, shown in grey and the 3'
catalytic subunit, encoded by the rpoC gene, is shown in pink. NFZ resistant mutants are
shown in cyan and NFZ sensitive mutants are shown in blue. Position of mutants
characterized in figure 9 (Asp320, Va1287 and Asp 185) are labeled.
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Figure 9. rpoB mutants show altered survival after nitrofurazone treatment. A-D)
Quantification of selected rpoB mutants in a variety of backgrounds. A) wild-
type/AB1157, B) nusAll, C) AuvrA, and D) AdinB. All experiments were done at 370 C
except for those done in a nusAll background, which were performed at 300 C.
Concentration of nitrofurazone is 2 pg/mL. Error bars represent the standard deviation
determined from three independent cultures.
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Figure 10. Models of transcription-coupled translesion synthesis (TC-TLS) and
alternative transcription-coupled repair (TCR). A) In the model of TC-TLS NusA,
associated with elongating RNA polymerases, can recruit TLS polymerases to fill in gaps
opposite to lesions in the transcribed strand in order to allow for the continuation of
transcription. B) A new class of TCR, NusA-dependent TCR, where NusA participates in
a previously unrecognized branch of the TCR pathway. NusA is capable of recruiting
NER to sites of stalled RNAP's to repair DNA lesions on the transcribed strand.
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Table 1. RNA polymerase mutants isolated as nitrofurazone resistant or sensitive
Plasmid Mutation Amino acid Amino Acid Phenotype
name DNA position: resuide change
Change number
1A6 847:A--T 283 Lys->Stop Sensitive
867: T4-A 289
1174: G--A 392
1A10 * Sensitive
1F5 801: C-A 267 Arg-Arg Sensitive
1221: T-)C 407 Arg4Arg
1280: A-)G 427 Asp -Glu
1G12 495: T--C 166 Ser-)Pro Sensitive
607: -1
frameshift
1H7 460: G-A 154 Gly- Ser Sensitive
920: C-A 307 Gly-)Gly
1179: C-)T 393 Asn--Asn
1BI * Sensitive
1C7 * Resistant
2A7 553: G-T 185 Asp-)Tyr Sensitive
2F4 * Sensitive
2E9 31: A-G 11 Ile4Val Sensitive
55:C--T 19 Pro--Ser
352:A-G 118 Lys-Glu
2F8 * Sensitive
4A8 860: T-)C 287 Val-)Ala Resistant
4B8 * Sensitive
4F2 1153: T4C 385 Phe-4Leu Resistant
457: C-)T 153 Pro-) Ser
727:AT- 244 Glu--Val
4H3 108: G-)A Resistant
901: T-+A
931: T4A
1032:-1
frameshift
5A2 * Sensitive
5El 1 772: A-)T 258 Asn-)Tyr Sensitive
5G3 958:G-A 320 Asp-Asn Resistant
6DI * Resistant
7A3 1637: A-G 546 Glu-Gly Sensitive
1179:-1
frameshift
7D9 1529: A-G 510 Gln4-Arg Sensitive
1561:C-T 521 Leu- Leu
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1679: -1
frameshift
7D12 1792:G-T 598 Val-Phe Sensitive
1973:A-G 658 Gln--Arg
2377:G->T 793 Glu--Stop
7F3 1964:T--C 655 Val--Ala Sensitive
2278:A-G 760 Asn-)Asp
7F7 2258:T4C 753 Leu-)Pro Sensitive
7F10 1157:T-4G 506 Phe- Cys Sensitive
9A7 1315:A->G 439 Lys->Glu Sensitive
9A10 1606: G--A Sensitive
1979: -1
frameshift
9B10 1596: A-T 532 Ala-Ala Sensitive
1898: T->A 633 Leu- H-is
1974: G-T 658 Gln--His
9Bl * Sensitive
9C5 1702/1703: 568 Asn-Gly Sensitive
AA--GG
1875: A->T 625 Glu-Asp
9C7 1317: A-G 439 Lys-Arg Sensitive
1493: T-C 498 Ile-Thr
9D3 1845: T-)C 615 Val--Val Sensitive
2235: A--G 745 Glu-)Glu
2372: T-*C 791 Leu-Pro
9E2 1328: A4T 443 Asp--Val Sensitive
9F7 2228: C--T 743 Pro -Leu Sensitive
2333: A-G 778 Glu-Gly
2482: T-C 828 Phe--Leu
9G10 1836:C--T 612 Gly--Gly Sensitive
1948: G-A 650 Val-Ile
1985: C-)A 662 Ser-)Thr
2016: A-)T 672 Glu-- Asp
*Sequencing of these mutants either failed completely or was not able to identify
mutation
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Table 2. Strains and plasmids used in this study
Strains Genotype Reference
AB 1157 thr-1 leuB6 proA2 hisG4 Ihil argE3 lacYl Lab Stock
galK2 ara-14 xyl-5 mil-1 isx-33 rpsL31 supE44
AB1157 As ABI 157 except AdinB::frt This work
AdinB: :frt
(SEC95)
SEC164 As ABI 157 except nusA 1 zha0132::Tn10 This work
TP651 As ABI 157 except AsuIA::Tet Murphy et al.,
2000
CAG 12127 Lai- sf 'B3198::Tn 10 Okan rph- 1 CGSC
SEC302 As AB 1157 except msAll sfvB3198::Tnl0kan This work
SEC524 As SEC302 except AsulA::Tet This work
AB1157 As AB1157 except lexA 300::Spc sulA ll Lab Stock
lexA(Def)
SS996 F- lacAMS286 argE3 his-4 thi-1 xyl-5 mtl-i McCool et al.,
sulB103 del(attB):PsulA-gfp 2004
CAG18341 nadA3052::TnlOkan, rph-1 CGSC
SS996 nadA As SS996 except nadcA3052::TnlOkan This work
SEC677 As AB 1157 except del(attB):PsulA-gfp This work
SEC678 As AB 1157 except lexA300::Spc sulA]] This work
del(attB):PsulA-gfp
SEC679 As SEC164 except del(attB):PslA-gfp This work
SS3041 F- lacM1S286 argE3 his-4 thi-1 xyl-5 mtl-i Renzette et al.,
sulB 03 ygaDl::kan recAol403 2005
recA4136:: gfp901
SEC477 As AB 1157 except ygaD1::kan recAo1403 This work
recA 4136: :gfp901
SEC604 As SEC 164 except ygaD]::kan recAol403 This work
recA4136: :gfp901
JW4019-2 F-, A(araD-araB)567, AlacZ4787(::rrnB-3), Baba et al., 2006
LAM, rph-1, J(rhaD-rhaB)568,
JuvrA753::kan, hsdR514
SEC316 As AB 1157 except AuvrA753::kan This work
SEC317 As SEC95 except AuvrA753..kan This work
SEC318 As SEC164 except AuvrA753::kan This work
AB 1157 As AB 1157 except Amfd::kan Selby and Sancar,
Amfd: :kan
AB 1157 As AB1157 except AdinB::Cm Jarosz et al., 2006
AdinB::Cm
SEC194 As AB 1157 except Amfd::kan AdinB::Cm This work
SEC 199 As SEC164 except Amfd::kan This work
DM49 As AB 1157 except lexA3(Ind-) Lab stock
SEC900 As DM49 except AdinB::frt This work
136
SEC813 As DM49 except nusAll zha0132::Tn]O This work
MDS42 MG1655 with -14% of genome deleted Posfai et al., 2006
MDS42AnusA As MDS42 except AnusA::Cm Cardinale et al.,
2008
MDS42 AdinB As MDS42 except AdinB749::kan This work
MDS42 nusAll As MDS42 except nusAll zha0132::Tn]O This work
SEC29 Same as P90C except nusAll zha0132::TnlO Cohen et al., 2009
JW0221-1 F, A(araD-araB)567, JdinB749::kan, Baba et al., 2006
AlacZ4787(::rrnB-3), LAM, rph-1, A(rhaD-
rhaB)568, hsdR514
Plasmid
pWSK29 Vector, pSC 101-like replicon, AmpR Jarosz et al., 2006
pYG768 DinB under its native promoter in a low copy Kim et al., 1997
number pWSK29 plasmid
pYG782 dinB ene cloned in the pWSK30 plasmid Kim et al., 1997
(Amp ) which is the same as pWSK29 but with
the MCS cloned in the opposite orientation
under the lac promoter
pYG768(K217E) As pYG768 with indicated mutation introduced This work
using quickchange site-directed mutagenesis
pYG782(K217E) As pYG782 with indicated mutation introduced This work
using quickchange site-directed mutagenesis
pRL706 Encodes C-terminal His6-tagged version of the Severinov et al.
rpoB gene, under control of a lac-repressor- 1997
regulated trc promoter cloned into pBR322,
AmpR
mutagenized As pRL706 except mutagneized by error prone Santangelo et al.,
pRL706 PCR 2003
pDFJ1 DinB expression plasmid under T7 promoter in Jarosz et al., 2006
pET 11t backbone; AmpR
pDFJ1(K217E) As pDFJ 1 with indicated mutation introduced This work
using quickchange site-directed mutagenesis
pNusA N-terminal His 6-tagged full length NusA cloned Mah et al., 1999
into pET11 d
pBR322 Empty vector, AmpR New England Bio
labs
pNAG2010 NusA cloned into pBR322 under its own Craven et al., 1994
promoter
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Chapter 5
A Novel DinB Variant Reveals Diverse Physiological
Consequences of Incomplete Extension by a Y-family DNA
Polymerase
This Chapter has been submitted for publication as: Daniel F. Jarosz, Susan E. Cohen,
James C. Delaney, John M. Essigmann, and Graham C. Walker. A novel DinB variant
reveals diverse physiological consequences of incomplete extension by a Y-family DNA
polymerase. My contributions include Figures 4, 5, 6 and Supplemental Figure 3.
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ABSTRACT
DinB and its mammalian ortholog pol rc catalyze proficient bypass of damaged
DNA in translesion synthesis (TLS). DinB is also the only Y-family DNA polymerase
conserved among all domains of life. Y-family DNA polymerases, including DinB, have
been implicated in diverse biological phenomena ranging from adaptive mutagenesis in
bacteria to several human cancers. Complete TLS requires dNTP insertion opposite a
replication blocking lesion and subsequent extension with several dNTP additions. Here
we report the first example of preferential TLS extension by any Y-family DNA
polymerase. We also describe a new class of TLS DNA polymerase mutant resulting
from mutation of an evolutionarily conserved tyrosine (Y79), generating a DinB variant
that catalyzes formal lesion bypass, but cannot finish the subsequent extension steps that
are required to complete TLS, stalling three nucleotides after an N2-dG lesion. Expression
of this variant in vivo dramatically enhances killing during challenge with DNA
damaging agents, transforming a bacteriostatic drug nitrofurazone into a bactericidal
drug. Diverse gene products modulate this toxicity associated with incomplete TLS
extension, including the toxin-antitoxin module MazEF and the iron import protein
TonB. Together, these results not only indicate that DinB is specialized to perform
remarkably proficient TLS insertion and extension, but also expose unexpected
connections between the products of incomplete TLS and cell fate.
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INTRODUCTION
Y-family DNA polymerases are found in virtually all organisms and possess the
remarkable ability to copy over lesions that would otherwise stall DNA replication, a
process termed translesion synthesis (TLS) (45). Such broadened substrate specificity
often comes at a mutagenic cost, however, as these enzymes display lower fidelities on
undamaged DNA templates than their replicative counterparts (9, 17, 20). Organisms
have therefore developed elaborate regulatory systems to restrict the access of Y-family
DNA polymerases to primer termini where TLS is required (1, 2, 4, 11, 12, 25, 26, 33,
55).
Studies of Y-family DNA polymerase function in prokaryotes, eukaryotes, and
archea have revealed that diverse mechanisms contribute to regulation of their function
(17, 18, 20, 47, 60). In E. coli, the function of both DinB (DNA pol IV) and UmuD'2C
(DNA pol V) is strongly influenced by interactions with the 3 processivity clamp of DNA
polymerase III (2, 3, 59) and the umuD gene products, UmuD2 and UmuD' 2 (10, 15, 49,
55, 57). Other protein-protein interactions, notably with single stranded DNA binding
protein (SSB) (10, 49), RecA (50-52), and RecFOR (13) also play critical roles in
regulating TLS. In eukaryotes, TLS is similarly controlled in numerous ways including
by association with the PCNA processivity clamp (1, 33, 44, 47, 64), interaction with
recombination proteins (40, 48), and by ubiquitylation of both PCNA and the
polymerases themselves (1, 4, 19, 26, 32, 44, 47).
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Several Y-family DNA polymerases display a remarkable intrinsic preference for
catalytic action on particular damaged substrates. Pol r from both S. cerevisiae and H.
sapiens copies preferentially over cyclobutane pyrimidine dimers (23, 37, 39), whereas E.
coli DinB and its mammalian ortholog M musculus DNA polymerase K (pol K) each
display strikingly elevated catalytic proficiencies for dC insertion across from certain N2-
dG lesions (21). Numerous diverse structural features of Y-family DNA polymerases
contribute to their novel catalytic capabilities. For example, relatively accommodating
active sites (35, 53, 63) and divergent C-terminal 'little finger' domains (5) have been
shown to facilitate TLS by several Y-family DNA polymerases. Specialized TLS
function does not arise exclusively from open active sites, however. Indeed, the active
sites of both pol K (36) and DinB (15) are somewhat closed under many conditions, and
this may occur at least in part through interaction with other proteins.
Although some of the multiple protein-protein interactions that govern access of
Y-family DNA polymerases to primer termini are understood, comparatively little is
known about their intrinsic biochemical preference for activity on particular damaged
substrates. Specific active site residues in both pol ri and DinB are critical for TLS
function. In E. coli DinB and S. cerevisiae pol rI, mutation of F13 or F34, respectively,
generates polymerase variants that are proficient for normal DNA synthesis but unable to
catalyze TLS (21, 43). Similarly, mutation of Y52 in human DNA polymerase ni
profoundly affects UV-induced mutagenesis, but does not alter its ability to perform
canonical DNA synthesis (14). Other such molecular determinants of TLS function
assuredly exist (5), some of which may be common to all Y-family DNA polymerases
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and others of which may be restricted to certain such polymerases according to their
distinct substrate specificities.
Complete TLS involves insertion of a nucleotide opposite an adducted base (i.e.
lesion bypass) and extension from that position by several subsequent nucleotide
additions. In eukaryotes, these steps are often catalyzed by at least two distinct DNA
polymerases (47). Replication by the TLS polymerase must continue for several
nucleotides beyond the site of DNA damage, greater than 5 nucleotides in the case of pol
V in E. coli, in order to avoid reversal by the proofreading activity of the replicative
DNA polymerase (11). Consistent with a role in surveying the products of TLS, the E.
coli dnaQ+ gene, which encodes the c proofreading subunit of DNA polymerase III (pol
III), affects several mutagenic phenomena that depend on dinB+ (29-31). Consequently,
regulating the length of the products formed during TLS appears to be of critical
importance, as those that are too small risk being removed by proofreading and those that
are too long may carry undue mutagenic potential.
More broadly, recent studies hint that TLS may be connected to cellular stress
response networks in unexpected ways (16, 41, 46). Curiously, lethality induced by
hydroxyurea (HU)-mediated dNTP depletion can be abrogated by UmuC variants that
lack several regulatory motifs, and this rescue requires dinB+ (16). Cytotoxicity from HU
exposure also requires the toxin-antitoxin modules mazEF and relBE (16); these genes
act synergistically to effect HU resistance in a wild-type background (6).
Here we report that DinB catalyzes strikingly proficient and preferential extension
after dC incorporation opposite an N2-furfuryl-dG DNA lesion. Moreover, a cluster of
aromatic hydrophobic residues surrounding DinB's 'steric gate' dictate its function in
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TLS extension. Specifically, we demonstrate that Y79, which is invariant among DinB
orthologs, critically influences the extension steps of DinB-catalyzed TLS. Our data also
indicate that cellular survival is coupled to completion of TLS and that the toxicity of
abortive TLS is mediated by both the toxin-antitoxin module MazEF and the iron import
protein TonB. These observations strongly indicate that the detailed execution of TLS is
coupled to fundamental aspects of cellular physiology.
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RESULTS
DinB catalyzes preferential extension on an N2-dG damaged template
We systematically analyzed the activity of wild-type DinB around a site-specific
N2-furfuryl-dG lesion by performing a series of staggered primer extension assays.
Individual standing start assays were performed using primers with 3' termini starting
four base pairs before the site of the lesion and ending four base pairs after the lesion
(Figure 1 A; Supplemental Table I). The apparent catalytic proficiency of DinB
(Vmax/Km) on the damaged template is comparable to an undamaged control for the first
several additions tested, and as we previously reported, DinB is exceptionally proficient
at catalyzing dC insertion opposite this lesion due to a reduced Km for dCTP on the
damaged substrate (21). Additionally, we found that DinB is even more proficient at
extending from the dC opposite the N2-furfuryl-dG lesion, showing a 25-fold increased
catalytic proficiency on the damaged template for this reaction (Figure IB). This striking
difference in activity arises primarily from a low Km for dATP addition at the +1 position
immediately following the the N2-furfuryl-dG lesion (Figure 1B). Subsequent extension
steps proceed with comparable efficiencies on both damaged and undamaged templates.
These observations reveal that in addition to highly proficient insertion opposite an N2-
furfuryl-dG lesion, efficient extension immediately after the lesion is also a specialized
function of DinB. The exceptional proficiency with which DinB catalyzes such TLS
supports our hypothesis that at least one of its key biological roles is to replicate over
ubiquitously occurring classes of N2-dG adducts (21, 22). Intriguingly, as described
below, an independent line of investigation pointed to the further physiological
importance of later extension steps that proceed with more modest proficiency.
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Aromatic residues surrounding DinB's steric gate are critical for its function
We previously reported that, in addition to its well established role in
discrimination against improper rNTP incorporation (7), the steric gate residue of DinB
(F13) is indispensable for its TLS function (21). This insight grew out of our efforts to
develop a structural model of DinB encountering an N2-furfuryl-dG lesion. We
subsequently undertook a more detailed examination of this model to ascertain whether
additional residues might contribute to the preferential activity of DinB on a damaged
substrate. We noted that F13 is surrounded by a cluster of aromatic residues: F12, F76,
and Y79 (Figure 2A). In our homology model, Y79 stacks with DinB's F13 steric gate,
while F76 and F12 are oriented with a rotation of roughly 90 degrees relative to it (Figure
2A). Provocatively, conservation of F12 is universal among Y-family DNA polymerases
(Figure 2B) and this residue corresponds to F34 of S. cerevisiae Pol Tr, mutation of
which selectively eliminates its TLS function (43). F76, in contrast, is comparatively
weakly conserved even among DinB orthologs. Y79 is invariant among DinB sequences
from diverse organisms. Intriguingly, E. coli UmuC also shares a tyrosine residue at this
position, whereas the related but functionally distinct enzymes Rev1 and Rad30 possess a
phenylalanine instead (Figure 2B).
To examine the effect of these amino acids on DinB function, we mutated each of
F12, F76, and Y79 to valine and examined the ability of low copy number plasmids
encoding these variants under the control of the wild-type dinB promoter to complement
the sensitivity of a AdinB strain to the DNA damaging agents nitrofurazone (NFZ) and 4-
nitroquinoline- I-oxide (4-NQO) (21). Mutation of F12 generates a DinB variant that is
unable to complement NFZ sensitivity, but shows a far less dramatic phenotype than the
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extreme sensitivity conferred by the steric gate mutant dinB(F13V) (Figure 2C). This
observation indicates that the equivalent phenylalanine residues in S. cerevisiae DNA
polymerase fl may have a unique function in that subfamily of TLS DNA polymerases.
Mutation of F76 also impairs complementation (Figure 2C), but again does not confer
similarly increased NFZ sensitivity to dinB(F13V). Strikingly, mutations that alter Y79
(Y79A, Y79V, Y79L) have a profound effect on sensitivity to both NFZ and 4-NQO
(Figure 2D-E). For example, a plasmid expressing DinB(Y79L) is not only unable to
complement the NFZ sensitivity of a AdinB strain, but also confers a further 10-50-fold
sensitivity beyond that of an empty vector control. These observations are consistent
with a critical role for Y79 in the in vivo bypass of N2-dG adducts, and reveal that its
mutation produces catastrophic effects when cells are exposed to NFZ or 4-NQO.
DinB(Y79) mutant proteins catalyze proficient lesion bypass
We initially suspected that the inability of DinB(Y79L) to restore NFZ or 4-NQO
resistance to a AdinB strain (Figure 2C-E) would be due to an inability to catalyze TLS
over the N2-dG lesions produced by these agents, just as the with DinB(F13V) mutant
protein we previously described (21). Unexpectedly, when we examined the TLS activity
of DinB(Y79L) in vitro, we discovered that it is entirely able to bypass an N2-furfuryl-dG
lesion and has comparable activity to wild-type DinB on undamaged DNA (Figure 3A).
However, the products synthesized by DinB(Y79L) are much shorter than those produced
by wild-type DinB and the majority appear to arise from stalled synthesis three
nucleotides past the site of the lesion. This phenomenon may arise from exacerbation of
a natural pause site at the +3 position, as wild-type DinB also shows modest
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accumulation of this product at lower enzyme concentrations. Notably, wild-type DinB
also stalls three nucleotides following the site of an N2-dG DNA-protein crosslink in
independent primer extension assays (42).
Expression of DinB(Y79L) does not result in an increased frequency of mutation
to rifampicin resistance upon NFZ treatment (4.2 + 2.0 x10 8 for pDinB(Y79L) vs. 5.5 +
3.0 xl 08 for pDinB; average mutation frequency and standard deviation from five
independent cultures), suggesting that any TLS it carries out in vivo is relatively accurate.
Thus, DinB(Y79L) defines a new class of Y-family DNA polymerase mutants that are
able to catalyze formal lesion bypass but are unable to finish the subsequent extension
steps that are required physiologically to complete TLS. These combined observations
strongly indicate that the extension steps of TLS have at least as much physiological
importance as lesion bypass itself.
To precisely recapitulate the TLS extension defect of DinB(Y79L) we examined
its activity on a primer synthetically elongated three base pairs beyond the site of the N2-
furfuryl-dG lesion. Whereas DinB(Y79L) retains roughly half of the activity of wild-
type DinB for this addition on an undamaged template, it is impaired by more than 20-
fold on the damaged substrate (Figure 3B). This result reveals that the stalling behavior
of DinB(Y79L) likely arises from communication between the lesion and the enzyme's
active site at the +3 position. There is an emerging precedent for such interactions with
the template past the site of synthesis dictating polymerase activity. Structural studies of
the archaeal DinB ortholog Dbh have revealed that its ability to catalyze -1 frameshift
mutagenesis in polyG regions requires specific interactions between the enzyme and the
template at the +3 position that stabilize an extrahelical base (62). Similarly, specific
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contacts between enzyme and template allow replicative DNA polymerases to couple
distal mismatch recognition to synthesis in the active site (24). Our observations
regarding DinB(Y79L) indicate that Y79 plays a critical role in catalysis at the +3
position during TLS.
We also tested whether the function of Y79 requires its hydroxyl group by
constructing a Y79F mutation. A plasmid expressing DinB(Y79F) fully complements the
NFZ sensitivity of a AdinB strain over the dose regime used in our initial experiments
(Supplemental Figure lA). Unexpectedly, pDinB(Y79F) confers remarkable resistance
to a AdinB strain when treated with a ca. 10-fold higher dose of NFZ (Supplemental
Figure 1 B). The reason for this effect is unclear, but it may indicate that Y79 either
participates in a specific hydrogen-bonding interaction(s) or is posttranslationally
modified under conditions of elevated NFZ exposure. Phosphorylation of Y79 is
unlikely, however, as deletion of either of the tyrosine kinases in E. coli (etk or wzc) does
not phenocopy the effects of pDinB(Y79F) at high NFZ doses (data not shown).
Interestingly, deletion of dinB itself confers relatively little sensitivity under these
conditions, suggesting that DinB(Y79F) likely either gains a function that promotes
survival or interferes with a process that mediates cell death.
Genetic interactions between dinB and the s proofreading subunit of DNA Pol III
Although DinB(Y79L) and DinB(F13V) are both unable to carry out complete
TLS, it is unclear why their expression causes such a profound increase in killing by NFZ
in a AdinB strain (Figure 2C,D) and even strikingly in a wild-type dinB+ background
(Figure 4A). In contrast, a plasmid expressing the catalytically deficient DinB(cat-)
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mutant protein, which also cannot carry out TLS, does not cause a similar increase in
NFZ sensitivity (Supplemental Figure 2). These observations, along with the
biochemical properties of DinB(Y79L) and DinB(F13V), hinted that these mutant
proteins may exert their effects during NFZ exposure by inducing a futile cycle in which
the immature TLS intermediates they produce are constantly destroyed by the action of
the c proofreading activity of DNA polymerase III, encoded by the dnaQ+ gene. A
similar behavior has been observed for pol V (11). Indeed, recent studies have revealed
that extension of a TLS product by a single base pair is sufficient to rescue it from e-
mediated degradation (12).
We therefore examined the effects of DinB(Y79L), DinB(F13V), and
DinB(Y79F) expression in a AdnaQ dinB+ background. Deletion of dnaQ does not
prevent DinB(Y79L) or DinB(F13V) expression from conferring increased sensitivity to
NFZ in a dinB+ background (Figure 4A-B). E. coli strains bearing dnaQ deletions
commonly acquire suppressor mutations in dnaE, referred to as spq-2 (34, 54); the spq-2
suppressor mutation does not affect the phenotypes of any of the dinB alleles used in this
study (data not shown). We also employed the dnaQ903 allele, which encodes an c
variant that lacks one its three exonuclease domains as well as the C-terminal amino acids
that are required for interaction with the at catalytic subunit of DNA polymerase III (54,
56). The striking mutator frequency of strains bearing dnaQ903 indicate that it is
defective in proofreading function (56). Expression of either DinB(F 3V) or
DinB(Y79L) still enhances NFZ killing in a dnaQ903 strain (Figure 4C) compared to a
vector control. Curiously, we observed a strikingly reduced transformation efficiency of
pDinB in the dnaQ903 strain (Figure 5C) and the infrequent pDinB transformants that we
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did obtain displayed highly variable phenotypes, suggesting that they had acquired
suppressor mutations. These results indicate that the NFZ killing seen upon DinB(F13V)
or DinB(Y79L) expression is not primarily due to a futile cycle of abortive TLS followed
by proofreading. Indeed, further experiments following up on these unexpected findings
revealed considerably increased complexity (see below).
We were surprised to find that mutation of dnaQ has no effect on the NFZ
sensitivity conferred by DinB(Y79L) or DinB(F 13V) expression given the abundance of
data suggesting genetic interactions between dnaQ+ and TLS polymerases, including
dinB+ (11, 29-31). We therefore examined the consequences of dinB deletion combined
with dnaQ deletion or the dnaQ903 proofreading-deficient allele. Both of the dnaQ
alleles confer sensitivity to NFZ, although the degree of sensitivity differs (Figure 5A-B).
Like a AdnaQ mutation, the dnaQ903 allele abolishes proofreading (54, 56). However,
the N-terminal portion of the DnaQ protein is present, providing a possible explanation
for the differing magnitudes of NFZ sensitivity. We observed an epistatic relationship
with respect to NFZ sensitivity for each dnaQ allele and AdinB (Figure 5A-B) in which
the double mutants behave most similarly to the dnaQ mutants alone. These observations
confirm that dnaQ+ affects dinB+ function under conditions of NFZ exposure. However,
the data presented in Figure 4B-C indicate that this interaction does not mediate the NFZ
sensitivity observed upon DinB(F13V) or DinB(Y79L) expression.
Unexpectedly, we observe a diversion from this paradigm in the case of
DinB(Y79F), which is transformed into an enhancer of cytotoxicity during NFZ exposure
in a AdnaQ strain (Figure 4A-B). This striking reversal may reflect an increased
importance of dnaQ+in regulating the function of this DinB variant. We observed that
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the transformation efficiency of both dnaQ mutant strains is reduced relative to wild-
type. However this phenomenon is particularly striking for pDinB and pDinB(Y79F)
(Figure 5C). Furthermore, we were unable to transform pDinB(Y79F) into a dnaQ903
strain, reinforcing our conclusion that there is an interaction between dinB and dnaQ that
is independent of DnaQ's biochemical proofreading activity. Together these phenomena
underscore the importance of dnaQ+ in relieving the consequences of a deleterious DinB
function that may be exacerbated in the DinB(Y79F) mutant.
Toxin-antitoxin pairs and metal homeostasis modulate toxicity of abortive TLS
The extreme effects of DinB(Y79L) and DinB(F13V) expression in a dinB
background led us to investigate the mechanism of NFZ sensitivity by examining
recovery of viable bacteria from regions between colonies on NFZ agar plates.
Consistent with NFZ being a bacteriostatic rather than bactericidal agent (38), we were
able to recover an equivalent number of colony forming units from strains expressing
either DinB or DinB(Y79F). Remarkably, we were unable to recover bacteria from
strains expressing DinB(Y79L) or DinB(F13V) (data not shown), suggesting that NFZ is
transformed into a bactericidal agent in these mutants.
To further characterize the mechanisms of DinB(Y79L)- and DinB(F13V)-
mediated cytotoxicity, we considered their effects in a variety of mutant backgrounds.
The mazEF and relBE genes encode toxin-antitoxin modules that alter cellular
physiology and metabolism in response to environmental stress, such as antibiotic
exposure (8, 28). Inactivation of mazEF or relBE increases resistance to replication
inhibition by hydroxyurea (Godoy et al. 2006). We considered whether toxin-antitoxin
pairs might similarly mediate the lethality of replication intermediates produced by
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DinB(Y79L) or DinB(F13V). Strains bearing deletions of mazEF, relBE, or an
alternative toxin-antixoin pair hipAB are not themselves sensitive to NFZ (Supplemental
Figure 3). Although the effects of DinB(Y79L) and DinB(F13V) expression are
unchanged in ArelBE and AhipAB strains, DinB(Y79L) expression confers increased cell
death in a AmazEF strain (Figure 6A), indicating that the mazEF gene products may
protect the cell from the abortive TLS intermediates it produces. In contrast,
DinB(F 13V) expression still promotes NFZ-mediated killing in a AmazEF strain (Figure
6B).
We also examined the effect of deleting tonB on cytotoxicity associated with
DinB(Y79L) and DinB(F13V) expression. The tonB gene encodes a ferric iron import
protein that mediates cellular lethality due to oxidative stress (58) and HU exposure (6),
but not due to bactericidal drugs (27). Strikingly, we observed that deletion of tonB
partially suppresses the lethality associated with expression of DinB(Y79L) and to a
greater extent DinB(F13V) (Figure 6C-D), suggesting that incomplete TLS induces
cellular toxicity that is linked to metal homeostasis. While the precise mechanism of
TonB-mediated cytotoxicity remains to be elucidated, these observations suggest that
diverse cellular stress responses are coupled to the faithful execution and completion of
TLS.
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DISCUSSION
Our previous observation that mutation of DinB's F13 'steric gate' abolishes its
TLS activity stimulated us to investigate other possible determinants of DinB function.
In so doing, we discovered that DinB is also specialized to catalyze the first extension
step of TLS over an N2-dG lesion with a striking catalytic proficiency that is more than
25-fold greater than on an undamaged substrate. Thus, in contrast to two polymerase
models proposed in eukaryotes (47, 61, 64) in which distinct polymerases promote the
insertion and extension steps of TLS, E. coli DinB appears capable of catalyzing both
steps with remarkable proficiency during TLS over N2-dG lesions.
In an effort to explain these findings and identify structural determinants of
DinB's specialized TLS function, we revisited our model of DinB encountering a minor
groove N2-dG lesion and noted that F12, F76, and Y79 along with F13 comprise an
evolutionarily conserved core of aromatic residues within the active site. Mutational
analysis reveals that each of them contribute differently to dinB+-dependent NFZ
resistance. Mutation of F76 or F12 results in a dinB variant that is unable to fully
complement the NFZ sensitivity of a AdinB strain. Mutation of Y79 (A, V, L) results in
DinB variants that are entirely unable to complement NFZ sensitivity, and furthermore
increase NFZ sensitivity by as much as 50-fold. Based on our previous observation of
similar behavior for the DinB(F13V) steric gate mutant, we anticipated that DinB(Y79L)
might behave similarly in a lesion bypass assay. To our complete surprise, DinB(Y79L)
is entirely proficient at dNTP insertion opposite an N2-furfuryl-dG adduct and the
immediately subsequent extensions, but appears unable to carry out the final extension
steps of TLS. Strikingly, the toxicity of DinB(F 13V) and DinB(Y79L) expression
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indicate that cellular survival is coupled to successful completion of TLS. Moreover, the
comparable NFZ sensitivities in each case suggest that the final extension steps of TLS
are at least as physiologically important as insertion of a dNTP opposite an adducted
base.
This surprising result offered a potential model for the striking cytoxicity in NFZ
induced by DinB(Y79L) expression. Insightful and detailed studies have revealed that
short TLS intermediates produced by pol V (<5 nucleotides) are subject to the
proofreading function of DNA pol III, thereby establishing a futile cycle of abortive DNA
synthesis and exonucleolytic reversal (11). This phenomenon initially seemed a possible
explanation for the effects of DinB(Y79L) expression. However, this does not appear to
be the case as dnaQ mutants do not suppress the effects of DinB(Y79L) expression.
Further investigations suggested that a complex set of genetic interactions
mediates the lethality observed upon DinB(Y79L) or DinB(F 13V) expression.
Inactivation of the toxin-antitoxin pair mazEF enhances lethality brought about by
expression of DinB(Y79L) but not DinB(F13V), suggesting that it may serve to protect
cells from the consequences of certain types of incomplete TLS. Moreover, the
production of immature TLS intermediates by either DinB(Y79L) or DinB(F 3V) leads
to cell death through a mechanism involving the TonB iron import protein. Thus, the
mechanisms of lethality differ depending on the nature of the abortive DNA synthesis.
These observations underscore the notion that unexpected cellular stress responses are
coupled to the precise execution of TLS at several stages.
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How are the phenomena we observe related to other types of replication stress?
Deletion of tonB mitigates sensitivity to nucleotide starvation induced by HU treatment
(Davies et al., submitted). Similarly, the effects of DinB(F 13V) and DinB(Y79L)
expression are suppressed in a AtonB strain. We have previously observed that AmazEF
strains are also strikingly resistant to HU (16). In contrast, deletion of mazEF increases
NFZ sensitivity upon DinB(F13V), but not DinB(Y79L) expression. These and other
data provide convincing evidence that mazEF and tonB are linked to replication stress.
However, although there are some similarities between lethality caused by inhibition of
dNTP synthesis and lethality induced by abortive TLS intermediates, there are clearly
also significant differences.
Expression of DinB(Y79L) or DinB(F13V) not only fails to complement the NFZ
sensitivity of a AdinB strain, but also exerts a dominant effect on survival in dinB+
backgrounds. In contrast, a catalytically deficient DinB variant fails to complement the
NFZ sensitivity of a AdinB strain but has no dominant effect on survival in a dinB' strain.
This unexpected observation could in part be explained by the unique features of each
mutant protein. The TLS defect of a catalytically-deficient DinB variant is manifested
before dNTP insertion opposite a replication blocking lesion ever takes place. In
contrast, both DinB(F13V) and DinB(Y79L) are able to participate in the initial steps of
TLS preceding nucleotide insertion opposite the damaged base. The relatively late
manifestation of their TLS defects may restrict which alternative mechanisms the cell can
employ (Figure 7). Furthermore, the inability of wild-type DinB expressed from the
chromosome to negate the effects of DinB(F 13V) or DinB(Y79L) expression is
especially unexpected. One possible explanation is that once TLS is initiated dynamic
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exchange of DinB at the replication fork is considerably reduced, a commitment that
necessitates increased regulation.
Together, our data point to the critical importance of the extension phase in DinB-
mediated TLS. DinB itself is strikingly proficient at dNTP addition immediately
following an N2-furfuryl-dG lesion, showing a ca. 25-fold elevated catalytic proficiency
relative to an undamaged template. Failure to complete further extensions results in
pronounced lethality upon NFZ exposure. This physiological response is genetically
complex and mediated by several unexpected factors. Our observations strongly indicate
that TLS is far more nuanced than mere insertion of a dNTP opposite to a damaged base
and its subsequent extension. Indeed, the precise execution of TLS is connected to a
variety of cellular processes with roles extending well beyond DNA metabolism.
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MATERIALS AND METHODS
Bacterial strains and plasmid construction
The strains, plasmids, and primers used in this study, along with strain construction
information are described in Supplemental Table I. The plasmid borne dinB variants
were produced from the low copy number plasmid pYG768 (Kim et al. 1997), which
contains dinB+ under its own promoter or the DinB expression plasmid pDFJ1 (Jarosz et
al. 2006) using a Quikchange site directed mutagenesis kit (Stratagene) according to the
manufacturer's instructions. Plasmids were maintained with ampicillin (100 ig/mL)
when necessary.
DNA damage sensitivity, mutation frequency, and transformation efficiency
determinations
Sensitivity to DNA damaging agents was determined essentially as described previously
(Beuning et al. 2006; Jarosz et al. 2006). Briefly, overnight E. coli cultures were
diluted 1,000-fold and grown to exponential phase in LB medium before being plated on
LB agar containing between 0-50 [M NFZ or 4-NQO. A concentrated stock solution of
each DNA damaging agent was first made in N,N-dimethylformamide, stored at -20 0C,
and diluted appropriately for each experiment. Percent survival was determined relative
to growth in the absence of DNA damaging agent. Mutation frequency was measured by
reversion to rifampicin resistance at 100 jig/mL as previously described (Beuning et al.
2006; Jarosz et al. 2006). Transformation efficiencies were determined in triplicate by
transforming increasing amounts of plasmid DNA into a constant quantity of competent
cells and measuring colony forming units.
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Oligonucleotide synthesis
The synthesis and post-synthetic derivitization and characterization of the
oligonucleotides used as templates in this study was as in (Jarosz et al. 2006). The
nested primers used to define the range of preferential DinB TLS activity were purified
by gel electropheresis prior to use and are described in Supplemental Table I.
Protein purification and primer extension assays
Purification of wild-type DinB and DinB(Y79L) was performed as previously described
(Beuning et al. 2006; Jarosz et al. 2006). Briefly, each protein was expressed from the
plasmid pDFJ1 or its DinB(Y79L) expressing derivative in BL21(DE3) pLysS cells by
induction with 1 mM IPTG at an OD 600 of 0.6, and the cultures were incubated at 300C
for the duration of the induction. After four hours, cells were harvested by centrifugation
and subjected to lysozyme treatment. The resulting lysate was treated with DNAse and
RNAse as described (Jarosz et al. 2006) and purified on monoS and phenylsepharose
columns (GE Healthcare). DinB(Y79L) purified virtually indistinguishably from wild-
type DinB, except for exhibiting a slightly broader peak during elution from the
phenylsepharose column. Similar specific activity is maintained through the entire peak.
Primer extension assays were performed as described previously (Jarosz et al. 2006),
using equivalent concentrations of wild-type DinB and DinB(Y79L). Products were
separated on a 16% denaturing polyacrylamide gel and quantified using a
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phosphorimager (GE Healthcare). In cases where nucleotide addition resulted in multiple
products the sum of all products was used to calculate an apparent Vmax and Km.
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Figure 1
A 4 Denotes the site of the
G4
.... _ G-3
G-2
G-1
G+
G+
B Primer Vmax, Vmax, Km, Km, Vmax/Km, Vmax/Km, N-FG/G
G NM-FG G N -FG G N -FG Preference
G-5 557.8 668.9 83.2 27.9 6.7 x 106  2.4 x 107  3.6
G-4 755.9 2492.7 173.9 129.3 4.4 x 106 1.9 x 107  4.4
G-3 464.2 304.6 9.6 5.1 4.8 x 107  6.0 x 107  1.2
G-2 1081.7 1149.6 109.0 51.7 9.9 x 106  2.2 x 107  2.2
G-1 894.3 990.5 231.6 16.0 3.9 x 106 6.2 x 107  16.0
G 619.8 886.3 42.2 2.35 1.5 x 107  3.8 x 108 25.7
G+1 240.4 167 67.1 41.7 3.6 x 106  4.0 x 106  1.1
G+2 188.2 150.3 24.9 8.4 7.6 x 106 1.8 x 107  2.4
G+3 446.1 438.2 59.8 19.6 7.5 x 106  2.2 x 107  3.0
Figure 1. Staggered primer extension assays reveal a ca. 25-fold catalytic preference for
extension from an N2-furfuryl-dG lesion. A) Schematic of the lesion bearing template
(blue) and primers (red) employed. The site of the N2-furfuryl-dG is indicated by the
cyan star. B) Steady state kinetic parameters for primer extension assays using the 5'-
32 P-labeled primers described above. Vmax units are pmol min- mg-'; Km units are tM;
Vmax/Km units are pmol min 1 mg' M1. Reactions were carried out as described in
materials and methods. In cases where more than one addition was catalyzed by the
addition of a single dNTP substrate, the product is defined as the sum of all radiolabeled
oligonucleotides present with a greater length than the primer. Undamaged template
designated G; N2-furfuryl-dG abbreviated as N2-FG.
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Figure 2. A pocket of aromatic hydrophobic residues in DinB's active site modulates its
TLS function. A) Structural model of conserved residues in the active site of DinB
suggests potential interactions between the side chains (red), the N2-furfuryl moiety
(yellow), and the incoming nucleotide (blue). B) Alignment of DinB sequences from
diverse organisms reveals conservation of F12 and the F/Y13 steric gate residues.
Whereas Y79 is universally present among DinB orthologs, F76 shows weaker
conservation. Consensus symbols are as follows: (!) represents I/V, (%) represents F/Y,
(#) represents N/D/Q/E. C) Mutation of residues in this hydrophobic pocket results in
dinB variants that are unable to complement the NFZ sensitivity of a AdinB strain.
Chromosomal genotype in all cases is AdinB. Error bars represent the standard deviation
determined from thee independent cultures. D-E) Mutation of Y79 eliminates the ability
of DinB to complement the NFZ or 4-NQO sensitivity of a AdinB strain, respectively.
Chromosomal genotype is AdinB. Error bars represent standard deviations determined
from three independent experiments.
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WT DinB DinB(Y ) WT Din5 Din(Y9L)
tu
dG
3 nt aifter F-FG
- Opposite #P-FG
I I-ur
M-furfuryl-dG
Template Enzyme K (pMf) V. V 'Km Fold change
G-cntrol,(G+3) WT DmB 59.8 446. 1 7.5 x 1 
-
DmB(Y79L) 330.0 1072.0 3.2 x 10 2.3
?V-FG'(G-3) WT DiB 19.6 438.2 22 x 10' 
-
DmB(Y79L) 1551.0 1416.0 0.9 x 10' 24.0
Figure 3. DinB(Y79L) catalyzes lesion bypass. A) DinB(Y79L) bypasses N2-furfuryl-
dG and stalls three nucleotides following the lesion. Primer extension assays with 1, 5,
and 50 nM DinB and DinB(Y79L) indicate that DinB(Y79L) is able to catalyze lesion
bypass, but cannot complete the extension phase of TLS as the majority of products stall
three nucleotides following the site of the lesion. B) Steady state kinetic parameters for
extension from the G+3 primer by DinB(Y79L). Reactions conditions are as described in
materials and methods. Vmax units are pmol min-1 mg'; Km units are jtM; Vmax/Km units
are pmol min' mg- M 1.
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Figure 4. Consequences of DinB variant expression in wild-type and dnaQ backgrounds
A) Expression of pDinB(Y79L) (closed triangles) or pDinB(F13V) (closed squares)
results in profound toxicity to NFZ relative to pDinB (closed circles), an empty vector
control (pWSK29; open circles), or pDinB(Y79F) (cross marks). Chromosomal genotype
is dinB+. In this and all graphs in this figure, error bars represent the standard deviation
determined from three independent transformants. B-C) Dominance of pDinB(Y79L),
pDinB(F 13V) and pDinB(Y79F) in AdnaQ and dnaQ903 backgrounds, respectively.
Symbols and error bars as in A).
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A B
C
Transformation Fold
Strain Plasmid Efficiency per ag reduction
AB51157 pWSK29 1950000 
-
pDinB 1820000 1.
pDinB(Y79F) 743000 3
.adnaQ::kan pWSK29 461000
pDinB 48500 10
pDinB(Y79F) 16600 28
dnaQ903::tetpWSK29 17200
pDinB 166 103
pDinB(Y79F) <1 >20600
Figure 5. Evidence for a genetic interaction between dinB and dnaQ. A-B) The AdnaQ
and dnaQ903 alleles are epistatic to a AdinB with respect to NFZ sensitivity at 10 pM
NFZ. Error bars represent the standard deviation determined from four independent
transductants. C) Transformation efficiencies in colony forming units per ptg of DNA for
wild-type and dnaQ strains.
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Figure 6. The toxin-antitoxin module mazEF and the iron import protein tonB modulate
the toxicity of DinB(Y79L) and DinB(F13V). A) Deletion of the toxin-antitoxin (TA)
pair mazEF enhances the killing of DinB(Y79L) expression, consistent with a role for
mazEF in protection from abortive TLS. Black lines/symbols represent the wild-type
strains and red lines/symbols represent AmazEF strains. Plasmids are pWSK29 (open
circles), pDinB(Y79L) (closed triangles). Error bars represent the standard deviation
determined from three independent transformants. B) Deletion of mazEF does not affect
pDinB(F13V) toxicity in NFZ. Lines and symbols as in A); pDinB(F13V) (closed
squares). C-D) Deletion of the tonB gene, which encodes an iron import protein,
mitigates the toxicity of DinB(Y79L) and DinB(F13V) expression. Black lines/symbols
represent wild-type strains and red lines/symbols represent AtonB strains. Symbols
otherwise as in A-B). Error bars represent one standard deviation determined from three
independent experiments.
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Figure 7
Commitment to TLS
DinB
Handoff to DNA Pol III
4DNA Pol III
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Successful TLS
B 'DinB (Y79L)
DinB (FI3V)
Incomplete TLS
, DinB (D 01N)
TLS not initiated
-o-4-*Survival
Figure 7. Model for phase separation in TLS. DinB(Y79L) and DinB(F13V) behave
normally during the early phases of TLS, manifesting their defects only at or after the
point at which the cell has committed to lesion resolution by TLS. The abortive products
that they induce diverse physiological responses that affect cell fate. A catalytically
deficient DinB variant manifests its phenotype early in TLS, thereby allowing other
mechanisms for lesion resolution. Figure adapted from (Fujii and Fuchs, 2004).
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Supplemental Figure 1
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Supplemental Figure 1. A) DinB(Y79F) complements the NFZ sensitivity of a AdinB
strain. Error bars represent the standard deviation determined from three independent
experiments. B) Expression of DinB(Y79F) confers ca. 200-fold resistance to killing at
high doses of NFZ. Plasmids are as described in Supplemental Table I and expressed in a
AdinB background. Strains were treated on plates containing 40 pM NFZ.
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Supplemental Figure 2
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Supplemental Figure 2. Expression of a catalytically deficient DinB variant does not
affect resistance of NFZ in a wild-type background. Expression of pDinB(cat-) (filled
squares) does not affect NFZ resistance in a wild-type background relative to pDinB
(closed circles) or an empty vector control (pWSK29; open circles).
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Supplemental Figure 3
100
CU)
ci)009
CL
10,
0.1
+ AB1157
- AmazEF::Kan
*- ArelBE::Kan
, AhipBA::Kan
,,m AtonB::Kan
0 5 10
NFZ (uM)
Supplemental Figure 3. Deletion of mazEF, relBE, hipAB and tonB do not affect killing
upon NFZ treatment.
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Strains Genotype Reference
BL21 (DE3) pLysS
AB1157
AB 1157 AdinB
AB 1157 AdnaQ
AB 1157 AdnaQ
AdinB
AB 1157 dnaQ903
AB 1157 dnaQ903
AdinB
AB 1157 dnaE(spq-2)
AB 1157 AhipBA
AB 1157 ArelBE
AB 1157 AmazEF
AB 1157 AtonB
AB 1157 Aetk
AB 1157 Awzc
E. coli B. Standard strain used for protein overproduction
thr-1 araC-14 leuB-6(Am) A(gpt-proA)62 lacY] tsx-33 qsr'-O
glnV44(AS) galK2(Oc) LAM Rac-O hisG4(Oc) rjbC1 mgl-51
rpoS396(Am) rpsL31 kdgK51 xylA5 mtl-1 argE3(Oc) thi-1
As AB 1157 but AdinB:.Cm
As AB 1157 but AdnaQ:.kan
As above but AdinB::Cm
As AB 1157 but dnaQ903::tet
As above but AdinB:.:Cm
As AB 1157 but dnaE(spq-2)
As AB 1157 but AhipBA
As AB 1157 but ArelBE
As AB 1157 but AmazEF
As AB1157 but AtonB.::kan
As AB1157 but Aetk:.:kan
As AB 1157 but Awzc::kan
GCW lab stock
GCW lab stock
(3)
This work.
Transduction from
Keio collection
This work
(6)
This work
(5)
This work; (2)
This work; (2)
This work; (2)
Transduced from
Keio collection (1)
Transduced from
Keio collection (1)
Transduced from
Keio collection (1)
Plasmids
pDFJ1
pDFJ (Y79L)
pDFJl(Y79F)
pDinB
pDinB(Fl2V)
DinB expression plasmid under T7 promoter in pET l1T
backbone; Ampicillin resistance
As pDFJ1 with indicated mutation introduced using
quikchange site-directed mutagenesis
As pDFJ1 with indicated mutation introduced using
quikchange site-directed mutagenesis
pYG768. DinB under its native promoter in a low copy
number pWSK29 plasmid
As pDFJ 1 with indicated mutation introduced using
quikchange site-directed mutagenesis
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(3)
This work
This work
(4)
This work
pDinB(F76V)
pDinB(Y79A)
pDinB(Y79V)
pDinB(Y79L)
pDinB(Y79F)
pWSK29
pDinB(cat-)
Primers
G-5
G-4
G-3
G-2
G-1
G
G+I
G+2
G+3
As pDFJ 1 with indicated mutation introduced using
quikchange site-directed mutagenesis
As pDFJ 1 with indicated mutation introduced using
quikchange site-directed mutagenesis
As pDFJ 1 with indicated mutation introduced using
quikchange site-directed mutagenesis
As pDFJ1 with indicated mutation introduced using
quikchange site-directed mutagenesis
As pDFJ1 with indicated mutation introduced using
quikchange site-directed mutagenesis
Empty vector for pDinB and derivatives
As pDinB with D 104N mutation
GCATATGATAGTACAGCTGCAGCCGGA
GCATATGATAGTACAGCTGCAGCCGGAC
GCATATGATAGTACAGCTGCAGCCGGACG
GCATATGATAGTACAGCTGCAGCCGGACGC
GCATATGATAGTACAGCTGCAGCCGGACGCC
GCATATGATAGTACAGCTGCAGCCGGACGCCC
GCATATGATAGTACAGCTGCAGCCGGACGCCCA
GCATATGATAGTACAGCTGCAGCCGGACGCCCAG
GCATATGATAGTACAGCTGCAGCCGGACGCCCAGG
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This work
This work
This work
This work
This work
(4)
(7)
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Summary of Results
The observation that mutations in the Escherichia coli genes umuC4 and umuD+
abolish mutagenesis induced by UV-light strongly supported the counterintuitive notion
that the introduction of mutations into the genome was an active rather than passive
process (9). Biochemical studies have revealed that the umuC and homolog dinB+,
encode for low to moderate fidelity DNA polymerases, with the ability to catalyze
synthesis on imperfect/damaged DNA templates in a process termed translesion synthesis
(TLS) (6, 13). Many of these translesion DNA polymerases are members of the Y-family
of DNA polymerases and are present in all domains of life. The existence of such a class
of DNA polymerase raises a series of questions including, i) how is that these
polymerases are regulated, as they display reduced fidelity on undamaged DNA and ii)
out of so many polymerases available, how is it that cell knows which one to used? Here
I discuss the identification of a potential regulatory factor, NusA. I report for the first
time a function for the transcriptional modulator NusA in promoting survival after DNA
damage. I suggest that NusA is required to couple the processes of both TLS and
nucleotide excision repair to transcription, allowing cells to cope with the lethal effects of
DNA damage.
In Chapter Two, we show that a DinB affinity column used to search for potential
DinB-interacting proteins within lysates of cells that constitutively express the SOS
response, bound the transcriptional modulator NusA. This interaction is a direct
interaction as determined by far-western analysis. Furthermore, the use of cellulose filter
peptide arrays to search for peptides of NusA that might potentially interact with DinB
revealed that one potential DinB binding region of NusA encompasses several surface
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residues around the site of the temperature sensitive mutation of the nusA 1 (ts) allele
(12). The peptide array data led us to consider the possibility that elevated levels of DinB
might stabilize the NusAl 1 protein, resulting in dinB+ serving as a multicopy suppressor
of the temperature sensitivity of a nusA I strain. I found that increased expression of
DinB indeed suppresses the temperature sensitivity of the nusAll strain, in manner
requiring the catalytic activities of DinB. This multicopy suppression of the nusAll
temperature sensitivity extends to the other TLS polymerase in E. coli encoded by the
umuDC gene products, similarly requiring the catalytic activities of both umuD and
umuC. In order to explain these data I have suggested a model of transcription-coupled
translesion synthesis (TC-TLS), where NusA associated with elongating RNA
polymerases (RNAP) can recruit TLS DNA polymerases to fill in gaps opposite to lesion
in the transcribed strand.
In Chapter Three, I describe a set of experiments that show a requirement for
nusA+ in the phenomenon of adaptive mutagenesis. Adaptive mutagenesis describes the
accumulation of mutations that occur in non-growing cells over time. In the widely used
system devised by Cairns and Foster a lacI33-lacZ fusion reporter is used to monitor the
appearance of adaptive mutants from a Lac- to a Lac+ phenotype in E. coli (3). While
many cellular processes are implicated in the adaptive response, loss of DinB (DNA pol
IV) function results in loss of 50 to 85 percent of adaptive mutants (5, 10). I show that
strains containing the nusAl l(ts) mutation, at the permissive temperature, are completely
incapable of adaptive mutagenesis. I present evidence that the defect in adaptive
mutagenesis seen in the nusAll strain, likely involves a role for NusA in the adaptive
response that extends beyond an interaction with DinB. Furthermore, the defect in the
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nusAll strains is not due to a transcriptional defect of the adaptive mutagenesis lacI33-
lacZ reporter, but rather an inability to adapt and mutate in response to environmental
stress under growth limiting conditions.
In Chapter Four, I describe a set of experiments that establish NusA as a critical
factor in allowing cells to cope with the lethal effects of DNA damage. My results are
the first to implicate NusA, which is associated with RNA polymerase throughout
elongation and termination of transcription, in the processes of DNA repair/damage
tolerance. Mutation of nusA results in reduced viability after exposure to DNA damaging
agents and even without the addition of exogenous DNA damaging agents, nusA mutants
display phenotypes of altered DNA processing. Furthermore, I can genetically link
transcription/RNA polymerase to the nusA-dependent events that help promote survival
after DNA damage, through the isolation of RNA polymerase mutants with altered ability
to deal with the lethal effects of DNA damage. Together, my results suggest that NusA,
in addition to its roles in transcription elongation and termination, is important for
coordinating the cellular responses to DNA damage by coupling the processes of
translesion DNA synthesis and nucleotide excision repair to transcription.
In Chapter Five, in work done in collaboration with Daniel Jarosz, we report the
first example of preferential TLS extension by any Y-family DNA polymerase. We also
describe a new class of TLS DNA polymerase mutant resulting from mutation of an
evolutionarily conserved tyrosine (Y79), generating a DinB variant that catalyzes formal
lesion bypass but cannot finish the subsequent extension steps that are required to
complete TLS, stalling three nucleotides after an N2-dG lesion. Expression of this variant
in vivo dramatically enhances killing during challenge with DNA damaging agents, and
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in fact, transforms the bacteriostatic drug nitrofurazone into a bactericidal drug. Diverse
gene products modulate this toxicity associated with incomplete TLS extension,
including the toxin-antitoxin module MazEF and the iron import protein TonB. Together,
these results not only indicate that DinB is specialized to perform remarkably proficient
TLS insertion and extension, but also expose unexpected connections between the
products of incomplete TLS and cell fate.
Implications of transcription-coupled translesion synthesis (TC-TLS)
I have proposed that, by binding to DinB or some complex involving UmuC and
the umuD gene products, NusA can couple the process of transcription to the process of
translesion synthesis to enable transcription-coupled translesion synthesis (TC-TLS), in a
manner analogous to the coupling of transcription to nucleotide excision repair during
transcription-coupled repair (TCR). In principle, a process of TC-TLS could be helpful
when transcription becomes stalled by gaps in the transcribed strand that are opposite
lesions in the non transcribed strand. If a process of transcription-coupled translesion
synthesis does exists, and if it is universal as most DNA repair and DNA damage
tolerance processes tend to be, it might be of particular importance in mammals where
some mRNAs can take many hours to transcribe (16) so that the consequences of
encountering a template gap late in the transcriptional process would be severe. I
propose the use of gapped plasmids containing a site-specific lesion to test this model of
TC-TLS. Such plasmids have been generated to test the bypass frequency for particular
DNA lesions (1, 17, 18). I suggest that construction of such a plasmid with a N2-furfuryl-
dG) lesion, opposite a gap in a transcribed gene under the control of a strong promoter or
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without any promoter, would allow me to determine the role of transcription in plasmid
maintenance, where the repair of the gap would allow for propagation of the plasmid.
This type of experiment would allow me to test the model of TC-TLS in vivo, and avoid
the complications of excluding several possible unknown factors (see below). If a
mechanism of TC-TLS were to exist, it would raise more questions than it would answer
(see below).
How would NusA recruit DinB/TLS polymerases to sites of stalled RNAP?
NusA is associated with all elongating RNAP (11), so how could DinB be specifically
recruited to RNAP that have been stalled by a gap in the transcribed strand. It is possible
that NusA undergoes a conformational change upon the stalling of RNAP, and it is this
conformation that DinB/TLS polymerases can now be recruited. One could also envision
a situation where DinB/TLS polymerases are always associated with elongating RNA
polymerases, through an interaction with NusA. In this case, every time the RNAP
encountered a gap opposite a lesion DinB would already be present to fill in this gap.
However, there is not likely to be enough DinB/TLS polymerases to always be associated
with all elongating RNA polymerases.
What are the other factors involved in TC-TLS? If the proposed mechanism
of TC-TLS were to exist, there would likely need to be several other proteins in addition
to RNAP, NusA and TLS polymerases involved in this process. In order for TLS
polymerases to fill in a gap opposite a lesion, it would need to reach the opposite end of
the gap relative to the RNA polymerase. These gaps could be anywhere from 12-1000
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nucleotides in length (discussed in Chapter Two), and thus there would likely need to be
a hand-off of the TLS polymerase from NusA/Stalled RNAP to the appropriate
primer/termini end. Possibilities for this hand-off factor include RecA, a ssDNA binding
protein that can also interact with TLS polymerases DinB and UmuD'2C. Additionally,
the histone-like protein HupA, which preferentially binds to gapped DNA (4), was also
identified as binding to a DinB affinity column (8), suggesting another hand-off
possibility.
What role would NusA have in TC-TLS and recruiting TLS polymerases?
NusA is classified as a general transcription elongation factor and has been found to be
associated with all elongating RNA polymerases (11), therefore one can come up with
two ideas for the potential role for NusA in the model of TC-TLS. One idea is that since
NusA is associated with all elongating RNA polymerases it is a platform, allowing for
recruitment and/or binding of TLS polymerases to the site of the stalled RNAP. This
idea would not require NusA's ability to function as a transcriptional terminator/
antiterminator. Alternatively, one could hypothesize that NusA, using its abilities to
pause or stall elongating RNA polymerases, could sense the upstream gap in the
transcribed strand and pause the RNAP before it encounters a situation in which it has
run out of template. In this situation, NusA would also function as a "platform" by
recruiting TLS DNA polymerases, however it would also utilize its own functions as a
transcriptional terminator/antiterminator. In collaboration with Bob Landick at the
University of Wisconsin Madison, I will be testing the activity of RNAP activity on a
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gapped substrate in vitro, where I can then asses the role of NusA in RNAP
pausing/stalling.
NusA-dependent TCR, an alternative to Mfd-dependent TCR
My model for a new class of transcription-coupled repair suggests that NusA can
recruit NER machinery to sites of RNAP stalled by a lesion in the transcribed strand in a
fashion that is independent of Mfd. Why the existence of a second class of TCR? One
intriguing possible explanation involves a particular of a class of DNA lesion, such as an
N2-dG lesion, which can be efficiently bypassed by DinB and thus is not a hindrance
during replication. However, such lesions would then cause a problem when
transcription is attempted. In this case, a novel class of TCR involving NusA could be
important for the recognition and removal of these DNA lesions. Since some of these
minor groove lesions are not efficiently recognized by normal NER (2, 8), NusA-TCR
could help a cell remove this class of lesions from its DNA.
As in the case of my model of TC-TLS, if there were to exist a new class of TCR
mediated by NusA, there would most likely be several yet-to-be-determined molecular
determinants. For example, the C-terminal half of Mfd is comprised of seven helicase
domains and a translocase domain, which are important for the translocation of the stalled
RNA polymerase (14, 15). NusA, does not contain such motifs and thus it is likely that
one/or more factors would need to involved in translocating the stalled RNAP in this new
class of transcription coupled repair.
What about other organisms/domains of life?
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NusA is universally conserved throughout bacterial and archaeal domains of life
however no sequence or functional homolog has been identified in eukaryotes. Would
the functions that I have implicated for E. coli NusA in DNA repair/damage tolerance,
hold true for NusA in archaea. Similarly, would there be transcription-coupled
translesion synthesis or a second class of transcription-coupled repair in eukaryotes. If
these mechanisms were to exist, what would be the factors involved. Mfd, like NusA, is
extremely conserved throughout bacteria and archaea however a sequence homolog in
eukaryotes does not exist (7). However, the human transcription repair coupling factor
(TRCF) gene has been identified as ERCC6/CSB (19). Despite the fact that ERCC6/CSB
and mfd share no significant sequence homology, they are structurally and functionally
homologous. Thus it is possible that there exists a function homolog of NusA in
eukaryotes.
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Appendix A
Lethal Combinations: synthetic lethality of nusAl and lexA(Def)
mutants in Escherichia coli
Authors for this work are Susan E. Cohen and Graham C. Walker
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INTRODUCTION
The Escherichia coli SOS network coordinates the expression of more than 50
genes (21) in response to DNA damage which is regulated by the LexA transcriptional
repressor that binds to operator sequences inhibiting transcription of downstream genes
(6). In addition to roles for the recA+ gene product in homologous recombination, RecA
also plays a central role in controlling the SOS response. Upon DNA damage RecA
forms a nucleoprotein filament with ssDNA, which interacts with LexA and induces its
own proteolytic digestion, inactivating LexA as a transcriptional repressor. Here I report
that the mutation of nusA (nusAll) is lethal when in combination with a lexA(Def) allele
in E. coli. The results presented in Chapter Four have suggested that the essential
transcriptional modulator NusA is also important in promoting survival after challenge
with DNA damage. NusA is an essential protein that functions in both termination and
antitermination of transcription, and is associated with the RNA polymerase throughout
the elongation and termination steps of transcription (3, 5, 8, 12-14, 16, 20). Several
genetic links between nusA and the SOS response to DNA damage were discussed in
Chapter Four, including partial chronic SOS induction observed in sub-population of
nusAll(ts) cells at the permissive temperature. These results lead me to question how
survival after exposure to NFZ would be altered in a nusAll strain which is constitutively
expressed for the SOS response. The lexA(Def) strain, which is deleted for lexA, results
in the constitutive expression of the SOS response (9, 11, 17, 19). However, for this
mutation to result in viability, a mutation in sulA must also be present, as constitutive
expression of the LexA-repressed sulA+ gene otherwise leads to lethal filamentation (7).
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Here I show that the mutation of nusA (nusA]) is synthetically lethal when put in
combination with a lexA(Def) allele. In addition, the synthetic lethality can be prevented
by plasmid-borne nusA+ or lexA+. Synthetic lethality is defined as when the combination
of two otherwise non-lethal mutations results in an inviable cell. Although there have
been recent efforts to identify such synthetic genetic interactions in E. coli (22), a
synthetic lethality involving nusA would not have been identified since nusA is an
essential gene. Synthetic lethality seen with loss-of-function alleles has been proposed to
arise from at least four different mechanisms (10): i) one gene can buffer the effects of
the other, that is it can compensate for the effects of the other. ii) they can function in
uniquely redundant roles with respect to an essential function iii) they might be two
subunits of an essential multi-protein complex iv) they might be two interconnected
components in an essential linear pathway such that each mutation decreases the flow
through the pathway.
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RESULTS AND DISCUSSION
Independent of which allele was used as donor or recipient, attempts to construct
a lexA(Def) nusAll mutant by Plvir transduction were unsuccessful (Tables 1 and 2). As
noted in Table 1, on rare occasion a viable mutant was recovered when the nusAll
mutation (linked to a KanR marker) was transduced in to the lexA(Def) background.
However, this is likely due to a secondary suppressor mutation. Although this viable
strain was temperature sensitive (indicative of nusA l) and deleted for lexA as confirmed
by PCR, these strains did not express the correct antibiotic resistance markers and
displayed a mucoid morphology. This phenomenon is not due to a lethal interaction
between nusA and sulA, as the nusAllAsulA mutant was constructed, nor is it a reflection
of the failure of nusAI mutant strains to express spectinomycin resistance, as other
spectinomycin markers could be expressed. Moreover, the lethality of the nusAll
lexA(Def) can be prevented by plasmid-borne nusA +, expressed under its native promoter
(data not shown).
In an attempt to understand the physiology underlying this phenomenon I
conducted a suppressor screen, looking for genes that when expressed in multicopy
allowed for the construction of the nusAll lexA(Def) mutant. An E. coli genomic library,
present in a multicopy plasmid (23), was transformed into nusAllAsulA strains and 140
isolates screened for viability of a nusAll lexA300(Def) mutant. Plasmids harboring lexA
were isolated nine times, showing that this phenotype can be complemented by lexA in
trans as well. Interestingly, a plasmid harboring nusA was not isolated, implying that
perhaps more plasmids should be screened. Five other plasmids were isolated that
permitted construction of the nusAll lexA(Def) strain (Table 3). However, the identity of
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these genes did not reveal any obvious reason why this otherwise lethal combination now
results in viability. Perhaps expression of these gene products allows the cells to deal
with or tolerate a toxic intermediate that accumulates in this background. Additionally, a
screen based on stabilization of an otherwise unstable plasmid (1, 2) was used to screen
for additional mutations that resulted in lethality when in combination with the lexA(Def)
mutation. This screen yielded two transposon insertion mutations that when in
combination with the lexA(Def) allele, stabilized the otherwise unstable plasmid carrying
lexA (S. Cohen and L. Addae, unpublished). However, the identity of these mutants was
never resolved.
At the permissive temperature, a sub-population of the nusAl cells constitutively
express the SOS response (Chapter Four), leading me to question why some cells, but not
all, can be constitutively SOS induced. Furthermore, nusAll strains, at the permissive
temperature, do not have a defect in UV-induced mutagenesis (Figure 1), implying that
they are able to perform "SOS mutagenesis", as measured by reversion of an argE3
mutant to Arg+. This is in comparison to an un-mutable strain where the umuDC genes,
which encode the SOS inducible translesion DNA polymerase V, are deleted. Although
these data seem to be in conflict with the synthetic lethality observed with the nusAll
and lexA(Def) mutations, they show that this relationship is a complicated one with more
experiments required to understand this set of complex interactions. For example, a null
mutation of lexA could imply that induced expression of any one/or many of the SOS
regulated genes could be the reason for the synthetic lethal interaction with nusA.
Moreover, the fact that SOS can be constitutively induced in a sub-population but not the
whole population of cells could imply a role for cellular communication in this
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phenomenon.
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MATERIALS AND METHODS
Strains and Growth Conditions
All experiments were performed with AB 1157 derived strains (thr-1 leuB6proA2 hisG4
thil argE3 lacY1 galK2 ara-14 xyl-5 mtl-1 tsx-33 rpsL31 supE44). nusAll
sfsB3198::Tnl OKan (SEC302), AsulA::Tet (TP651) (18), lexA(Def) (AsulA::Tet
AlexA300::Spc (9)) (SEC305), and nusAll sfsB3198::Tnl OKan AsulA::Tet (SEC816).
For all experiments cultures were grown in Luria-Bertani (LB) medium at 300 C. When
necessary plasmids were maintained with 100tg/mL ampicillin. During strain
construction antibiotics were used at the following concentrations: 12jig/mL tetracycline,
30tg/mL kanamycin or 60g/mL spectinomycin.
Plvir transductions
Plvir phage-mediated transduction was performed was previously described (15). All
steps of the transduction procedure were performed at 300 C.
Multicopy suppressor screen
An E. coli genomic library, present in a multicopy plasmid (23), was transformed into
SEC816. This library was then scored for ability to allow for construction of nusAll
lexA(Def) mutant. Donor: lexA300(Def), Recipient: AsulA::Tet nusAll. All steps were
performed at 300 C.
Mutagenesis Assays
SOS mutagenesis assays were performed according to the published method (4). Briefly,
equal numbers of cells from cultures growing exponentially in LB were washed with
0.85% saline, exposed to 25 J m- 2 UV light from a germicidal lamp (General Electric),
and then plated on M9 minimal plates with trace arginine (1 [tg ml-1). Colony-forming
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units were scored after 48 h of growth at 300 C. Survival was determined by plating on
equivalent M9 minimal plates with 40 [ig ml-1 arginine. Non-UV-irradiated cultures were
treated identically, but without UV irradiation, to assess the spontaneous mutation
frequency. The data represent the average of at least three independent experiments.
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Table 1
Total number Co-
colonies transduction
screened Frequency
AsulA lexA+ 336 16%
AsulA 288 0.7%
lexA300(Def) Specs
Table 2
# Transductants lexA locus
AsulA nusA+  153 lexA(Def)
AsulA nusAl 1 0 NA
sfsB:: Tn I OKan
Table 1 and 2. Transduction frequencies suggest that a nusA]H, lexA(Def) strain is
inviable. Table 1. Donor: nusAll sfsB::TnlOKan. Recipient: AsulA (lexA+ or
lexA300(Def)). Co-transduction determined as transductants that were both KanR and
temperature sensitive. Table 2. Donor: lexA300(Def). Recipient: AsulA (nusA+ or
nusAl]). lexA locus column denotes that deletion of lexA was confirmed by PCR. In the
first row, 16 transductants were checked for deletion of lexA by PCR. In the second row,
there were not any transductants to check.
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Table 3
Isolate Gene Name Description
SC13 ynfF Oxidoreductase subunit
SC14 fdoGHI Formate dehydrogenase-O large subunit
Formate dehydrogenase-O Fe-S subunit
Cytochrome b556 subunit
SC15 yhjDE Conserved inner membrane protien
Predicted transporter
SC17 elaC (rbn) elaD Binuclear zinc phosphodiesterase
Hypothetical protein
SC19 yjhG Predicted dehydratase
Table 3. Plasmids that when in multicopy allows for construction of the nusA I
lexA(Def) mutant.
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AumuDC nusAll
Figure 1. nusAll mutants, at the permissive temperature, are not defective in UV-
induced mutagenesis (scored as Arg- to Arg+), compared to a wild-type (AB 1157) and
AumuDC controls.
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Appendix B
Overlapping physiological responses of Escherichia coli to
mutation of the essential transcriptional modulator nusA and
exposure to the DNA damaging agent nitrofurazone
Authors for this work are Susan E. Cohen, Michael A. Kohanski, James J. Collins and
Graham C. Walker
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INTRODUCTION
In both prokaryotes and eukaryotes coordinated responses to genotoxic stress
includes the induction of various cellular factors, many of which are involved in DNA
repair, mutagenesis and cell cycle control (7). In Escherichia coli, the SOS response to
DNA damage influences the expression of more than fifty genes involved in diverse
cellular functions that allow the cell to combat the challenges of DNA damage (4, 7, 20,
21, 23) and is regulated by the lexA+ and recA+ gene products (7).
The SOS network is regulated by the LexA transcriptional repressor which, binds
to operator sequences inhibiting transcription of downstream genes (7). In addition to the
roles for the recA+ gene product in homologous recombination, RecA also plays a central
role in controlling the SOS response. Upon DNA damage RecA forms a nucleoprotein
filament with ssDNA, which interacts with LexA and induces its own proteolytic
digestion, inactivating LexA as a transcriptional repressor. However, several lines of
investigation have underscored the notion that a simplistic view of the SOS response is
far from complete. For example, analysis of gene expression in E. coli cells that have
been irradiated with ultraviolet (UV) light identified genes that became induced in a lexA
independent manner as well as genes whose expression decreased after UV treatment (4).
Furthermore, exposure of E coli to the DNA-damaging agent MMC results in expression
changes of >1000 genes (10).
Our previous results have suggested that the essential transcriptional modulator
NusA is important for allowing cells to cope with the lethal effects of DNA damage
(Chapter Four). NusA is an essential protein that functions in both termination and
antitermination of transcription, and is associated with the RNA polymerase throughout
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the elongation and termination steps of transcription (2, 6, 9, 12-14, 18, 22). Originally
reported in 1974, NusA forms an antitermination complex with kN protein that is
required for successful k phage infection (8). We have reported that the temperature
sensitivity of the nusAll(ts) allele (19) can be suppressed by overexpression of two SOS
induced DNA polymerases DinB (Pol IV) or UmuD'2C (Pol V), in a manner that requires
the catalytic capabilities of DinB, UmuD and UmuC (3). Furthermore, nusA l(ts)
mutants at the permissive temperature (30'C) are: defective for adaptive mutagenesis
(Chapter Three), sensitive to the DNA damaging agents nitrofurazone and 4-
nitroquinolone- 1-oxide, and display chronic partial SOS induction (Chapter 4).
Here we report the changes in mRNA profiles for E. coli cells harboring the
nusAll(ts) mutation as well as cells exposed to the DNA damaing agent nitrofurazone
(NFZ). Our analysis show that for either the nusAl] strains or wild-type E. coli exposed
to NFZ, the changes are mostly metabolic and have a significant amount of overlap.
These data imply that E. coli cells respond in a similar manner to either mutation of nusA
or to NFZ exposure. Furthermore, the SOS response is not induced under either of these
conditions. Together these data underscore the notion that the cellular response to DNA
damage is far more complex in even the well studied organism such as E. coli.
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RESULTS AND DISCUSSION
The essential transcription factor NusA, is a key component of all elongating
RNA polymerases, however our results suggests that NusA allows cells to cope with the
lethal effects of DNA damage. I have shown that at the permissive temperature,
nusAll(ts) mutants display the phenotype of chronic partial SOS induction, where
approximately 2.5% of the population are SOS induced (Chapter 4). This phenotype of
chronic partial SOS induction is often seen in strains carrying mutations of genes that are
involved in the processing of DNA (17). Furthermore, and increased number of RecA-
GFP foci in the nusAll mutant, at the permissive temperature, indicate an accumulation
ssDNA (Chapter 4). In an attempt to further elucidate the role for nusA+ in modulating
the cellular physiology after exposure to DNA damaging agents in E. coli, in
collaboration with Jim Collins at Boston University we examined the global effects of
wild-type or nusAll mutants exposed to nitrofurazone using microarray analysis. We
chose to look at nitrofurazone because, although the nusAll mutation has a broad effect
on cellular physiology even at the permissive temperature, the nusAll mutation is
specifically sensitive to the DNA damaging agents nitrofurazone (NFZ) and 4-
nitroquinolone- 1-oxide, which can form mostly covalet adducts on the N2 position of
guanine in addition to a variety of other DNA adducts (7).
To our surprise, we found that compared to a nusA+ isogenic parent the changes in
mRNA levels in the nusAl mutant did not include the SOS regulatory network but
rather included genes involved in metabolism (Table 1-2). These data suggested that
SOS induction in a small population of cells (2.5%) may not be enough to display an
effect as can be detected by microarray analysis. Strikingly, the global changes that
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occurred when wild-type (AB 157) cells were treated with nitrofurazone resembled those
in the nusA]] mutant (Table 3-4). Analysis of the mRNA profiles showed that under
these two conditions there was a significant amount of overlap with both genes that are
up-regulated (Figure 1A) as well as with genes that were down-regulated (Figure IB).
Analysis of the pathways that these genes are involved in revealed that most of the
pathways were involved in cellular metabolism (Table 5-8). The up-regulation of genes
involved in nitrate metabolism and assimilation, iron ion binding, and oxidoreductase
activity and the down-regulation of pathways including glyoxylate metabolism, aerobic
metabolism, and the TCA cycle, for example, were not what we would have expected for
a DNA damaging agent and mutation of gene involved in DNA repair/damage tolerance.
Though these results were initially surprising, especially for the DNA damaging
agent NFZ (24), work done on nitrofurazone and other nitrofurans in the 1970's
suggested a possible explanation. It had been reported that mutation frequency increases
when E. coli cells are treated with 240p1 M NFZ (1, 15), a much higher concentration than
was used for the microarray analysis (5pM). At the concentration used for mutagenesis
experiments, it was assumed that the SOS response was induced and error prone
mutagenesis can occur. We chose to use a lower dose of NFZ because cells carrying
mutations in DNA repair/damage tolerance pathways are sensitive to NFZ in the dose
range of 2-10pM NFZ. While these data may be specific to the conditions we tested, it is
curious to note that the cellular responses of both the nusAll mutation and exposure to
NFZ are similar. Moreover, there are not a lot of additional genes that are differentially
regulated when nusAll cells are treated with NFZ compared to untreated nusAll cells,
suggesting that the cells may have already been induced for a NFZ-like response.
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Taken together these data show that the cellular response to either mutation of
nusA (nusAl]) or exposure to the DNA damaging agent NFZ, are similar and involve
mostly metabolic processes. However, it is unclear as to what this could all mean. It is
possible that the nusA I mutant strains suffer from a higher amount of endogenous DNA
damage that resembles damage caused by nitrofurazone, or has difficulty dealing with
this endogenous DNA damage. The existence of a particular class of endogenously
generated N2-dG lesion, produced by metabolites of lipid peroxidation or the glycolysis
pathway (16, 25), which could be dealt with at the replication fork (bypassed by TLS
polymerases) but cause problems when transcription is attempted. This type of model
could explain why the changes in the nusAl] mutant resemble those of cells treated with
nitrofurazone. However, why is it that cells treated with nitrofurazone are not induced
for the SOS response? It is possible that there are two modes in which a cell can deal
with the effects of nitrofurazone, one that occurs at low doses (through metabolism) and
antoher at high doses (SOS induction). These data uncover the complexity of how cells
deal with DNA damage and/or mutation of nusA, and support the notion that a complete
understanding of the DNA damage response in E. coli and the SOS response is far from
complete.
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MATERIALS AND METHODS
Strains and Growth Conditions
All experiments were performed with ABI1157 derived strains (thr-1 leuB6proA2 hisG4
thil argE3 lacY1 galK2 ara-14 xyl-5 mtl-i tsx-33 rpsL31 supE44). Independent cultures
of AB 1157 (nusA+) or AB 1157 nusA ll zha0132::Tnl O (SEC164) were grown in Luria-
Bertani (LB) medium to saturation at 300C. Cultures were then diluted 1:1000 into fresh
LB medium with or without 1 g/mL (5 pM) nitrofurazone (stock solution made in N,N-
dimethylformamide) and were grown at 300 C for 6 hours.
Gene Expression Analysis
RNA samples were prepared from cultures treated as described above using an RNEasy
kit (QIAGEN) according to manufacturer's directions. Contaminating DNA was
removed by DNAase treatment (DNA free kit from Ambion). Microarray data collection
and analysis was performed as previously described (5, 11).
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Figure 1
WT vs. WT+Nfz
38
3
WT vs. WT+Nfz
vs. nusAll
WT vs. nusAll
Figure 1. Venn-diagrams show that there exist a significant overlap in induced changes
both in the up-regulation (A) and down-regulation (B). Genes that are either up-
regulated or down-regulated in the nusAll mutant compared to nusA+ are shown in black,
genes up or down-regulated in the wild-type treated with nitrofurazone compared to an
untreated control are shown in white, genes that overlap between these data sets are
shown in grey.
217
Table 1. Genes up-regulated in nusAll background
gene fold change p value Description
(nusA11/nusA') (up)
adhE 5.735108049 1.06E-06 enzyme; Energy metabolism, carbon: Fermentation;fused acetaldehyde-CoA dehydrogenase/iron-
dependent alcohol dehydrogenase/pyruvate-formate lyase deactivase;CoA-linked acetaldehyde
dehydrogenase and iron-dependent alcohol dehydrogenase; pyruvate-formate-ly
adiY 3.149172241 0.00046 putative regulator; Not classified;DNA-binding transcriptional activator;putative ARAC-type regulatory
protein
ahpF 2.596788171 5.83E-07 enzyme; Detoxification;alkyl hydroperoxide reductase, F52a subunit, FAD/NAD(P)-binding;alkyl
hydroperoxide reductase, F52a subunit; detoxification of hydroperoxides
cadB 3.473838458 0.00016 transport; Transport of small molecules: Amino acids, amines;predicted lysine/cadaverine
transporter;transport of lysine/cadaverine
caiF 2.226390514 0.00051 regulator; Central intermediary metabolism: Pool, multipurpose conversions;DNA-binding transcriptional
activator;transcriptional regulator of cai operon
cysG 2.361200141 4.21E-09 enzyme; Biosynthesis of cofactors, carriers: Heme, porphyrin;fused siroheme synthase 1,3-
dimethyluroporphyriongen III dehydrogenase and siroheme ferrochelatase/uroporphyrinogen
methyltransferase;uroporphyrinogen III methylase; sirohaeme biosynthesis
dcuB 1.925820624 0.0005 transport; Transport of small molecules: Carbohydrates, organic acids, alcohols;C4-dicarboxylate
antiporter;anaerobic dicarboxylate transport
dcuC 6.506081975 3.56E-10 transport; Transport of small molecules: Carbohydrates, organic acids, alcohols;anaerobic C4-
dicarboxylate transport;transport of dicarboxylates
dmsA 4.211071389 0.0001 enzyme; Energy metabolism, carbon: Anaerobic respiration;dimethyl sulfoxide reductase, anaerobic,
subunit A;anaerobic dimethyl sulfoxide reductase subunit A
dmsB 3.337174978 0.0019 enzyme; Energy metabolism, carbon: Anaerobic respiration;dimethyl sulfoxide reductase, anaerobic,
subunit B;anaerobic dimethyl sulfoxide reductase subunit B
dmsC 2.158540757 7.98E-05 enzyme; Energy metabolism, carbon: Anaerobic respiration;dimethyl sulfoxide reductase, anaerobic,
subunit C;anaerobic dimethyl sulfoxide reductase subunit C
Eno 3.376618838 1.97E-06 enzyme; Energy metabolism, carbon: Glycolysis;enolase
fdnG 2.370388721 0.00072 enzyme; Energy metabolism, carbon: Anaerobic respirationll.4.1 metabolism; energy
production/transport; electron donorll.3.7 metabolism; energy metabolism, carbon; anaerobic
respirationl7.1 location of gene products; cytoplasm;formate dehydrogenase-N, alp
fdnl 2.472314023 0.00011 enzyme; Energy metabolism, carbon: Anaerobic respiration;formate dehydrogenase-N, cytochrome B556
(gamma) subunit, nitrate-inducible;formate dehydrogenase-N, nitrate-inducible, cytochrome B556(Fdn)
gamma subunit
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fruA 3.200994061 6.17E-11 regulator; Degradation of small molecules: Carbon compounds;fused fructose-specific PTS enzymes:
II Bcomponent/llIIC components;PTS system, fructose-specific transport protein
fruB 4.076052593 1.42E-09 enzyme; Transport of small molecules: Carbohydrates, organic acids, alcohols;fused fructose-specific
PTS enzymes: IIA component/HPr component;PTS system, fructose-specific IIA/fpr component
fruK 4.08609855 2.8E-09 enzyme; Energy metabolism, carbon: Glycolysis;fructose-1 -phosphate kinase
glk 2.555277545 8.93E-06 enzyme; Degradation of small molecules: Carbon compounds;glucokinase
gpmM 8.394286284 1.31E-10 putative enzyme; Not classified;phosphoglycero mutase III, cofactor-independent;putative 2,3-
bisphosphoglycerate-independent phosphoglycerate mutase
hcp 4.231792827 2.18E-12 orf; Not classified;hybrid-cluster [4Fe-2S-20] protein in anaerobic terminal reductases
hypA 3.314238287 0.00036 phenotype; Energy metabolism, carbon: Anaerobic respiration;protein involved in nickel insertion into
hydrogenases 3;pleiotrophic effects on 3 hydrogenase isozymes
hypC 3.568366172 0.00012 phenotype; Energy metabolism, carbon: Anaerobic respiration;protein required for maturation of
hydrogenases 1 and 3;pleiotrophic effects on 3 hydrogenase isozymes
hypD 3.042116353 0.0004 phenotype; Energy metabolism, carbon: Anaerobic respiration;protein required for maturation of
hydrogenases;pleiotrophic effects on 3 hydrogenase isozymes
malF 5.138480014 1.86E-07 transport; Transport of small molecules: Carbohydrates, organic acids, alcohols;maltose transporter
subunit;part of maltose permease, periplasmic; membrane component of ABC superfamily
maIG 2.879537945 0.0009 transport; Transport of small molecules: Carbohydrates, organic acids, alcohols;maltose transporter
subunit;part of maltose permease, inner membrane; membrane component of ABC superfamily
maiM 5.099412342 6.75E-05 phenotype; Degradation of small molecules: Carbon compounds;maltose regulon periplasmic
protein;periplasmic protein of mal regulon
malP 4.817508905 0.00032 enzyme; Degradation of small molecules: Carbon compounds; maltodextrin phosphorylase
malQ 3.790749175 3.58E-06 enzyme; Degradation of polysaccharides;4-alpha-glucanotransferase (amylomaltase)
malS 1.919713033 6.72E-06 enzyme; Degradation of polysaccharides;alpha-amylase
mtlD 2.537978182 0.000457 enzyme; Degradation of small molecules: Carbon compounds;mannitol-1 -phosphate dehydrogenase,
NAD(P)-binding;mannitol-l -phosphate dehydrogenase
mtlR 2.359258771 7.24E-05 regulator; Degradation of small molecules: Carbon compounds;DNA-binding repressor;repressor for mtl
napB 3.820503195 8.06E-07 carrier; Energy metabolism, carbon: Electron transport;nitrate reductase, small, cytochrome C550
subunit, periplasmic;cytochrome c-type protein
napC 2.88821405 1.36E-06 putative enzyme; Energy metabolism, carbon: Electron transport;nitrate reductase, cytochrome c-type,
periplasmic;cytochrome c-type protein
napG 2.21680059 0.000219 carrier; Energy metabolism, carbon: Electron transport;ferredoxin-type protein essential for electron
transfer from ubiquinol to periplasmic nitrate reductase (NapAB);ferredoxin-type protein: electron transfer
napH 2.204583824 0.000159 carrier; Energy metabolism, carbon: Electron transport;ferredoxin-type protein essential for electron
transfer from ubiquinol to periplasmic nitrate reductase (NapAB);ferredoxin-type protein: electron transfer
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narG 14.97353203 2.41E-08 enzyme; Energy metabolism, carbon: Anaerobic respiration;nitrate reductase 1, alpha subunit;
narH 16.84230472 2.25E-12 enzyme; Energy metabolism, carbon: Anaerobic respiration;nitrate reductase 1, beta (Fe-S)
subunit;nitrate reductase 1, beta subunit
narl 3.207194837 5.33E-07 enzyme; Energy metabolism, carbon: Anaerobic respiration;nitrate reductase 1, gamma (cytochrome
b(NR)) subunit;nitrate reductase 1, cytochrome b(NR), gamma subunit
narJ 8.583132878 7.74E-13 enzyme; Energy metabolism, carbon: Anaerobic respiration;molybdenum-cofactor-assembly chaperone
subunit (delta subunit) of nitrate reductase 1 ;nitrate reductase 1, delta subunit, assembly function
narK 4.740064421 1.02E-05 transport; Transport of small molecules: Anions;nitrate/nitrite transporter;nitrite extrusion protein
narL 3.401172866 7.33E-06 regulator; Energy metabolism, carbon: Anaerobic respiration;DNA-binding response regulator in two-
component regulatory system with NarX (or NarQ);pleiotrophic regulation of anaerobic respiration:
response regulator for nar, frd, dms and tor genes
narX 1.916479634 0.00089 enzyme; Energy metabolism, carbon: Anaerobic respiration;sensory histidine kinase in two-component
regulatory system with NarL;nitrate/nitrate sensor, histidine protein kinase acts on NarL regulator
nikA 2.179043001 0.00058 transport; Transport of small molecules: Cations;nickel transporter subunit; periplasmic binding protein for
nickel; periplasmic-binding component of ABC superfamily
nirB 16.19808848 1.02E-11 enzyme; Energy metabolism, carbon: Anaerobic respiration;nitrite reductase, large subunit, NAD(P)H-
binding;nitrite reductase (NAD(P)H) subunit
nirC 5.33028005 1.92E-12 enzyme; Energy metabolism, carbon: Anaerobic respiration;nitrite transporter;nitrite reductase activity
nirD 7.007253066 1.56E-09 enzyme; Energy metabolism, carbon: Anaerobic respiration;nitrite reductase, NAD(P)H-binding, small
subunit;nitrite reductase (NAD(P)H) subunit
nrdD 3.403250469 1.33E-05 enzyme; 2'-Deoxyribonucleotide metabolism;anaerobic ribonucleoside-triphosphate reductase
nrdG 2.186385302 0.00015 enzyme; Central intermediary metabolism: Nucleotide interconversions;anaerobic ribonucleotide
reductase activating protein
nrfA 7.175334058 0 carrier; Energy metabolism, carbon: Electron transport;nitrite reductase, formate-dependent,
cytochrome;periplasmic cytochrome c(552): plays a role in nitrite reduction
nrfB 10.18408646 2.18E-14 enzyme; Energy metabolism, carbon: Anaerobic respiration;nitrite reductase, formate-dependent, penta-
heme cytochrome c;formate-dependent nitrite reductase; a penta-haeme cytochrome c
nrfC 5.57579299 0 enzyme; Energy metabolism, carbon: Anaerobic respiration;formate-dependent nitrite reductase, 4Fe4S
subunit;formate-dependent nitrite reductase; Fe-S centers
nrfD 2.611775694 3.36E-11 enzyme; Energy metabolism, carbon: Anaerobic respiration;formate-dependent nitrite reductase,
membrane subunit;formate-dependent nitrate reductase complex; transmembrane protein
nrfE 2.307190293 8.55E-12 enzyme; Energy metabolism, carbon: Anaerobic respiration;heme lyase (NrfEFG) for insertion of heme
into c552, subunit NrfE;formate-dependent nitrite reductase; possible assembly function
nrfF 2.119163157 1.62E-11 enzyme; Energy metabolism, carbon: Anaerobic respiration;heme lyase (NrfEFG) for insertion of heme
into c552, subunit NrfF;part of formate-dependent nitrite reductase complex
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ompX 2.8276378 8.2E-05 membrane; Outer membrane constituents;outer membrane protein;outer membrane protein X
pfkA 4.247727841 3.95E-10 enzyme; Energy metabolism, carbon: Glycolysis;6-phosphofructokinase I
rsuA 2.535220095 8.28E-06 enzyme; RNA synthesis, modification, DNA transcription;16S rRNA pseudouridylate 516 synthase;16S
pseudouridylate 516 synthase
speB 2.079383224 0.000196 enzyme; Central intermediary metabolism: Polyamine biosynthesis;agmatinase
tpiA 2.810790641 7.46E-05 enzyme; Energy metabolism, carbon: Glycolysis;triosephosphate isomerase
treC 7.560421492 9.51 E-05 enzyme; Degradation of small molecules: Carbon compounds;trehalose-6-P hydrolase;trehalase 6-P
hydrolase
ttdR 2.205861687 2.86E-07 putative regulator; Not classified;predicted DNA-binding transcriptional regulator;putative transcriptional
regulator LYSR-type
yagL 2.002763406 0.00094 phenotype; Not classified;CP4-6 prophage; DNA-binding protein;DNA-binding protein
yccM 2.592288583 9.65E-08 predicted 4Fe-4S membrane protein
ydhY 2.140839539 0.000836 putative enzyme; Not classified;predicted 4Fe-4S ferridoxin-type protein;putative oxidoreductase, Fe-S
subunit
yeeX 3.654682303 5.035E- phenotype; Not classified;conserved protein;putative alpha helix protein
05
yeiS 2.07610393 4.42E-05 predicted inner membrane protein
yeiT 2.046121289 0.00173 putative enzyme; Not classified;predicted oxidoreductase;putative oxidoreductase
yfbT 1.935859166 0.00016 putative enzyme; Not classified; predicted hydrolase or phosphatase; putative phosphatase
yfbU 2.612685249 0.0002 conserved protein
yfeX 2.423612973 0.00034 conserved protein
yhfL 2.238008734 8.8E-05 conserved secreted peptide
yjfW 2.252942771 1.5E-05 putative enzyme; Not classified;predicted pyruvate formate lyase activating enzyme;putative activating
enzyme
ysaA 2.070622658 0.00039 predicted hydrogenase, 4Fe-4S ferredoxin-type component
ytfE 3.99084155 8.4E-07 predicted regulator of cell morphogenesis and cell wall metabolism
zwf 2.193005353 0.000111 enzyme; Energy metabolism, carbon: Oxidative branch, pentose pathway;glucose-6-phosphate
dehydrogenase;
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Table 2. Genes down-regulated in nusA ll background
gene fold change p value Description
(nusAll/nusA') (down)
aceA 0.110595148 0.000459383 Enzyme; Central intermediary metabolism: Glyoxylate bypass;isocitrate lyase;
aceB 0.089286446 2.02405E-05 Enzyme; Central intermediary metabolism: Glyoxylate bypass;malate synthase A;
aceK 0.403636254 1.76342E-06 Enzyme; Central intermediary metabolism: Glyoxylate bypass;isocitrate dehydrogenase
kinase/phosphatase;
acnB 0.390477953 0.000481602 enzyme; Energy metabolism, carbon: TCA cycle;bifunctional aconitate hydratase 2/2-methylisocitrate
dehydratase;aconitate hydrase B
acs 0.140472179 1.13673E-06 Enzyme; Fatty acid and phosphatidic acid biosynthesis;acetyl-CoA synthetase;
actP 0.19209728 4.33943E-07 Electrochemical potential driven transporters; Porters (Uni-, Sym- and Antiporters); The
Solute:Sodium Symporter (SSS)
aer 0.34916447 8.25391E-05 regulator; Degradation of small molecules: Carbon compounds; motility (incl. chemotaxis,
energytaxis, aerotaxis, redoxtaxis); location of gene products; inner membrane
aldB 0.358437048 1.3429E-05 enzyme; Degradation of small molecules: Carbon compounds;aldehyde dehydrogenase B;aldehyde
dehydrogenase B (lactaldehyde dehydrogenase)
argT 0.182902834 5.6505E-05 transport; Transport of small molecules: Amino acids, amines;lysine/arginine/ornithine transporter
subunit;lysine-, arginine-, ornithine-binding periplasmic protein; periplasmic-binding component of
ABC superfamily
astA 0.34927033 0.00064757 arginine succinyltransferase
astB 0.293346632 3.52003E-05 succinylarginine dihydrolase
astD 0.378667279 0.000566122 Putative enzyme; Not classified;succinylglutamic semialdehyde dehydrogenase;
bax 0.442453475 0.000300443 orf; Not classified;conserved protein;putative ATP-binding protein
betA 0.554510109 0.000300744 Enzyme; Osmotic adaptation;choline dehydrogenase, a flavoprotein
betB 0.367049956 0.000695898 enzyme; Osmotic adaptation;betaine aldehyde dehydrogenase, NAD-dependent;NAD+-dependent
betaine aldehyde dehydrogenase
csiD 0.221475855 0.000197082 predicted protein
csiR 0.462104486 2.09504E-06 Putative regulator; Not classified;DNA-binding transcriptional dual regulator;putative transcriptional
regulator
cstA 0.119351147 2.8756E-09 phenotype; Global regulatory functions;carbon starvation protein;
cycA 0.360648168 1.76137E-07 transport; Transport of small molecules: Amino acids, amines;D-alanine/D-serine/glycine
transporter;transport of D-alanine, D-serine, and glycine
cyoA 0.267514748 0.000372546 Enzyme; Energy metabolism, carbon: Aerobic respiration;cytochrome o ubiquinol oxidase subunit II;
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cyoC 0.2828992 0.001226949 Enzyme; Energy metabolism, carbon: Aerobic respiration;cytochrome o ubiquinol oxidase subunit III;
cyoD 0.262441601 0.000757147 Enzyme; Energy metabolism, carbon: Aerobic respiration;cytochrome o ubiquinol oxidase subunit IV;
dctA 0.197320534 1.84937E-05 transport; Transport of small molecules: Carbohydrates, organic acids, alcohols;C4-dicarboxylic acid,
orotate and citrate transporter;uptake of C4-dicarboxylic acids
fadA 0.480167834 7.49294E-06 enzyme; Degradation of small molecules: Fatty acids;3-ketoacyl-CoA thiolase (thiolase 1);thiolase I; 3-
ketoacyl-CoA thiolase; acetyl-CoA transferase
fadB 0.360665167 1.40367E-05 enzyme; Degradation of small molecules: Fatty acids;fused 3-hydroxybutyryl-CoA
epimerase/delta(3)-cis-delta(2)-trans-enoyl-CoA isomerase/enoyl-CoA hydratase/3-hydroxyacyl-CoA
dehydrogenase;4-enzyme protein: 3-hydroxyacyl-CoA dehydrogenase; 3-hydroxybutyry
fimC 0.380000705 0.000894237 factor; Surface structures;chaperone, periplasmic;periplasmic chaperone, required for type 1 fimbriae
fimD 0.441438694 3.0633E-11 membrane; Outer membrane constituents;outer membrane usher protein, type 1 fimbrial
synthesis;outer membrane protein; export and assembly of type 1 fimbriae, interrupted
fimF 0.378665792 4.11158E-10 structural component; Surface structures;minor component of type 1 fimbriae;fimbrial morphology
fimG 0.404960004 3.42728E-09 structural component; Surface structures;minor component of type 1 fimbriae;fimbrial morphology
fimH 0.471194411 1.56479E-07 structural component; Surface structures;minor component of type 1 fimbriae;minor fimbrial subunit,
D-mannose specific adhesion
fiml 0.304366328 1.63941 E-05 structural component; Surface structures;fimbrial protein involved in type 1 pilus biosynthesis;fimbrial
protein
fumC 0.348283251 0.000110149 enzyme; Energy metabolism, carbon: TCA cycle;fumarate hydratase (fumarase C),aerobic Class
IIl;fumarase C= fumarate hydratase Class II; isozyme
gabD 0.134975082 2.45509E-09 enzyme; Central intermediary metabolism: Pool, multipurpose conversions;succinate-semialdehyde
dehydrogenase I, NADP-dependent;succinate-semialdehyde dehydrogenase, NADP-dependent
activity
gabP 0.206732913 6.63499E-10 transport; Transport of small molecules: Carbohydrates, organic acids, alcohols;gamma-
aminobutyrate transporter;transport permease protein of gamma-aminobutyrate
gabT 0.140903954 8.26911E-09 enzyme; Central intermediary metabolism: Pool, multipurpose conversions;4-aminobutyrate
aminotransferase, PLP-dependent;4-aminobutyrate aminotransferase activity
glcA 0.527723573 2.89262E-05 Putative transport; Not classified;glycolate transporter;putative permease
glcC 0.392796687 0.00067801 regulator; Degradation of small molecules: Carbon compounds;DNA-binding transcriptional dual
regulator, glycolate-binding;transcriptional activator for glc operon
glcD 0.225623618 1.32726E-07 enzyme; Degradation of small molecules: Carbon compounds;glycolate oxidase subunit, FAD-
linked;glycolate oxidase subunit D
glcF 0.209276613 9.66908E-10 enzyme; Central intermediary metabolism: Pool, multipurpose conversionsll.7.1 metabolism; central
intermediary metabolism; unassigned reversible reactions;glycolate oxidase iron-sulfur subunit;
gltA 0.250386092 0.000461589 Enzyme; Energy metabolism, carbon: TCA cycle;citrate synthase;
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gltl 0.279485692 0.000103931 putative transport; Not classified;glutamate and aspartate transporter subunit;periplasmic-binding
component of ABC superfamily
gltJ 0.601634415 0.001189155 transport; Transport of small molecules: Amino acids, amines;glutamate and aspartate transporter
subunit;glutamate/aspartate transport system permease; membrane component of ABC superfamily
gltK 0.421234644 5.25951 E-06 transport; Transport of small molecules: Amino acids, amines;glutamate and aspartate transporter
subunit;glutamate/aspartate transport system permease; membrane component of ABC superfamily
gltL 0.501808333 0.000131454 transport; Transport of small molecules: Amino acids, amines;glutamate and aspartate transporter
subunit;ATP-binding protein of glutamate/aspartate transport system
gudD 0.43271029 2.12847E-14 metabolism; carbon utilization; carbon compounds;(D)-glucarate dehydratase 1;(D)-glucarate
dehydratase 1 (L)-idarate dehydratase (L)-idarate epimerase (D)-glucarate epimerase
gudP 0.30503873 1.62807E-14 metabolism; carbon utilization; carbon compounds, transport; Electrochemical potential driven
transporters; Porters (Uni-, Sym- and Antiporters); The Major Facilitator Superfamily (MFS)
gudX 0.380512653 2.66966E-13 putative enzyme; Not classified; metabolism; carbon utilization; carbon compoundsll0 cryptic
genes;predicted glucarate dehydratase;putative (D)-glucarate dehydratase 2
iclR 0.279937047 8.36739E-12 regulator; Central intermediary metabolism: Glyoxylate bypass;DNA-binding transcriptional
repressor; repressor of aceBA operon
katG 0.45009299 5.80043E-06 Enzyme; Detoxification;catalase/hydroperoxidase HPl(l);catalase; hydroperoxidase HPI(I)
kgtP 0.311869059 0.000235894 transport; Transport of small molecules: Carbohydrates, organic acids, alcohols;alpha-ketoglutarate
transporter;alpha-ketoglutarate permease
maeB 0.412545171 7.85334E-05 putative enzyme; Not classified;fused malic enzyme predicted oxidoreductase/predicted
phosphotransacetylase; putative multimodular enzyme
me/A 0.195863707 2.00044E-08 enzyme; Degradation of small molecules: Carbon compounds;alpha-galactosidase, NAD(P)-
binding;alpha-galactosidase
melB 0.178412178 2.59135E-13 transport; Transport of small molecules: Carbohydrates, organic acids, alcohols;melibiose:sodium
symporter;melibiose permease II
mglB 0.115572629 1.57266E-05 transport; Transport of small molecules: Carbohydrates, organic acids, alcohols;methyl-galactoside
transporter subunit;galactose-binding transport protein; receptor for galactose taxis; periplasmic-
binding component of ABC superfamily
msrB 0.320055573 0.001398159 methionine sulfoxide reductase B
osmY 0.187566185 0.000381873 phenotype; Osmotic adaptation;periplasmic protein;hyperosmotically inducible periplasmic protein
paaA 0.280288087 6.64484E-11 predicted multicomponent oxygenase/reductase subunit for phenylacetic acid degradation
paaB 0.278280489 1.18474E-11 predicted multicomponent oxygenase/reductase subunit for phenylacetic acid degradation
paaC 0.234718425 1.14119E-12 predicted multicomponent oxygenase/reductase subunit for phenylacetic acid degradation
paaD 0.274807827 1.4343E-11 predicted multicomponent oxygenase/reductase subunit for phenylacetic acid degradation
paaE 0.355750577 1.07573E-10 putative enzyme; Not classified;predicted multicomponent oxygenase/reductase subunit for
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phenylacetic acid degradation;
paaF 0.371448988 1.15089E-07 Putative enzyme; Not classified;enoyl-CoA hydratase-isomerase;
paaG 0.304574346 1.86533E-13 Putative enzyme; Not classified;acyl-CoA hydratase;
paaH 0.426133783 1.12526E-06 Putative enzyme; Not classified;3-hydroxybutyryl-CoA dehydrogenase;
paal 0.355785018 2.32621E-08 predicted thioesterase
paaJ 0.490811968 0.00020562 Putative enzyme; Not classified;predicted beta-ketoadipyl CoA thiolase
paaK 0.49149955 0.000278699 phenylacetyl-CoA ligase
phoH 0.2625074 2.69858E-05 regulator; Central intermediary metabolism: Phosphorus compounds;conserved protein with
nucleoside triphosphate hydrolase domain;PhoB-dependent, ATP-binding pho regulon component;
may be helicase; induced by P starvation
psiF 0.341049251 0.001166297 phenotype; Central intermediary metabolism: Phosphorus compounds;conserved protein;induced by
phosphate starvation
putA 0.251873573 1.02918E-09 enzyme; Degradation of small molecules: Amino acids;fused DNA-binding transcriptional
regulator/proline dehydrogenase/pyrroline-5-carboxylate dehydrogenase;proline dehydrogenase,
P5C dehydrogenase
putP 0.238599512 2.14126E-09 transport; Transport of small molecules: Cations;proline:sodium symporter;major sodium/proline
symporter
puuA 0.43502021 0.000660315 Putative enzyme; Not classified;gamma-Glu-putrescine synthase;putative glutamine synthetase
puuB 0.523912456 0.000501581 Putative enzyme; Not classified;gamma-Glu-putrescine oxidase, FAD/NAD(P)-binding; probable
oxidoreductase
rsd 0.376519633 0.000127568 Putative regulator; Not classified;stationary phase protein, binds sigma 70 RNA polymerase subunit;
sdhA 0.194048161 9.1402E-05 Enzyme; Energy metabolism, carbon: TCA cycle;succinate dehydrogenase, flavoprotein subunit;
sdhB 0.2703314 0.000306873 enzyme; Energy metabolism, carbon: TCA cycle;succinate dehydrogenase, FeS subunit;succinate
dehydrogenase, iron sulfur protein
sdhC 0.107800093 0.000116112 enzyme; Energy metabolism, carbon: TCA cycle;succinate dehydrogenase, membrane subunit, binds
cytochrome b556;succinate dehydrogenase, cytochrome b556
sdhD 0.119944036 1.68936E-05 enzyme; Energy metabolism, carbon: TCA cycle;succinate dehydrogenase, membrane subunit, binds
cytochrome b556;succinate dehydrogenase, hydrophobic subunit
sthA 0.330950189 0.001185807 Putative enzyme; Not classified;pyridine nucleotide transhydrogenase, soluble;
trg 0.420885973 0.000604859 regulator; Chemotaxis and mobilityl3.1.3.3 regulation; type of regulation; posttranscriptional; inhibition
/ activation of enzymesl5.3 cell processes; motility (incl. chemotaxis, energytaxis, aerotaxis,
redoxtaxis)16.1 cell structure; membranel7.3 locatio
xylA 0.313659609 2.868E-09 Enzyme; Degradation of small molecules: Carbon compounds;D-xylose isomerase;
xylB 0.612513409 1.10237E-06 Enzyme; Degradation of small molecules: Carbon compounds;xylulokinase;
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xylE 0.42593957 5.87207E-08 transport; Transport of small molecules: Carbohydrates, organic acids, alcohols;D-xylose
transporter;xylose-proton symport
xylF 0.054094898 4.41422E-33 transport; Transport of small molecules: Carbohydrates, organic acids, alcohols;D-xylose transporter
subunit;xylose binding protein transport system; periplasmic-binding component of ABC superfamily
xylG 0.211959079 5.05658E-21 putative transport; Not classified;fused D-xylose transporter subunits of ABC superfamily: ATP-
binding components;putative ATP-binding protein of xylose transport system
xylH 0.372509468 2.39477E-13 putative transport; Not classified;D-xylose transporter subunit;putative xylose transport, membrane
component; membrane component of ABC superfamily
yagG 0.283705233 6.74303E-18 Putative transport; Not classified;CP4-6 prophage; predicted sugar transporter; putative permease
yagH 0.41380969 2.2821E-11 Putative enzyme; Not classified;CP4-6 prophage; predicted xylosidase/arabinosidase;putative beta-
xylosidase
ybdD 0.194482287 6.94258E-09 conserved protein
ycgF 0.363185288 1.77842 E-05 predicted FAD-binding phosphodiesterase
ydcV 0.351223594 7.65526E-05 putative transport; Not classified;predicted spermidine/putrescine transporter subunit;membrane
component of ABC superfamily
ydcW 0.372058917 6.14181E-05 Putative enzyme; Not classified;medium chain aldehyde dehydrogenase;putative aldehyde
dehydrogenase
yeaC 0.271203744 0.00036309 conserved protein
yeaH 0.299470542 0.001314735 conserved protein
ygaF 0.166971371 1.15205E-05 predicted enzyme
ygeW 0.446157295 3.28832E-11 Putative enzyme; Not classified;conserved protein;putative carbamoyl transferase
yicl 0.440291531 5.34762E-10 predicted alpha-glucosidase;
yjcH 0.09130251 3.24052E-07 conserved inner membrane protein involved in acetate transport;
ylaC 0.350253086 0.000529873 predicted inner membrane protein;
ytfQ 0.254173642 1.78428E-05 putative regulator; Not classified;predicted sugar transporter subunit: periplasmic-binding component
of ABC superfamily; putative LACI-type transcriptional regulator
ytfR 0.528872794 5.02833E-06 putative transport; Not classifiedl4.3.A.1.a transport; Primary Active Transporters; Pyrophosphate
Bond (ATP, GTP, P2) Hydrolysis-driven Active Transporters; The ATP-binding Cassette (ABC)
Superfamily + ABC-type Uptake Permeases; ABC superfamily ATP bindi
ytfT 0.597638502 1.20382E-05 putative transport; Not classified;predicted sugar transporter subunit: membrane component of ABC
superfamily; putative transport system permease protein
ytjA 0.184682661 5.39328E-05 predicted protein
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Table 3. Genes up-regulated by nitrofurazone treatment
gene fold change p value Description
([wt +nfz]/wt) (up)
adhE 4.179370 5.186E- enzyme; Energy metabolism, carbon: Fermentation;fused acetaldehyde-CoA dehydrogenase/iron-dependent
05 alcohol dehydrogenase/pyruvate-formate lyase deactivase;CoA-linked acetaldehyde dehydrogenase and
iron-dependent alcohol dehydrogenase; pyruvate-formate-ly
cadB 4.322040 1.248E- transport; Transport of small molecules: Amino acids, amines;predicted lysine/cadaverine
05 transporter;transport of lysine/cadaverine
dcuB 2.830658 1E-07 transport; Transport of small molecules: Carbohydrates, organic acids, alcohols;C4-dicarboxylate
antiporter;anaerobic dicarboxylate transport
focA 4.459106 1.93E-06 putative transport; Degradation of small molecules: Carbon compounds;formate transporter; probable formate
transporter (formate channel 1)
fruA 3.00309 5.93E-10 regulator; Degradation of small molecules: Carbon compounds;fused fructose-specific PTS enzymes:
I IBcomponent/lIC components;PTS system, fructose-specific transport protein
fruB 4.198856 6.571E- enzyme; Transport of small molecules: Carbohydrates, organic acids, alcohols;fused fructose-specific PTS
10 enzymes: IIA component/HPr component;PTS system, fructose-specific IIA/fpr component
fruK 4.023795 4.195E- enzyme; Energy metabolism, carbon: Glycolysis;fructose-1-phosphate kinase
09
glk 2.159431 0.00021 enzyme; Degradation of small molecules: Carbon compounds;glucokinase
gpmM 8.579813 8.59E-11 putative enzyme; Not classified;phosphoglycero mutase III, cofactor-independent; putative 2,3-
bisphosphoglycerate-independent phosphoglycerate mutase
hcp 2.307125 2.99E-05 orf; Not classified;hybrid-cluster [4Fe-2S-20] protein in anaerobic terminal reductases
hypA 3.38108 0.00029 phenotype; Energy metabolism, carbon: Anaerobic respiration;protein involved in nickel insertion into
hydrogenases 3;pleiotrophic effects on 3 hydrogenase isozymes
hypC 3.89353 4.47E-05 phenotype; Energy metabolism, carbon: Anaerobic respiration;protein required for maturation of
hydrogenases 1 and 3;pleiotrophic effects on 3 hydrogenase isozymes
hypD 3.347746 0.00013 phenotype; Energy metabolism, carbon: Anaerobic respiration;protein required for maturation of
hydrogenases;pleiotrophic effects on 3 hydrogenase isozymes
malF 6.300699 5.45E-09 transport; Transport of small molecules: Carbohydrates, organic acids, alcohols;maltose transporter
subunit;part of maltose permease, periplasmic; membrane component of ABC superfamily
malG 3.890495 3.087E- transport; Transport of small molecules: Carbohydrates, organic acids, alcohols;maltose transporter
05 subunit;part of maltose permease, inner membrane; membrane component of ABC superfamily
malK 19.08041 6.63E-07 transport; Transport of small molecules: Carbohydrates, organic acids, alcohols;fused maltose transport
subunit, ATP-binding component of ABC superfamily/regulatory protein;ATP-binding component of transport
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system for maltose
maiM 6.69887 4.17E-06 phenotype; Degradation of small molecules: Carbon compounds;maltose regulon periplasmic
protein;periplasmic protein of mal regulon
malP 5.25455 0.00015 enzyme; Degradation of small molecules: Carbon compounds;maltodextrin phosphorylase;
malQ 3.96927 1.71E-06 enzyme; Degradation of polysaccharides;4-alpha-glucanotransferase (amylomaltase);
malS 3.11986 1.55E-14 enzyme; Degradation of polysaccharides;alpha-amylase;
mt/R 2.38399 6E-05 regulator; Degradation of small molecules: Carbon compounds;DNA-binding repressor;repressor for mtl
narH 5.22495 2.54E-05 enzyme; Energy metabolism, carbon: Anaerobic respiration;nitrate reductase 1, beta (Fe-S) subunit;nitrate
reductase 1, beta subunit
nirB 10.1864 1.16E-08 enzyme; Energy metabolism, carbon: Anaerobic respiration;nitrite reductase, large subunit, NAD(P)H-
binding;nitrite reductase (NAD(P)H) subunit
nirC 2.93892 3.86E-06 enzyme; Energy metabolism, carbon: Anaerobic respiration;nitrite transporter;nitrite reductase activity
nirD 4.04102 1.07E-05 enzyme; Energy metabolism, carbon: Anaerobic respiration;nitrite reductase, NAD(P)H-binding, small
subunit;nitrite reductase (NAD(P)H) subunit
nrfA 3.51683 5.3E-08 carrier; Energy metabolism, carbon: Electron transport;nitrite reductase, formate-dependent,
cytochrome;periplasmic cytochrome c(552): plays a role in nitrite reduction
nrfB 5.11644 5.46E-08 enzyme; Energy metabolism, carbon: Anaerobic respiration;nitrite reductase, formate-dependent, penta-heme
cytochrome c;formate-dependent nitrite reductase; a penta-haeme cytochrome c
nrfC 3.05401 6.59E-10 enzyme; Energy metabolism, carbon: Anaerobic respiration;formate-dependent nitrite reductase, 4Fe4S
subunit;formate-dependent nitrite reductase; Fe-S centers
pfkA 4.22563 4.55E-10 enzyme; Energy metabolism, carbon: Glycolysis;6-phosphofructokinase
ravA 2.77391 1.32E-06 putative regulator; Not classified;fused predicted transcriptional regulator: sigma54 activator
protein/conserved protein;putative 2-component regulator
tff 2.568639 0.00012 Novel sRNA, function unknown;identified in a large scale screen; function unknown
treC 7.28554 0.000124 enzyme; Degradation of small molecules: Carbon compounds;trehalose-6-P hydrolase;trehalase 6-P
hydrolase
yccM 2.235655 5.48E-06 predicted 4Fe-4S membrane protein
ydhY 2.236260 0.00044 putative enzyme; Not classified;predicted 4Fe-4S ferridoxin-type protein;putative oxidoreductase, Fe-S
subunit
yjiA 2.192145 0.00032 predicted GTPase
yjiX 3.117484 3.38E-06 conserved protein
yjiY 6.189454 3.87E-05 orf; Not classified;predicted inner membrane protein;putative carbon starvation protein
y#W 2.2473185 1.65E-05 putative enzyme; Not classified;predicted pyruvate formate lyase activating enzyme;putative activating
enzyme
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Table 4. Genes down-regulated by nitrofurazone treatment
fold p value Description
change (down)
([wt
+nfz]/wt)
aceB 0.159 gene enzyme; Central intermediary metabolism: Glyoxylate bypass;malate synthase A
aceK 0.4650 4.54E-05 enzyme; Central intermediary metabolism: Glyoxylate bypass;isocitrate dehydrogenase kinase/phosphatase;
acnB 0.34382 8.92E-05 enzyme; Energy metabolism, carbon: TCA cycle;bifunctional aconitate hydratase 2/2-methylisocitrate
dehydratase;aconitate hydrase B
acs 0.2044 6.5E-05 enzyme; Fatty acid and phosphatidic acid biosynthesis;acetyl-CoA synthetase
actP 0.232 6.75E-06 4.2.A.21 transport; Electrochemical potential driven transporters; Porters (Uni-, Sym- and Antiporters); The
Solute:Sodium Symporter (SSS) Family6.1 cell structure; membranel7.3 location of gene products; inner
membrane;acetate transporter
aldB 0.4183 0.000180 enzyme; Degradation of small molecules: Carbon compounds;aldehyde dehydrogenase B;aldehyde
dehydrogenase B (lactaldehyde dehydrogenase)
csiR 0.4356 3.63917E- putative regulator; Not classified;DNA-binding transcriptional dual regulator;putative transcriptional regulator
07
cstA 0.209 9.20E-06 phenotype; Global regulatory functions;carbon starvation protein;
cycA 0.398 2.12E-06 transport; Transport of small molecules: Amino acids, amines;D-alanine/D-serine/glycine transporter;transport of
D-alanine, D-serine, and glycine
fadA 0.4899 1.27E-05 enzyme; Degradation of small molecules: Fatty acids;3-ketoacyl-CoA thiolase (thiolase I);thiolase I; 3-ketoacyl-
CoA thiolase; acetyl-CoA transferase
fumC 0.329 5.07E-05 enzyme; Energy metabolism, carbon: TCA cycle;fumarate hydratase (fumarase C),aerobic Class IIl;fumarase C=
fumarate hydratase Class II; isozyme
gabD 0.175 1.93E-07 enzyme; Central intermediary metabolism: Pool, multipurpose conversions;succinate-semialdehyde
dehydrogenase I, NADP-dependent;succinate-semialdehyde dehydrogenase, NADP-dependent activity
gabP 0.223 4.22E-09 transport; Transport of small molecules: Carbohydrates, organic acids, alcohols;gamma-aminobutyrate
transporter;transport permease protein of gamma-aminobutyrate
gabT 0.174 2.45E-07 enzyme; Central intermediary metabolism: Pool, multipurpose conversions;4-aminobutyrate aminotransferase,
PLP-dependent;4-aminobutyrate aminotransferase activity
garK 0.282 2.45E-09 carbon utilization; carbon compounds;glycerate kinase
garL 0.2595 2.68E-05 carbon utilization; carbon compounds;alpha-dehydro-beta-deoxy-D-glucarate aldolase
garP 0.302 2.50E-05 carbon utilization; carbon compounds; Electrochemical potential driven transporters; Porters (Uni-, Sym- and
Antiporters); The Major Facilitator Superfamily (MFS)
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garR 0.22 2.64E-08 carbon utilization; carbon compounds; central intermediary metabolism; glycolate metabolism;tartronate
semialdehyde reductase;tartronate semialdehyde reductase (TSAR)
glcA 0.313 1.53E-13 putative transport; Not classified;glycolate transporter;putative permease
glcB 0.0691 1.05E-17 enzyme; Central intermediary metabolism: Glyoxylate bypass;malate synthase G
glcC 0.471 0.004974 regulator; Degradation of small molecules: Carbon compounds;DNA-binding transcriptional dual regulator,
glycolate-binding;transcriptional activator for glc operon
glcD 0.112 2.03E-14 enzyme; Degradation of small molecules: Carbon compounds;glycolate oxidase subunit, FAD-linked;glycolate
oxidase subunit D
glcF 0.122 4.03E-16 enzyme; Central intermediary metabolism: Pool, multipurpose conversions; central intermediary metabolism;
unassigned reversible reactions;glycolate oxidase iron-sulfur subunit
glcG 0.126 2.86E-14 conserved protein
glnH 0.294 0.000966 transport; Transport of small molecules: Amino acids, amines;glutamine transporter subunit;periplasmic
glutamine-binding protein; permease
gltl 0.302 0.00025 putative transport; Not classified;glutamate and aspartate transporter subunit;periplasmic-binding component of
ABC superfamily
gltJ 0.576 0.000489 transport; Transport of small molecules: Amino acids, amines;glutamate and aspartate transporter
subunit;glutamate/aspartate transport system permease; membrane component of ABC superfamily
gltK 0.445 1.87E-05 transport; Transport of small molecules: Amino acids, amines;glutamate and aspartate transporter
subunit;glutamate/aspartate transport system permease; membrane component of ABC superfamily
gudD 0.371 2.35E-19 carbon utilization; carbon compounds;(D)-glucarate dehydratase 1;(D)-glucarate dehydratase 1 (L)-idarate
dehydratase (L)-idarate epimerase (D)-glucarate epimerase
gudP 0.298 5.51E-15 carbon utilization; Electrochemical potential driven transporters; Porters (Uni-, Sym- and Antiporters); The Major
Facilitator Superfamily (MFS)
gudX 0.397 2.826E-12 putative enzyme; putative (D)-glucarate dehydratase 2
iclR 0.264 9.52E-13 regulator; Central intermediary metabolism: Glyoxylate bypass;DNA-binding transcriptional repressor;repressor of
aceBA operon
katG 0.419 9.08E-07 enzyme; Detoxification;catalase/hydroperoxidase HPl(l);catalase; hydroperoxidase HPI(I)
melA 0.384 0.000641 enzyme; Degradation of small molecules: Carbon compounds;alpha-galactosidase, NAD(P)-binding;alpha-
galactosidase
melB 0.347 4.74E-06 transport; Transport of small molecules: Carbohydrates, organic acids, alcohols;melibiose:sodium
symporter;melibiose permease II
mg/B 0.163 0.00023 transport; Transport of small molecules: Carbohydrates, organic acids, alcohols;methyl-galactoside transporter
subunit;galactose-binding transport protein; receptor for galactose taxis; periplasmic-binding component of ABC
superfamily
paaA 0.372 2.97E-07 predicted multicomponent oxygenase/reductase subunit for phenylacetic acid degradation
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paaB 0.351 2.27E-08 predicted multicomponent oxygenase/reductase subunit for phenylacetic acid degradation
paaC 0.310 7.25E-09 predicted multicomponent oxygenase/reductase subunit for phenylacetic acid degradation
paaD 0.353 4.22E-08 predicted multicomponent oxygenase/reductase subunit for phenylacetic acid degradation
paaE 0.398 8.024E-09 putative enzyme; Not classified;predicted multicomponent oxygenase/reductase subunit for phenylacetic acid
degradation
paaF 0.435 7.17E-06 putative enzyme; Not classified;enoyl-CoA hydratase-isomerase
paaG 0.356 1.52E-10 putative enzyme; Not classified;acyl-CoA hydratase
paaH 0.418 7.009E-07 putative enzyme; Not classified;3-hydroxybutyryl-CoA dehydrogenase
paal 0.371 8.27E-08 predicted thioesterase
paaJ 0.494 0.000239 putative enzyme; Not classified;predicted beta-ketoadipyl CoA thiolase
phoH 0.298 0.000132 regulator; Central intermediary metabolism: Phosphorus compounds;conserved protein with nucleoside
triphosphate hydrolase domain;PhoB-dependent, ATP-binding pho regulon component; may be helicase; induced
by P starvation
putA 0.266 4.59E-09 enzyme; Degradation of small molecules: Amino acids;fused DNA-binding transcriptional regulator/proline
dehydrogenase/pyrroline-5-carboxylate dehydrogenase;proline dehydrogenase, P5C dehydrogenase
putP 0.277 7.416E-08 transport; Transport of small molecules: Cations;proline:sodium symporter;major sodium/proline symporter
rsd 0.387 0.000192 putative regulator; Not classified;stationary phase protein, binds sigma 70 RNA polymerase subunit;
xylF 0.310 8.748E-07 transport; Transport of small molecules: Carbohydrates, organic acids, alcohols;D-xylose transporter
subunit;xylose binding protein transport system; periplasmic-binding component of ABC superfamily
yagG 0.394 1.396E-10 putative transport; Not classified;CP4-6 prophage; predicted sugar transporter;putative permease
yagH 0.495 7.726E-08 putative enzyme; Not classified;CP4-6 prophage; predicted xylosidase/arabinosidase;putative beta-xylosidase
ybdD 0.246 6.187E-07 conserved protein
ycgF 0.441 0.00042 predicted FAD-binding phosphodiesterase
ydcV 0.408 0.00059 putative transport; Not classified; predicted spermidine/putrescine transporter subunit;membrane component of
ABC superfamily
ydcW 0.428 0.00050 putative enzyme; Not classified;medium chain aldehyde dehydrogenase; putative aldehyde dehydrogenase
ygaF 0.234 0.000297 predicted enzyme
yqiJ 0.509 1.707E-05 putative enzyme; Not classified;predicted inner membrane protein;putative oxidoreductase
ytfQ 0.238 7.485E-06 putative regulator; Not classified;predicted sugar transporter subunit: periplasmic-binding component of ABC
superfamily; putative LACI-type transcriptional regulator
ytfR 0.4915 4.258E-07 putative transport; Not classifiedl4.3.A.1.a transport; Primary Active Transporters; Pyrophosphate Bond (ATP,
GTP, P2) Hydrolysis-driven Active Transporters; The ATP-binding Cassette (ABC) Superfamily + ABC-type
Uptake Permeases; ABC superfamily ATP
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Table 7. Pathways up-regulated in a nusA 1] background
Pathway genes in pathway
nitrate metabolism narK, nirD, narG, narH, nirB, nirC, narJ, narl, narX, narL
nitrate assimilation narK, nirD, narG, narH, nirB, nirC, narJ, narl, narX, narL
iron ion binding yjjW, hcp, narG, ydhY, ysaA, narH, nirB, narl, hcr, fdnG, nrfB, nrfC, napG, nrfA, napB, fdnl, napH, dmsA,
yccM, adhE, napC, nrdG, nrfF
generation of precursor yjjW, hcp, narG, ydhY, ysaA, narH, nirB, ahpF, narJ, narl, hcr, fdnG, nrfB, pfkA, napG, tpiA, nrfC, napB, nrfA,
metabolites and energy fdnl, dmsC, napH, yccM, dmsA, glk, treC, eno, napC
cation binding malS, hcp, zraS, yegX, nrdD, nikA, malQ, maIZ, nrfB, napG, napH, yccM, dmsA, hypA, adhE, nrdG, yjjW,
narG, narH, ysaA, ydhY, nirB, hcr, narl, fdnG, nrfC, nrfA, napB, fdnl, speB, treC, napC, nrfF
oxidoreductase activity, acting on Hcp, narJ, nirD, narl, nrfA, narG, narH, nirB
other nitrogenous compounds as
donors
ion binding malS, hcp, hypD, zraS, yegX, nrdD, nikA, malQ, maIZ, nrfB, pfkA, napG, napH, yccM, dmsA, hypA, adhE,
eno, nrdG, yjjW, narG, ydhY, narH, ysaA, nirB, hcr, narl, fdnG, nrfC, nrfA, napB, fdnl, speB, treC, napC, nrfF
electron transport yjjW, hcp, narG, ydhY, ysaA, narH, nirB, ahpF, narJ, narl, hcr, fdnG, nrfB, nrfC, napG, nrfA, napB, fdnl,
dmsC, napH, dmsA, yccM, napC
oxidoreductase activity yjjW, hcp, narG, ydhY, ysaA, narH, nrdD, nirB, ahpF, narJ, narl, hcr, fdnG, cysG, zwf, nrfC, napG, nirD, nrfA,
fdnl, dmsC, napH, dmsA, yccM, mtlD, ygfF, adhE, nrdG
iron-sulfur cluster binding yjjW, hcp, napG, nrfC, narG, ydhY, ysaA, narH, napH, yccM, nirB, dmsA, hcr, fdnG, nrdG
metal cluster binding yjjW, hcp, napG, nrfC, narG, ydhY, ysaA, narH, napH, yccM, nirB, dmsA, hcr, fdnG, nrdG
transition metal ion binding yjjW, hcp, narG, ydhY, ysaA, narH, zraS, nrdD, nirB, nikA, narl, hcr, fdnG, nrfB, napG, nrfC, napB, nrfA, fdnl,
napH, yccM, dmsA, speB, adhE, hypA, napC, nrdG, nrfF
metal ion binding yjjW, malS, hcp, narG, hypD, ydhY, ysaA, narH, zraS, nrdD, nirB, nikA, narl, hcr, fdnG, nrfB, pfkA, napG,
nrfC, napB, nrfA, fdnl, napH, yccM, dmsA, speB, adhE, hypA, eno, napC, nrdG, nrfF
4 iron, 4 sulfur cluster binding yjjW, napG, nrfC, narG, ydhY, ysaA, narH, napH, yccM, dmsA, fdnG, nrdG
nitrate reductase complex narJ, narl, narG, narH
nitrate reductase activity narJ, narl, narG, narH
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Table 8. Pathways down-regulated in a nusAll background
pathway genes in pathway
acetyl-CoA metabolism aceB, aceK, acs, aceA, acnB, fumC, sdhB, gltA, sdhD, sdhA, sdhC
tricarboxylic acid cycle aceB, aceK, aceA, acnB, fumC, sdhB, gltA, sdhD, sdhA, sdhC
coenzyme catabolism aceB, aceK, aceA, acnB, fumC, sdhB, gltA, sdhD, sdhA, sdhC
acetyl-CoA catabolism aceB, aceK, aceA, acnB, fumC, sdhB, gltA, sdhD, sdhA, sdhC
Cofactor catabolism aceB, aceK, aceA, acnB, fumC, sdhB, gltA, sdhD, sdhA, sdhC
aerobic respiration aceB, aceK, aceA, acnB, fumC, sdhB, gitA, sdhD, sdhA, sdhC
catabolism bax, aceK, yagH, astB, aceA, sdhB, fadB, sdhD, gltA, xylA, aceB, astA, fadA, paaJ, acnB, astC, fumC, astD, putA,
sdhA, sdhC, allA, katG
cellular catabolism bax, aceK, yagH, astB, aceA, sdhB, fadB, sdhD, gltA, xylA, aceB, astA, paaJ, acnB, astC, fumC, astD, putA, sdhA,
sdhC, al/A, katG
cellular respiration aceB, aceK, aceA, acnB, fumC, sdhB, g/tA, sdhD, sdhA, sdhC
main pathways of aceB, aceK, maeB, aceA, acnB, melA, fumC, sdhB, sdhD, g/tA, iclR, xylA, sdhA, sdhC
carbohydrate metabolism
energy derivation by aceB, aceK, maeB, aceA, acnB, melA, fumC, sdhB, sdhD, g/tA, iclR, xylA, sdhA, sdhC
oxidation of organic
compounds
generation of precursor aceK, maeB, fadH, aceA, ygaF, sdhB, betA, sdhD, gltA, xylA, g/cF, aceB, cyoA, cyoD, trxC, g/cD, acnB, melA, fumC,
metabolites and energy paaE, ygfK, iclR, sthA, cyoC, sdhA, puuB, katG, sdhC
glutamine family amino astD, astA, putA, astB, astC
acid catabolism
arginine catabolism to astD, astA, astB, astC
glutamate
glyoxylate cycle aceB, aceK, iclR, aceA
glutamate metabolism astD, astA, putA, astB, astC
symporter activity dctA, putP, xylE, actP, kgtP, yicJ, melB, yagG
carboxylic acid metabolism aceK, maeB, betB, astB, acs, aceA, fadB, betA, ygeW, paaF, puuA, gabT, asnA, aceB, paaH, fadA, astA, paaJ, astC,
fumC, astD, putA, iclR, paaG
organic acid metabolism aceK, maeB, betB, astB, acs, aceA, fadB, betA, ygeW, paaF, puuA, gabT, asnA, aceB, paaH, fadA, astA, paaJ, astC,
fumC, astD, putA, iclR, paaG
coenzyme metabolism aceB, aceK, acs, aceA, acnB, fumC, sdhB, sdhD, gltA, sthA, xylA, sdhA, sdhC
oxidoreductase activity msrB, aidB, maeB, betB, fadH, ygaF, gabD, sdhB, fadB, beta, g/cF, ydcW, paaH, cyoA, cyoD, trxC, g/cD, melA, astD,
233
paaE, putA, ygfK, sthA, cyoC, sdhA, puuB, katG, sdhC
transport yejE, ytfR, cycA, kgtP, sdhB, ydcV, g/tJ, ytfT, ugpE, sdhD, xylF, garP, ytfQ, cyoA, cyoD, yejF, paaE, sdhA, mg/B,
sdhC, putP, g/tK, actP, gudP, yjfF, gltl, ugpB, xylE, melB, g/cF, ugpC, gabP, yicJ, trxC, xylG, yhhJ, yagG, dctA, cyoC,
xy/H, fimD, g/tL, argT
Arginine catabolism astD, astA, astB, astC
amino acid catabolism astD, astA, putA, astB, astC
amine catabolism astD, astA, putA, astB, astC
nitrogen compound astD, astA, putA, astB, astC
catabolism
glyoxylate metabolism aceB, aceK, iclR, aceA
enoyl-CoA hydratase fadB, paaF, paaG
activity
localization yejE, ytfR, cycA, kgtP, sdhB, ydcV, g/tJ, ytfT, ugpE, sdhD, xylF, garP, ytfQ, cyoA, cyoD, yejF, paaE, sdhA, mglB,
sdhC, putP, g/tK, actP, gudP, yjfF, gltl, ugpB, xylE, melB, g/cF, ugpC, gabP, yicJ, trxC, xylG, yhhJ, yagG, dctA, cyoC,
xylH, fimD, g/tL, argT
establishment of yejE, ytfR, cycA, kgtP, sdhB, ydcV, g/tJ, ytfT, ugpE, sdhD, xylF, garP, ytfQ, cyoA, cyoD, yejF, paaE, sdhA, mg/B,
localization sdhC, putP, g/tK, actP, gudP, yjfF, gl/t/, ugpB, xylE, melB, glcF, ugpC, gabP, yicJ, trxC, xylG, yhhJ, yagG, dctA, cyoC,
xy/H, fimD, g/tL, argT
Table 9. Pathways up-regulated by nitrofurazone treatment
Pathway genes in pathway
nitrate metabolism nirC, narJ, nirD, narH, nirB
nitrate assimilation nirC, narJ, nirD, narH, nirB
generation of precursor metabolites and energy yjjW, nrfC, hcp, nrfA, narH, ydhY, nirB, yccM, narJ, treC, g/k, nrfB, pfkA
oxidoreductase activity, acting on other nitrogenous hcp, narJ, nirD, nrfA, narH, nirB
compounds as donors
iron ion binding yjjW, nrfC, hcp, nrfA, narH, ydhY, nirB, yccM, adhE, nrfB, nrfF
nitrite reductase [NAD(P)H] activity nirD, nirB
phosphofructokinase activity fruK, pfkA
oxidoreductase activity, acting on other nitrogenous nirD, nirB
compounds as donors, with NAD or NADP as acceptor
234
Table 10. Pathways down-regulated by nitrofurazone treatment
pathway genes in pathway
glyoxylate metabolism aceB, g/cB, garR, aceK, iclR
aldehyde metabolism aceB, g/cB, garR, aceK, iclR
glyoxylate cycle aceB, g/cB, aceK, iclR
acetyl-CoA metabolism aceB, g/cB, aceK, acs, acnB, fumC
organic acid metabolism aceK, astB, acs, garK, betA, ygeW, paaF, gabT, asnA, paaH, aceB, garR, fadA, paaJ, fumC, g/cB, putA, paaG,
iclR
catabolism aceB, garR, fadA, aceK, yagH, paaJ, astB, acnB, fumC, glcB, putA, aliA, katG
carboxylic acid metabolism aceK, astB, acs, betA, ygeW, paaF, gabT, asnA, paaH, aceB, garR, fadA, paaJ, fumC, g/cB, putA, paaG, iclR
tricarboxylic acid cycle aceB, g/cB, aceK, acnB, fumC
coenzyme catabolism aceB, g/cB, aceK, acnB, fumC
acetyl-CoA catabolism aceB, g/cB, aceK, acnB, fumC
cofactor catabolism aceB, glcB, aceK, acnB, fumC
amino acid transporter activity gabP, gltl, g/tJ, putP, g/tK, cycA, g/nH, g/tL
amino acid transport gabP, gltl, g/tJ, putP, g/tK, cycA, glnH, g/tL
aerobic respiration aceB, g/cB, aceK, acnB, fumC
cellular catabolism aceB, garR, aceK, yagH, paaJ, astB, acnB, fumC, g/cB, putA, al/A, katG
amine transporter activity gabP, gltl, gltJ, putP, g/tK, cycA, g/nH, gltL
amine transport gabP, gltl, gltJ, putP, g/tK, cycA, g/nH, g/tL
main pathways of carbohydrate aceB, garR, aceK, acnB, melA, fumC, g/cB, iclR
metabolism
organic acid transporter activity gabP, putP, g/tK, cycA, actP, g/tJ, gltl, g/nH, g/tL
carboxylic acid transporter gabP, putP, g/tK, cycA, actP, g/tJ, gltl, g/nH, g/tL
activity
physiological process fadH, gabD, ydcV, yggG, phoH, xylF, garP, asnA, garR, gudX, g/cD, paaE, rsd, mglB, cdaR, actP, yjfF, astB,
gltl, ugpB, g/cF, ugpC, gabP, gudD, ulaC, yagG, yhhJ, yicl, paaG, xy/H, ytfR, aceK, cycA, acs, betT, g/tJ, ytfT,
betA, garK, paaF, ytfQ, paaJ, cstA, g/nH, allA, xylB, putP, g/tK, aldB, yagH, gudP, ygaF, ygeW, melB, ydcW,
gabT, paaH, aceB, fadA, recD, garL, melA, acnB, fumC, g/cB, putA, iclR, g/tL, katG
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